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Abstract
Cardiovascular disease is the major cause of morbidity and mortality, and
is preceded by chronic irregular blood flow. The resulting pathogenesis re-
cruit a platform of molecules, which require the reshuffle of the omnipresent
cytoskeleton.
Utilizing novel techniques including microfluidics and flexible membranes
we subject both endothelial and smooth muscle cells to specific shear stress
and cyclic strain. We then endeavor to understand the functions, signaling
mechanisms and cytoskeletal dynamics that involve moesin. We also try to
expand the nascent knowledge of microRNA regulation here.
The work show global regulation of major facets of mechanotransduction
(including proliferation, endothelial microparticle release, realignment), bymi-
croRNAs. Aswell, an array ofmicroRNAs is found sensitive to shear stress and
cyclic strain. Furthermore, expression pattern of these microRNAs are profiled.
Actin binding ERM protein moesin meanwhile, is seen as an important
modulator of mechanotransduction regulated by microRNA and Rho A. In
contrast to ERMprotein ezrin, moesinwe find is sensitive tomechanotransduc-
tion, and is atheroprotective buffering endothelial microparticle release, while
subtly sensitive to thrombosis and haemostasis. The spatial and temporal dy-
namics of moesin, studied with mechanotransduction, demonstrates its key
role, regulated by RGD-sensitive integrins.
Urokinase is known to effect the endothelial cells with cyclic strain and
injury. We find novel interaction of urokinase, requiring similar biochemical
change off moesin utilized during mechanotransduction. We delineate the dif-
ferent transducers including FPRL1, αVβ3 / α5β. Moesin under these trans-
ducers is critically involved in chemotaxis, angiogenesis and endothelial bar-
rier integrity. Moesin thus we discover is indispensable towards the normal
functioning of the vasculature.
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Chapter 1
Introduction
1.1 Pathogenesis of the Vascular system
Introduction to a thesis in vascular biology, usually starts by appreciating, how
deadly pathogenesis of the cardiovascular system can be. These stem from
certain other facts, which needs to be appreciated more.
1. Unhealthy diet
2. Physical inactivity
3. Tobacco use
4. Weight
Commonly referred to as modifiable facors, these contribute to 80% of deaths
due to cardiovacular diseases (CVD). This is no small factor, when according to
theWorld Health Organisation (WHO), CVD is the number one cause of global
deaths http : //www.who.int/topics/cardiovasculardiseases/en/.
The above list chronically leads to intermediate risk factors which are raised
blood pressure, raised blood glucose, raised blood lipids and obesity. Research
into the pathogenesis of the cardiovascular system is the only check point that
could challenge the projected 20 million deaths by 2015 due to CVD (Van Gaal
1
et al., 2006; Coca et al., 2008; Forman and Bulwer, 2006; Sniderman and Furberg,
2008)(Van Gaal et al., 2006)
The human circulatory system sustained by current medical advances, is a
system run beyond its evolved capacity. The blood vessels and heart are con-
stantly challenged by obesity, diabetes and chronic smoking. Meanwhile we
are living ever longer. Age alone outweighs all the other modifiable factors in
its ability to increase risk (Sniderman and Furberg, 2008). Classing it as a mod-
ifiable factor is currently beyond technological capability, as we can’t actually
modify it. Hundred years ago human beings didn’t have the lifespan we en-
joy. Rapid advance in research, has led to our ability to counter considerably at
a medical level. Age related concerns though, need a different perspective of
technology. Stem cell derived artificial vessels, might be in the right direction.
Stem cells, have been found to utilize mechanotransduction towards differen-
tiating as vascular cells. Studies into stem cell derived grafts, also find flow
to be an indispensable requirement for graft retention (McIlhenny et al., 2009;
North et al., 2009; Stolberg and McCloskey, 2009).
Body was not evolved to meet age related challenges it is presented with.
Considering these factors, it has to be appreciated this feat of engineering, that
is able to self-maintain, grow and adapt to its environment is truly remark-
able. Vascular vessels are not simply inert plumbing that delivers blood, but
rather is a dynamic organ. It has the ability to remodel and transform itself to
a changing environment. Over long periods of time, conduit vessels will re-
model considerably, according to the needs of a particular agonist. This is the
means by which pathogenesis takes hold, after exposure to modifiable factors
over a lifetime (Martinez-Lemus et al., 2009).
2
1.1.1 Vasculature
Figure 1.1: Cross Section of the Vasculature
The figure shows diagrammatic representation of an artery and vein, showing
different layers of the vessel. Note that the innermost layer is the endothelial
cell, which is a contact inhibited confluent monolayer of cells (Fox, 2002).
1.1.2 Endothelium
The first line of cells (Figure 1.1), the endothelium, is unique in its ability to
sense blood flow, which results in many different stimuli being constantly re-
layed to it (Rizzo, 2009). Derived from hemangioblasts, they maintain “re-
gional specialisation” dependent on the local needs. During pathogenesis,
3
there occurs activation of endothelium by tumour necrosis factor-α (TNF-α)
and othermolecules, resulting in inflammation that counter pathogenesis (Rask-
Madsen and King, 2007; Koh, 2008; Kubo et al., 2005).
As the role of the endothelium goes, it is primarily a component of the
vasculature, in direct contact with blood while surrounded by smooth mus-
cle cells, connective tissue (elastic and collagen fibers) and extracellular matrix
(ECM). It is non-thrombogenic in nature andwith the help of thrombomudulin,
tissue factor pathway inhibitor (TFPI), protein C, heparin sulphate proteogly-
cans (HSPG) it promotes fibrinolysis. It is also involved in the production of
prostacyclin, nitric oxide (NO), tissue-type plasminogen activator (tPA), uroki-
nase (uPA) and CD39 and inhibits platelet aggregation and clotting cascade
activation. It exists as a quiescent monolayer (Rask-Madsen and King, 2007;
Koh, 2008).
Endothelial cells signaling mechanisms constantly strive to achieve home-
ostasis rapidly in case of injury or trauma. With respect to flow, it clearly aligns
in the direction of blood flow (Goldfinger et al., 2008). Any disturbances in flow,
clearly disrupts the brushed alignment in the direction of flow. This is also
true with respect to studies that interfere with signaling pathways, that mould
the cells to align in this way. Actin and associated cytoskeletal proteins play
pivotal role towards this (Chien, 2008; Vartanian et al., 2008). Release of pro-
thrombotic factors including Von Willebrand Factor (vWF) with trauma is a
prelude to achieving homeostasis (Jacquemin, 2009; Oliveira et al., 2008). There
are other evidences in the literature that show vWF release withmechanotrans-
duction (Kearney et al., 2008). Weibel-palade bodies store and secrete vWF (von
Willebrand factor) in endothelial cells (Rondaij et al., 2008; Huang et al., 2008).
Endothelial cells also maintain a selective barrier to the onslaught of vari-
ous factors from blood especially, when lining organs. Endothelium controls
the selective permeability of water and solutes. The barrier/permeability spe-
cializes according to the needs of the cell, and thus is strictly dependent on
where the endothelial cells line. The endothelium is found to maintain a strict
barrier between the blood and brain (Weksler et al., 2005; Janzer and Raff, 1987).
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Glomerulus in the kidney is another areawhere endotheliummaintains a selec-
tive barrier (Satchell and Braet, 2009). Integrin αvβ3 is found to be a modulator
of endothelial barrier properties. Which of course recruit cytoskeletal adapter
molecules, that mould the cells for this specialisation. These are examples of
”regional specialisation” that endothelium undergoe dependent on the organ’s
need (Li et al., 2008).
Endotheliumdependent vasodilation is an atheroprotectivemechanism that
induce synthesis of nitric oxide (NO) and prostacyclin (Davignon and Ganz,
2004;Mitchell et al., 2008). Endothelial cells also derive endothelin-1, angiotensin
II, platelet derived growth factor (PDGF). Uniform linear laminar flow of blood
and physiological cyclic strain is another atheroprotectivemeasure. Pathogenic
hemodynamic flow conditions, will alert by downstream signaling the cells to
adapt and alleviate the circumstances. Normal physiological haemodynamic
flow results in NO and prostacyclin production. Transforming growth factor
(TGF)-β (transforming growth factor), is also induced by laminar shear stress
which counter inflammation (Libby et al., 2002; Koh, 2008).
Endothelial cells, due their contact with blood is in direct contact with
leukocytes. During inflammation and attack by pathogens, leukocytes are at-
tracted by endothelial cells by presentation of its inflammatory status. These
chemotactic and adhesivemolecules, help leukocytesmaintain a selective bind-
ing capability on endothelial cells (Vestweber, 2007; Baluk et al., 2007). A key
player in this are the polysaccharide glycosaminoglycans, in the form of pro-
teoglycans. Cell adhesion molecules such as selectins (P-selectins, E-selectin)
and immunoglobulin superfamilies (ICAM-1, PECAM-1) have roles in the leuko-
cyte interaction. Its important to be selective in endothelial cell’s stickiness to
leukocytes, while still maintaining blood flow (Ley et al., 2007; Woodfin et al.,
2009). This is to maintain them in circulation, which is controlled by endothe-
lium. This is significant, as chronic activation of endothelium at certain sites
lead to future plaques focussed to these areas. Without finite regulatory mech-
anisms in place, the flow of blood would be impeded constantly ending in
premature death (Koh, 2008; Vestweber, 2007; Baluk et al., 2007).
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Remodeling
Chronic inflammatory stimuli, will lead to the remodeling of the vasculature.
Dependent on the stimuli, endothelial cells mediate the adaptive response.
Non-uniform blood flow is consistently found to be the major factor. Chronic
hypoxia is also an usual suspect that induce remodeling (Chiang et al., 2009b;
Laughlin and Roseguini, 2008; Hahn and Schwartz, 2009). This remodeling
obviously starts a genetic program ending in expression of pro-angiogenic fac-
tors. Recently deceased distinguished scientist, Judah Folkman first to describe
angiogenesis and its uncontrollable continuous growth in tumours. He sug-
gested inhibition of angiogeneis to contain tumour growth. This has since been
used starve tumour and is a promising method to combat cancer (Koh, 2008;
Folkman, 2006, 2007). Clinical trials of various drugs are underway that target
angiogenesis in this manner (Crawford and Ferrara, 2009; Giaccone and van
Cruijsen, 2009; Giraudo and Hanahan, 2009).
Angiogenesis
During angiogenesis, vascular endothelial growth factor (VEGF), PDGF, basic
fribroblast growth factor (bFGF) are produced. This is regulated by utilizing
negative factors such as angiostatin and TGF-β. Also involved is uPA, ma-
trix metalloproteases (MMPs), plasminogen activator-inhibitor (PAI-1), tissue
inhibitors of MMPs which digests the basement membrane and extracellular
matrix (Lac, 2007; Neal et al., 2006; Goh et al., 2007; Shetty and Idell, 2007; Wong
et al., 2009). This paves the road forward by digestion, allowing new vessels to
sprout. Endothelial cells also regulate vascular tone and compliance, primarily
in response to blood flow (Reneman et al., 2006; Birukov, 2009b). Cyclic strain
and shear stress signaling mechanisms also thus feed into angiogenesis (Von
Offenberg Sweeney et al., 2005; Gee et al., 2009).
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1.1.3 Vascular Smooth Muscle cells
Vascular smooth muscle cells (VSMCs) (Figure 1.1), are elongated and bipolar.
They are pluripotent and retain their plasticity, which is dependent on environ-
mental cues. They play roles in contraction, owing to actin-myosin fibers an-
chored to dense bodies. They also have roles in immune regulation, laying the
matrix and in cytokine production (Ruan et al., 2006; Newby, 2006; Clempus
and Griendling, 2006). They are normally arranged in palisading rows, that
are part of tunica media (Figure 1.1). In pathogenic conditions with vascular
injury, they can be exposed to the neo-intima. They exist in higly differentiated
state, while retaining the ability to migrate. Contrasting studies exist regard-
ing their proliferation, though cyclic strain has been shown to regulate VSCM’s
proliferation (Rudijanto, 2007; Birukov, 2009b)
Normally, VSMCs sense haemodynamic force of shear stress by means of
paracrine signaling. This is mediated by endothelial cells, which in turn di-
rectly sense shear stress. Vascular smooth muscle cells, also generate increased
microparticles in response to diseased conditions (Ess, 2005). These signals,
also translate in endothelial cells due to the close proximity to VSMCs. VSMCs
meanwhile, are able to directly sense circumferential strain due to blood flow.
In an injured artery, such as after balloon angioplastywhen endothelial cells are
scraped exposing smooth muscle cells, VSMCs are able to directly sense shear
stress (Fitzgerald et al., 2008; Haga et al., 2007). Their characteristic response
to stretch is to produce vasoconstrictors and growth factors. With stretch they
also regulate ion-channels and signaling enzymes. It regulates the membrane
potential (Em) to four ions K+,Cl-, Na+ and Ca2+ (Haga et al., 2007). Cell-cell
and ECM-cell, paracrine interactions all feed into VSMC behaviour. In conclu-
sion VSMCsmaintain vascular tone and drives vascular remodeling (O’Rourke
et al., 2006; Haga et al., 2007)
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1.1.4 Flow of blood
Haemodynamic forces, result from the flow of blood, a primary reason, for
which the circulatory system evolved. There is the circumferential wall tension,
originating from the blood pressure. There is also the force of shear stress,
resulting from friction due to the blood dragging on the endothelium.
At the macro level, flow plays an essential role and is not a waste of energy
due to friction. The circulatory system utilises friction and flow. Flowmediated
friction is used to sense underlying problems, bymeans of various receptors on
the endothelial cells. At the micro level, this information is processed into well
established signaling pathways. When there are disturbances in flow of blood,
these signaling mechanisms adapt to alleviate flow abnormalities (Hahn and
Schwartz, 2009). With chronic pathogenesis, these mechanisms even lead to
remodeling of the system. The end goal of which, is to maintain continuous
supply of oxygen and nutrients throughout the body (O’Rourke et al., 2006;
Haga et al., 2007; Hahn and Schwartz, 2009).
Figure 1.2: Chronic non-uniform flow and its effects
The effects of chronic dysfunctional flow, over time in contrast to normal lami-
nar flow.
(Hahn and Schwartz, 2009)
Current knowledge about flow of blood suggests intervention in term of
good diet and excersice at an early age. Even a moderate level of excersice has
shown to increase the NO and prostacyclin at areas prone to fatty streak de-
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position (thus prone to plaque formation) (Belardinelli et al., 2006). These are
areas where non-laminar flow, low flow and sometimes oscillatory flow exists.
These turbulent flow patterns are usually realized in points of branching (con-
vex areas of branching) (Hahn and Schwartz, 2009). Over time dysfunctional
hemodynamic forces, cause vasculature to remodel and cause it to become dis-
eased (Figure 1.2). These fatty streaks are usually the map of areas prone to
future artherosclerotic beginnings (Figure 1.3) (Koh, 2008).
Figure 1.3: Fatty streak prone to future atherosclerosis
The map of fatty streak in endothelial cells, which is where, future atheroscle-
rotic beginnings occur with dysfucntional flow. Raised lesions later develop,
in same areas catalysed by modifiable factors and non-uniform flow. Fatty
streaks are stained in red with Oil Red-O for lipids, of a young male who died
of accidental cause.
(Koh, 2008)
It is hopeful, to note that atherosclerosis is reversible, if the modifiable fac-
tors are regulated early. Scientists are increasingly of the consensus, that mod-
ifiable factors need to addressed at an early stage of life, such as childhood.
Data gathered over decades, has led to this insight. (Helen H. Hobbs plenary
lecture oral communication, ISTH 2009).
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1.2 Molecular Players
The different signals percieved by the endothelium, with regard to flow and
other biochemical factors, are in turn controlled by intricate molecular mech-
anisms. These classically start from the genes to the removal of the protein.
Increasingly research has found diversions in any of these steps. Thus under-
standing in detail the molecular players, help to understand the complexities
of pathogenesis.
1.2.1 Rho GTPases
GTPases switch back and forth between two forms. The active form is guanine
tri-phosphate (GTP) bound, while the inactive form is guanine di-phophate
(GDP) bound. The shuttle between these forms are controlled by guanine nu-
cleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and gua-
nine nucleotide dissociation inhibitors (GDIs). This is a set of three proteins
whose brief function is listed below (Figure 1.4) (Etienne-Manneville and Hall,
2002).
1. GEFs: Encourage the binding of GTP and dissociating the GDP from Rho
and thus activating in its role. (Rossman et al., 2005)
2. GAPs: Increases the intrinsic GTPase activity of Rho protein, which in
turn inactivates the Rho GTPase (Etienne-Manneville and Hall, 2002).
3. GDI: As the name suggests it inhibits the dissociation, whereby the GDP
form of Rho is kept locked from dissociating. They, as well are able to
bind to C-terminal prenyl groups on some Rho proteins. This sequesters
them in the cytoplasm away from their regulators holding them in an
inactive form (DerMardirossian and Bokoch, 2005).
Rho GTPases number around 20, and are members of the Ras superfam-
ily of small G proteins. Their name Rho, is an abbreviation of Ras homologs.
The regulators of the Rho GTPases number in hundreds, thus enabling one to
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Figure 1.4: Rho cycling between GTP and GDP stages
The roles of GEFs, GAPS and GDI are shown in context of Rho cycling between
GTP and GDP stages.
appreciate the permutation and combination in which these interactions exists
and is controlled. Rho GTPases were discoverd in early 1990s, as important
regulators of the cytoskeleton. Since then, its role in many other areas are in-
creasingly appreciated. It has such diverse roles, some of which are in gene
regulation, cell cycle progression, blood pressure, platelet activation, wound
healing, cell adhesion, cell migration, barrier regulation and leukocyte extrava-
sation (Etienne-Manneville and Hall, 2002; Hall, 2005).
In simplified terms, there exists three classes, which is also highly con-
served between different organisms. These are Rho, Rac and CDC42 with dif-
ferential role on actin control. The explosion in discovery, has also led to some
newmembers, which include the atypical Rho. They are not regulated by GEFs
or GAPs, instead regulated by phosphorylation states, genetic expression, pro-
tein stability such as Rnd proteins, RhoH and CDC42 homologue1 (WRCH1),
also known as RhoU. Due to their atypical regulatory system, they came to
be called the atypical Rho GTPases. Including these, there exists a total of six
groups. These are Rho, Rac, Cdc42, Rnd, RhoD and TTF encompassing their
own members (Jaffe and Hall, 2005; Chardin, 2006).
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The well characterized three classes include Rho (RhoA, RhoB, and RhoC),
Rac (Rac1, Rac2, and Rac3, which is also known as Rac1B [RhoG]), Cdc42
(Cdc42Hs, Chp, G25K, and TC10). Rho is involved in the formation of stress
fibers, Rac regulates lamellipodia formation and CDC42 caters to filopodia
moulding. Specific inhibitor of all three isoforms of Rho, clostridial enzyme C3
transferase has been an invaluable tool in our understanding of Rho signaling.
The inhibitor is substantially more potent towards Rho (Novakofski et al., 2009;
Kumar and Lassar, 2009). All three are implicated with integrin signaling, and
thus in focal adhesion formation and matrix adhesion. Rho, infact induces the
formation of focal adhesion (Wennerberg and Der, 2004; Etienne-Manneville
and Hall, 2002; Hall, 2005).
Rnd proteins, the member of the atypical Rho GTPases are very similar to
RhoA. Due to their lack of GTPase activity, they are constitutively in the active
state. The name Rnd stands for round, and thats what it does when Rnd is
overexpressed (Chardin, 2006). It rounds cells, acting antagonistically to Rho
and Rac.
This is very interesting, as their expression state determines their activity,
with possible routes for microRNA based control as well. Generally, activ-
ity of Rho proteins is regulated by cytokine activity and hence its receptors,
G-coupled receptors, tyrosine kinases or via adhesion and integrin clustering
(Etienne-Manneville and Hall, 2002; Hall, 2005). Rho GTPases are also known
to be post translationally modified. This results in specific sub-cellular local-
ization (Rho et al., 2009). There are also, well knownmechanisms of microRNA
regulation such as p250GAP which is a direct target of miR132 (Wayman et al.,
2008).
1.2.2 The control of actin
The cytoskeleton’s main component is actin. It is an omnipresent protein, that
senses all mechanical load and capable to convey mechanical energy. Actin is
indeed, very important structural component of the cytoskeleton. Actin, also
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has many binding partners. It is such a molecule, that it requires an ability to
be regulated with plasticity and reversibility, which in fact is specific to its role.
Functionally, it is involved in almost everything, in line with its omnipresence.
Some examples include endocytosis, pathogenic entry, any sort of movement,
cyclic strain, shear stress in endothelial cells, woundhealing, entry or exit of
cargo from cells (Kaksonen et al., 2006; Burkhardt et al., 2008; Wang and Tham-
patty, 2006).
Actin changes from the globular (G) actin to filamentous (F) actin; G-actin to
F-actin. In the filamentous form it is of a flat conformation, which encourages
the subnunits to adhere, forming a helix (Heinrichs, 2009). Actin meshwork, is
anchored to the extracellular matrix by means of different transmebrane pro-
teins, such as integrins. Integrin adhere to extracellular matrix, which itself is
a dynamic process, which will be discussed later in the section covering with
integrins. Integrin clustering, leads to focal complexes. This in turn recruits a
functional platform of kinases and phosphatases. These include integrin bind-
ing proteins and other scaffolding proteins. Kinases such as focal adhesion
kinase (FAK) are involved in this process, further leading to focal adhesions
(Le Clainche and Carlier, 2008).
Actin polymerisation actually generates mechanical energy, as Brownian-
ratchet models prove (Kaksonen et al., 2006). Polymerisation also leads to
activation of the ATPase function of actin. The change from G-actin to F-
actin, brings closer the crucial Gln137 residue in the ATPase region and the γ-
phosphate together. This might allow the bound ATP to be hydrolysed (Hein-
richs, 2009).
The scaffolding proteins involved in the cytoskeleton, can harness this me-
chanical force, generated by the Arp 2/3 activation/inhibition as the polymeri-
sation /de-polymerisation occurs. A defining functional example would be
during migration. The nucleation by Arp 2/3 complex is rate limiting and
N-WASP and cortactin activate Arp 2/3 (Kaksonen et al., 2006). Meanwhile,
integrins are controlled from the inside, commonly referred to as “inside out
signaling”. There also exist outside in signaling, whereby cues from the out-
13
Figure 1.5: Actin and Force Generation
The various steps resulting in the generation of force via actin
(Geiger et al., 2009)
side is transduced to the inside. Actin remains sensitive to these signals, and
moulds the cell according to the force requirement. The inside out signaling is
catalysed by disocciation of complexes between GTP-bound Rho-GTPases and
Rho- GDI. This extends the membrane, by the release of active Cdc42 and Rac1
(Del Pozo et al., 2002).
This actin machinery is conserved across eukaryotes. So is most of the
machinery between functions, such as endocytosis, lamellapodia formation,
motility of cells (Kaksonen et al., 2006). The lipids such as phosphatidylinositol
4,5-bisphosphate (PIP2) are also important.
Pipmodulins are another class of molecules that are a group of proteins
called “GMC” proteins, that include GAP43, MARCKS and CAP23. They regu-
late actin by controlling the local availablity of PIP2. This is because many actin
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binding proteins bind to PIP2. PIP2, by binding to GMCproteins, is sequestered
inhibiting its function. When PKC activate GMC proteins by phosphorylation,
it releases these groups of PIP2 (Figure 1.6). The binding to calmoudin (CaM),
also release PIP2. There are other feedback loops that can stimulate production
of PIP2. This free PIP2, by binding to actin binding proteins of which moesin
is a member, stabilises them. The binding domain is the pleckstrin homology
(PH) domain, of which another example is talin, moesin.
This spur in PIP2 production is another controller of actin dynamics (Fig-
ure 1.6) (Laux et al., 2000; Lanier and Gertler, 2000).
Figure 1.6: PIP2 signaling and actin
PIP2 dynamics feed into actin machinery, with implications in various func-
tions such as cell motility, endocytosis, possibly in microparticle forma-
tion. The figure was taken from (Lanier and Gertler, 2000), but contextually
changed.
The integrins meanwhile are able to control a multitude of proteins, that
link to the actin and regulate it. This includes FERMdomain containing protein
talin and moesin, integrin linked kinase (ILK) via α-parvin and β-parvin. α-
actinin with and without vinculin also link integrins to actin. Vinculin can also
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associate with talin. Talin is controlled by PIP2 like moesin. By binding to PIP2,
talin increases association with integrins. Like moesin, specific localization of
talin near membrane depends on PIP2 binding (Martel et al., 2001).
There are many other molecules involved, such as formin-1 that nucleate
actin linearly, while arp 2/3 is acutally for branched actin filaments (Figure 1.7).
Ena/Vasp Proteins encourage continued elongation of existing filaments.
Figure 1.7: Regulation of actin Top(1):- The steps involved in cyclic barbed
end branching. This involves binding to the verprolin-cofilin-acidic (VCA) do-
main of WASP/N-WASP (or WAVE isoforms) by the barbed end of the mother
actin filament. Bottom(2):- Side branching model. Arp 2/3 is activated by the
COOH-terminal domain of WASP/N-WASP (or WAVE isoforms), which binds
to the side of an actin filament. Figure was taken from (Le Clainche and Carlier,
2008)
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This is due to its prevention of binding of capping proteins, by binding to
the quickly growing barbed ends (Barzik et al., 2005). There are other trans-
membrane receptors, such as cadherins, ICAMs which connect to actin, via
molecules such as α-actinin.
It is not only vinculin or α-actinin, but many other adapters swarm here,
such as zyxin, extracellular signal-regulated kinase 1/2 (Erk1/2), mitogen-
activated protein/extracellular signal-regulated kinase kinase 1 (MEKK1), pro-
tein kinase N (PKN) and the p85 subunit of phosphatidylinositol- 3 kinase (PI3-
K). FAK actually inhibits α-actinin binding to actin by phosphorylation. Inte-
grins also bind to filamin which enable orthogonal linkage to actin networks.
This also works in parallel. Integrins stimulate signaling to actin eg: via FAK
and Src-like kinases. This complex choreography of molecules thus regulate
and is controlled by actin (Brakebusch and FaÈssler, 2003).
1.2.3 Thrombin
Thrombin is a key enzyme of the blood coagulation system. This serine pro-
tease of the trypsin family, is also a key player in inflammation. Inflamma-
tion is a neccessary response of the body to regain homeostasis (Medzhitov,
2008). Underlying hyperlipidemia is cited to cause atherogenesis. Research
has meanwhile shown skewed mechanical stimuli and inflammation causing
hyperlipidemia. This chronically in concert with other factors lead upto athero-
genesis (Libby et al., 2002).
Thrombin is a 36 kDa molecule formed when the zymogen prothrombin is
cleaved, by a prothrombinase complex. It is well characterized for its roles in
fibrinolysis, tissue repair, blood coagulation and wound healing. As well, it is
involved in platelet and endothelial cell activation and the progression of neo-
plasia. Protease activated receptors (PARs) are thrombin receptors and PAR1,
PAR3, PAR4 are the receptors for thrombin. PAR receptor, is a G-protein and
is expressed in endothelium as well as in other cells (Mann, 2003). PAR1 is the
major mediator of thrombin, in inflammatory responses. This receptor, is acti-
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vated with cleavage by thrombin. This is unlike receptors of factor Xa, protein
C, and urokinase, that need not be cleaved for their downstream processing
(Strukova, 2001; Mann, 2003). As well, it dilates the vasculature, by releasing
NO which is mediated by PAR1 (Motley et al., 2007). This results in increased
vascular permeability which leads to edema (Laposata et al., 1983). Vascular
injury furthers thrombi formation. This is enhanced in instances of oscillatory
and low flow. Arthereosclerotic plaque formed by chronic hyperlipidemia, de-
posits lipids and lipid-laden macrophages (foam cells) which can then rupture
(Figure 1.8). The shedding of granules by platelets further to their accumula-
tion, ultimately leads to thrombus incorporating fibrin.
Figure 1.8: Thrombosis of the Artery and the Vein
A) Representation of various factors leading upto arterial thrombosis. B) Rep-
resentation of various factors leading upto venous thrombosis.
(Mackman, 2008).
Chemotaxis, is induced on monocytes and neutrophils by thrombin, from
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the endothelium (Zimmerman et al., 1985). This also increases the inflmma-
tory response, inducing intercellular gap formation (Mann, 2003). Thrombin is
also expressed highly in platelets, and is a major activator of the same (Leger
et al., 2006; Crawley et al., 2007). Chemokines, such as platelet activating factor
(PAF) via PAR1 are generated by thrombin. This encourages further inflamma-
troy response, inducing previously stated chemotaxis (Mann, 2003). Thrombin
induces angiogenesis by activating VEGF. This is achieved by increasing the
receptors for VEGF (Tsopanoglou and Maragoudakis, 1999).
Cytoskeletal proteins are rapidly recruited downstream of thrombin. The
proteins, thus associated with thrombin, needs the required sensitivity. Moesin
has been shown to associate dynamically with platelet cytoskeleton, within, a
minute of thrombin addition. This response is due to moesin phosphorylating
transiently, reaching basal levels soon after (Shcherbina et al., 1999b). Though
often associated as a pro-inflammatorymolecule, physiologically thrombin acts
to restore homeostasis (Strukova, 2001). Recruitment of other cells to the area
of inflammation, is a step towards this repair process. Integrins such as αMβ2
(Mac1 or CD 11b/CD 18), are expressed downstream of thrombin exposure,
on activated monocytes (Flick et al., 2004). Thrombin, thus enables exposure of
various adhesion molecules in various cells, including endothelium.
Thrombin is a mutifaceted molecule with sometimes contrasting roles, in-
ducing vasoconstriction by release of endothelin-1 (Marasciulo et al., 2006).
Thrombin also induce microparticle release (Simoncini et al., 2009). The group,
had previously shown thrombin to generate microparticle by ROCKII, acti-
vated in turn by caspase-2 (Sapet et al., 2006). These molecules also regulate
various cytoskeletal molecules, unravelling of which would be of interest. For
instance, there still doesn’t exist any drug that can prevent coagulation without
promoting bleeding.
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1.3 Integrins and the vascular cells
The cell needs molecules that communicate and interact at various levels, thus
sensing their outside and inside environment at the same time. This helps
the cell to regulate its growth efficiently and safely. Integrins (Figure 1.9) are
proteins, that provide such a requirement for the cells.
Figure 1.9: Basic Structure of Integrin Heterodimer
Over view of the basic structure of integrin heterodimer. A cell surface recep-
tor. http : //www.chemie.tu− darmstadt.de/bt/Endothel.html
1.3.1 Integrins
Integrins aremainly involved in forming specialised complex structures, termed
focal contacts or focal adhesions. These are formed between the cell and ex-
tracellular complexes (ECM) (Jockusch et al., 1995). Studies in this field, has
shown very clearly that cell adhesion complexes are not simply "static architec-
tural entities", but offers a more dynamic integrating system capable of control-
ling and regulating a range of cellular functions (Inoue et al., 1977). In the pro-
cess it interacts with various signaling molecules, the understanding of which
is important.
Integrins exist as heterodimers of an α and a β subunit. More than 24 dif-
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ferent types of integrins are formed by the association of 18α subunits and 8β
subunits (Hynes et al., 1999; Brakebusch and FaÈssler, 2003; Brakebusch et al.,
2002). The β integrins form heterodimers to form αIIβ3 and αvβ3 integrins.
The former is specific for the megakaryocytic lineage and latter is expressed
on endothelial cells, vascular and uterine smooth muscle cells, monocytes,
macrophages, osteoclasts (where it contributes to bone resorption), certain sub-
population of lymphocytes, Islets of Langerhans (duringmorphogenetic move-
ments), neural crest cells (Baker and Zaman, 2009; Ballestrem et al., 2001; Sadeghi
and Bender, 2007; Cirulli et al., 2000; Eliceiri and Cheresh, 1999; Shattil et al.,
1995; Avraamides et al., 2008).
The ligand binding domain of the integrins are globular regions near the
N-termini of the α and β subunits and are connected to the transmembrane
domains by long stalk like structure. Integrins are specific in binding to extra-
cellular matrices (ECM). α5β1 binds to fibronectin and αvβ3 to fibronectin but
also to vitronectin, fibrinogen and osteopontin (Luo et al., 2007; Hynes et al.,
1999)
1.3.2 ’Outside-in’ and ’Inside-out’ signaling by integrins
Integrin signaling is a bi-directional process (Luo et al., 2007; Shattil et al., 1995).
Outside-in signaling is when integrins are clustered following engagement to
the ECM. This is in turn acts to recruit various cytoskeletal proteins and signal-
ingmolecules. Molecules recruited thus affect cell growth, differentiation, gene
expression and programmed cell death. Inside-out signaling occurs vice-versa,
whereby the intracellular interactions have a profound effect on adhesion, pro-
gression and motility of the cell (Shattil et al., 1995). Thus the understanding
of components which immediately and directly binds to integrins, is impor-
tant to our understanding of the downstream events that regulate all major
cell modulating functions. The direct interactions, might be also important as
a therapeutic target against cancer metastasis (Ricono et al., 2009).
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1.3.3 Binding partners of integrin receptors
Integrin cytoplasmic domain bind directly to many different cytoskeletal pro-
teins, such as talin, which in turn act as adaptors to recruit signaling molecules
(Anthis et al., 2009). It has been reported that the β1A, β3 and β1D cytoplasmic
domains bind to talin, β1A tail bind to α-actinin, β1A,β2 and β7 tails bind to
filamin and the α4 tail binds to paxillin. Of these, filamin, paxillin associate
with other adaptors, signaling molecules and is important in effecting the sig-
naling (Stossel et al., 2001; Turner, 2000). The extracellular domain, cytoplasmic
domain are both involved in bidirectional signaling. Transmembrane domains
also involve in integrin signaling. They have been shown to be significant to
the heterodimer formation (Anthis et al., 2009). Integrins, thus provide a regu-
lated link for cytoskeleton to the outside of a cell. Integrins are also a commu-
nicative tool, enabling cytoskeletal molecules to interact with the extracellular
matrix and to the outside of the cell.
1.3.4 Significance of integrin receptors
Integrins thus recruit and localize various proteins. They help connect cy-
toskeleton to the various organelles with their enormous surface area. This
makes integrins an ideal binding partner to regulate the cellular machinery of
integrin adhesome (Janmey, 1998). This encompasses multitude of molecules
and is is complex. This is represented in (Figure 1.10).
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Figure 1.10: The integrin adhesome
Here the various integrin-mediated adhesions, linking extracellular matrix to
the actin cytoskeleton is shown, with 160 distinct components. The entire ad-
hesome consists of 700 links from which 55% are binding interactions, the rest
beingmodifying interactions. This shows the significance of the integrins in the
biological context and its hyper environmental sensitivity. Many different ki-
nases, phosphatase, G-proteins, regulators all mix, regulate each other pulling
and tugging at the actin mediated by this integrin-mediated adhesome.
(Geiger et al., 2009)
As integrins are a binding partner to the cytoskeleton, and because it is
linked to ECM, integrins, take cues from ECM and inside of the cell, enabling
them to be regulator of the cellular activities. Thus integrins are seen to be es-
sential in various processes, like cell migration and motility, angiogenesis and
apoptosis (Degryse et al., 2001). The ability of integrins to help a cell migrate
during normal cell development is hijacked for metastasis by tumour cells (Ri-
cono et al., 2009).
1.3.5 Role of kinases in Integrin function
Kinases are important regulatory proteins with respect to integrins. They re-
spond to mitogenic signals from growth factors, which are activation signals,
which trigger specialised cellular responses (such as secretory response in neu-
roendocrine cells and platelet aggregation), adhesion signals promoted by the
extracellular matrix, and signals which stimulate cell motility and progression
(Slack-Davis et al., 2009; Zou et al., 2007)
Studies have demonstrated integrin cytoplasmic domains to bind with pro-
tein tyrosine kinases. Focal adhesion kinase (FAK) was reported to bind to
peptides from β1 subunit (Romer et al., 2006). The sequence utilized for FAK
binding, is the same sequence in β1 that Talin exploits (Lewis and Schwartz,
1995). Phosphorylated FAK has been reported to directly associate with β5
cytoplasmic domain, which is critical for β5-mediated cell migration (Romer
et al., 2006).
The tyrosine kinase Syk meanwhile, bind directly to the β3 cytoplasmic
domain. The activation of the Syk is seen on the αIIβ3 integrin’s clustering.
This is a key upstream event in the activity of the platelets and locomotion
of heamopoiteic cells (Woodside et al., 2001). This interaction is mediated by
moesin and ezrin, which directly interact with Syk in an ITAM-dependent
manner (Urzainqui et al., 2002). A related kinase, ZAP-70, also has been impli-
cated to bind with β3 cytoplasmic tail via their tandem SH2 domain (Woodside
et al., 2001). Integrin linked kinase (ILK) also associate with the cytoplasmic do-
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main of β1 integrin (Zervas et al., 2001; Hannigan et al., 2005).
β3-endonexin is a protein, which has been shown to be very specific in bind-
ing to β3 integrin. It was discovered by a yeast two hybrid system, where the
β3 tail was used as a bait. Point mutation studies of the β3-cytoplasmic tail
where a serine to proline mutation at position 752 (associated with a bleeding
disorder) exhibitedmarkedly reduced spreading and focal adhesion formation,
following adhesion to fibrinogen (Shattil et al., 1995). Meanwhile αvβ3 is able
to provide a sustained ERK response (Kim et al., 2003). This has consequence
in cell proliferation possibly involving Cyclin D1 (Walker and Assoian, 2005).
Src-family kinases such as p120cc-cbl(Cbl) and PI-3 meanwhile have been
implicated with β1 signaling (Meng and Lowell, 1998). SH3 domain of Src is
the region of interaction with the β subunit at its cytoplasmic domain (Arias-
Salgado et al., 2003). Src family of kinases meanwhile phosphorylate ezrin
(member of FERM domain containing proteins), with implication in adhesion
and migration (Srivastava et al., 2005). This can lead to interference in het-
erodimer formation between other ERM proteins (such as moesin).
1.3.6 Integrins and Angiogenesis
Angiogenesis is the process bywhich new blood vessels aremade. This process
is very active in the normal foetal development, also while healing wounds, for
restoring blood flow to tissues after injury/insult (Folkman, 2007)
1.3.6.1 Molecules that drive angiogenesis
Angiogenesis depends on specific molecular interactions between the compo-
nents of ECM and the vascular cells. It is a complex process of interaction be-
tween growth factors, their receptors and as well, ECM and their receptors the
integrins (Tucker, 2006). Integrin αvβ3 is able to recognize a number of ECM
molecules in context of RGD adhesive sequence (Arginine-Glycine-Aspartic
acid) (Serini et al., 2006). αvβ3 integrin binds fibronectin, vitronectin, fibrino-
gen, thromabospondin, proteolysed collagen, vonWillebrand factor and osteo-
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pontinwhich have exposed RGD sequence. It is also binds tometallaproteinase-
2 (MMP-2) in a non-RGD dependent manner (Brooks et al., 1994, 1996).
1.3.6.2 Different Integrins, Different signaling
The involvement of the integrin and its cell-matrix interactions, is significantly
felt in vascular remodeling. This is because angiogenesis involves the invasion
of the ECM andmigration of endothelial cells through the ECM. Integrin medi-
ated angiogenesis, largely depends on the matrix the extracellular domains oc-
cupy. Thus, with fibronectin its major receptor α5β1 integrin comes to action.
While α6β4 integrin is utilized with increasing laminin-5 in the extracellular
matrix. The involvement of different integrins with different matrix is central
to controlled angiogenesis. Similarly, different agonists involve different inte-
grins for the same matrix (Figure 1.11) (Serini et al., 2006; Tucker, 2006).
In endothelial cells exposed to growth factors such as bFGF (Basic fibroblast
growth factor ) and VEGF (Vascular endothelial growth factor) it is noticed that
Von Willebrand factor, vitronectin, fibronectin, and fibrin that binds to αvβ3,
is expressed in large quantities (Yan et al., 2008; Presta et al., 2005; Shizukuda
et al., 1999; Tsou and Isik, 2001).
Integrins such as αvβ3, αvβ5, and α6β4, are found to be activated driving
angiogenesis mainly with tumour progression. αvβ3 integrin drives angiogen-
esis in such scenarios, both positively and negatively depending upon insolu-
ble or soluble vitronectin respectively (Serini et al., 2006; Tucker, 2006; Folkman,
2007). αvβ3 mediates endothelial cell attachment, migration and spreading
and thus gets transiently localized to endothelial cells at the tips of the cap-
illary sprouts during wound repair (Beauvais et al., 2009; Degryse et al., 2001;
Soldi et al., 1999).
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Figure 1.11: Different integrins involved with force transduction in fi-
bronectin
Force, as an example of different integrins involving at different stages of a cell.
Integrins α5β1, αIIbβ3 recognize the synergy site. This results in enhanced
binding to fibronectin, when the two sides are presented at the right distance.
This is changed with stretch, where, synergy-RGD distance is increased from
35 Å to 55 Å. Here, αvβ3 is found to be more specific.
(Vogel, 2006)
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αvβ3 is also heavily concentrated in granulation tissue than in normal skin
tissue. Newly formed blood vessels induced by bFGF in the CAM (chick chorioal-
lantoic membrane) assay show robust αvβ3 expression, this is not seen in un-
treated CAMs (Chandra, 2003; Eliceiri et al., 2002). Antibodies against αvβ3
meanwhile affect the bFGF induced vessel sprouting in the CAM, whereas
there is no effect seen on the preexisting vessels. The role of αvβ3 in blood ves-
sel growth is also felt in embryonic vascular development (Eliceiri and Cheresh,
1999).
Integrins such as the collagen receptor integrins α1β1 and α2β1 are induced
by VEGF. Antibodies against them drastically reduce the angiogenic processes
driven by VEGF. Studies using antibodies against α5β1 restricts the angiogenic
process specific to certain other growth factors but not that of VEGF (Kim et al.,
2000). Antibodies against αvβ5 has been shown to suppress VEGF stimulated
angiogenesis (Hynes, 2002b). In addition to different matrices regulating dif-
ferent integrins, different growth factors also seem to recruit distinct integrins
to grow new blood vessels.
These different integrins, initially by its differential adhesion to different
ECMs, drive angiogenesis. There are other molecules it interacts with both
extracellularly and intracellularly. The molecules both in the inside and the
outside of a cell, can’t communicate to each other without integrins. uPAR is
one such extracellular molecule that lacks a transmembrane and cytoplasmic
domain (Degryse, 2008). Meanwhile innards of the cell is spanned by the cy-
toskeleton. This is moulded by recruiting cytoskeletal adapter proteins such
as vinculin, α−actinin, profilin, cofilin and FERM domain containg protein
talin. In-vivo, blockade of ezrin (a FERM domain containing protein) has been
shown to increase transplanted endothelial cell proliferation and angiogenesis
in a mouse hind limb ischemia model (Hood and Cheresh, 2002; Kishore et al.,
2005)
There are as well, different regulatory mechanism employed. There are GT-
Pases such as Rap1 that regulate integrin activation with respect to angiogen-
esis (Carmona et al., 2009). With uniform laminar flow, increased NO down-
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stream regulates αvβ3 integrin mediated angiogenesis (Lee et al., 2000). Mean-
while NO has been shown to be detrimental to Rap1. While Rap1 is also known
to regulate αIIβ3 activity. Integrins are thus able to be modulated according to
the angiogenic cues both pro and otherwise, from inside and outside of a cell.
αvβ3 integrin knockout mice exhibit vessel abnormalities and hemorrhag-
ing in brain and intestinal vasculature. The role of αvβ3 integrin is not just in
binding to the ECM, but is seen in binding to matrix metalloproteinase-2 and
localizing the active form of the enzyme to the tips of the angiogenic blood
vessels (Brooks et al., 1996).
αvβ3 is postulated to locally degrade ECM, then adhering to themodulated
matrix mediates endothelial cell migration (Hynes et al., 2004). αvβ3 binding
also induce mitogen activated protein kinase activation and suppresses apop-
tosis in endothelial cells (Eliceiri and Cheresh, 1999). αvβ3 also, helps endothe-
lial cell survival by mediating intracellular pathways that promote prolifera-
tion and activation.
1.3.6.3 Angiogenesis and tumour growth
As the development of new blood vessels for any growing cell is important,
so it is for tumour cells. Angiogenesis in non tumorous cells is important. It
stabilises in normal circumstances and changes to accommodate remodeling
of tissues. In tumor cells angiogenesis are critically important as this is a high
metabolic area. In normal tissue blood vessels supply nutrients and remove
waste. Angiogenesis meanwhile is very essential in high density fast growing
cancerous tissue mass. Unlike normal cells, here angiogenesis is more active
and proliferative (Papetti and Herman, 2002). There are stimulants and in-
hibitors of angiogenesis in normal cells. These molecules tightly regulate the
process of angiogenesis via complex interactions. But, in tumour cells the stim-
ulants are overexpressed, which surges the blood supply helping to proliferate
cells. Therapeutic approach to use inhibitors or other mechanisms to regulate
the stimulants, will be a good approach for curtailing the growth of tumour
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(Folkman, 2007)
1.4 Ezrin,Moesin, Radixin (ERM) proteins andActin
Cell shape is a dynamic process, with plasticity essential in attaining its diverse
functions. Cytoskeleton by its very nature provides this plasticity to the cell.
Cell adhesion, migration, cell division, docking of cells and immunological
synapse are some of the functions influenced by cytoskeleton. This is enabled
by fluidity and reversibility of cytoskeleton, provided by actin and actin associ-
ated proteins (Chhabra and Higgs, 2007; Niggli and Rossy, 2008; Dustin, 2005).
Figure 1.12: Roles of ERM proteins
Roles of ERM proteins with respect to its actin binding capability. (Niggli and
Rossy, 2008)
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1.4.1 ERM proteins
Ezrin, Moesin, Radixin (ERM) proteins are a family of proteins that are mem-
brane associated. They are members of the erythrocyte protein 4.1 superfam-
ily, providing linkage between the plasma membrane and the actin based cy-
toskeleton (Sato, 1992). These function to regulate specific domain in the cell
cortex by conformational regulation (Pearson et al., 2000a). Originally charac-
terized 20 years ago, ERMproteins links plasmamembrane and the actin-based
cytoskeleton. They are found in actin-rich cell surface structures, such as mi-
crovilli, membrane ruffles, filopodia and cleavage furrows of various cell types
(Figure 1.12) (Sato, 1992).
These proteins are characterized by a shared FERM (Four-point one, Ezrin,
Radixin, Moesin) domain (300-residue globular N-terminal) (Bretscher et al.,
2002). Ezrin was discovered at the cell surface such as microvilli and mem-
brane ruffles (Pakkanen et al., 1987). While radixin was discovered at adherens
junctions, and moesin as a protein which binds to heparin (Tsukita et al., 1989;
Lankes et al., 1988). Merlin is another protein that shares the FERM domain,
while its carboxy terminal is more distantly related (James et al., 2001). Other
proteins of the 4.1 superfamily are talin, several tyrosine kinases and phos-
phatases.
1.4.2 Structure of ERM proteins
ERM proteins binds to membrane proteins and F-actin via its N-terminal and
C-terminal (ERMAD) regions respectively. TheN-ERMADbeing the conserved
domain spanning the ERM proteins referred to as the FERM domain (Gary and
Bretscher, 1995; Reczek and Bretscher, 1998; Turunen et al., 1994).
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Figure 1.13: ERM proteins
ERMproteins show very high conservation of sequence across each other. Mer-
lin has two isoforms, and are also more divergent from other ERM proteins.
Isoform 1 of Merlin ends in 16 residues, while isoform 2 ends in 11 residues.
The The ERM proteins are able to form intramolecular association via the N-
ERMAD contained in the FERM domain with C-ERMAD. Merlin cannot bind
to actin as it lacks the F-actin binding site, while moesin is able to bind to F-
actin. Moesin meanwhile, lacks the proline rich area found within radixin and
ezrin (Ramesh, 2004).
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Figure 1.14: Structure of Moesin
A) Ribbon structure of Moesin (from (Niggli and Rossy, 2008)). There are
three lobes in the FERM domain referred to as F1, F2 and F3 (coloured yel-
low). The α-helical domain is represented in blue colour. This extends and
folds into three helices, αA, αB and αC. These have residues that have contact
with FERM domain. There is a linker region (violet colour, residues are 461-
472), which basically links the α-helical domain and the C-terminal domain
(in red, and associated with lobes F2, F3 of the FERM domain). The linker
region meanwhile, interacts with the F1 lobe of the FERM domain. Moesin
binds to the membrane by adhering to PIP2, the region utilized for this is indi-
cated in black (top to bottom: lysines 64, 63, 60, 278, arginine 253, lysines 254,
262, 263). B) Cartoon representation of moesin crystal structure modified from
(Bretscher et al., 2002). FERM domain is a composite domain with F1 domain
containing ubiquitin, Ras-binding domain of Raf. Meanwhile, F2 domain has
Acyl-CoA-binding protein and F3 domain has phosphotyrosine binding(PTB),
a pleckstrin homology (PH) and an enabled/VASP-1 (EVH1) domain respec-
tively. The structure of ERM proteins are heavily conserved across most of
them. Note the compositeness of all domains, which makes ERM proteins an
ideal "super" adapter protein.
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The FERM domain is a globular structure, composed of three subdomains
(F1, F2 and F3) and arranged like a clover leaf (Figure 1.14 (Edwards and Keep,
2001). The carboxy terminal on the other hand, has a linear structure composed
of a α-strand and six helical regions, extending and covering the FERMdomain
(Pearson et al., 2000b; Edwards and Keep, 2001). The structure of the ERM
Protein is conformationally dependent. The N-terminal, C-terminal regions is
divided by an extended coiled –coil region (Bretscher et al., 2002).
The sizes of these different regions are 300 residues, 200 residues and 100
residues respectively for N-terminal, central coiled and C-terminal respectively
(Pearson et al., 2000b). Also, the 3 lobes F1(4-82 residues), F2(96-195 residues)
and F3 (204-297 residues) of moesin show homology to the proteins ubiquitin,
acyl CoA binding protein and phosphotyrosine binding(PTB), a pleckstrin ho-
mology (PH) or an enabled/VASP-1 (EVH1) domain respectively. The F3 lobe
homologue protein, enabled/VASP-1 (EVH1) domain has been found to bind
peptide and lipid ligands in both cytoskeletal proteins and signaling (Pearson
et al., 2000b; Hamada et al., 2000; Niggli and Rossy, 2008)
1.4.3 Self Association and Regulation
The N-terminal (N-ERMAD) region of an ERM protein, binds with high affin-
ity to the C-terminal (C-ERMAD) region. This state of the protein is that of a
non-active state, not enabling the C-terminal region to bind to the actin. Acti-
vation of the protein is usually enabled by the phosphorylation of its threonine
residue 558, located on helix C of the tail (in moesin). The interaction between
the C-ERMAD and FERM is weakened at this stage due to both electrostatic
and steric effects (Gary and Bretscher, 1993; Pearson et al., 2000b).
Hence, phosphorylated ERM proteins are found in cell-surface structures.
Thus phosphorylation at this specific threonine residue, dissociates the bind-
ing between C-ERMAD and N-ERMAD, activates ERM protein (Figure 1.15)
(Niggli and Rossy, 2008; Gautreau et al., 2000).
In the inactivated state where it doesn’t bind to other proteins or actin, ERM
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proteins are mostly found as monomer in the cytoplasm, whereby it is able to
bind its C-ERMAD to its own N-ERMAD. In homodimer formation, the ERM
protein form dimer with the same protein. Meanwhile interestingly, ERM pro-
teins are also found as heterodimer whereby it binds to another ERM protein
(eg:- ezrin with moesin). There are also oligomers known between different
proteins sharing the FERM domain (Gary and Bretscher, 1993; Berryman et al.,
1995; Bretscher et al., 1995). Merlin is one such oligomer forming molecule,
that actually has more affinity towards ERM proteins (McClatchey and Fehon,
2009)
Figure 1.15: Regulation of ERM proteins
Regulation of ERM proteins. The phosphorylation of ERM proteins (active
state) is regulated by various kinases. PIP2 the major binding partner at the
FERM domain stabilise ERM protein for this phosphorylation. (Niggli and
Rossy, 2008)
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Figure 1.16: Phosphorylation-Dephosphorylation of ERM proteins
ERM proteins are activated by phosphorylation, prior to this it exists
monomers (associated to itself), homodimers (eg:- moesin to moesin), Het-
erodimers (such merlin to moesin); note that merlin actually has more affinity
to other ERM proteins than to itself. There are some evidences towards even
oligomer formations. The association in all cases is via the C-ERMAD to N-
ERMAD. The oligomers can also be either homo-oligomer, or hetero-oligomer
(only monomers, heterodimer or homodimers are shown in the figure).
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Crystal structures ofmoeisnN-ERMAD—C-ERMAD complex, has revealed
C-ERMAD to be an elongated structure masking a large surface of the globu-
lar N-ERMAD domain(Pearson et al., 2000b). Threonine residues that need to
be phosphorylated to activate ERM protein varies, i.e, Thr567 in ezrin, Thr564
in radixin, Thr 558 in moesin. And, conversely dephosphorylation achieves
deactivation of ERM proteins (McClatchey and Fehon, 2009; Ivetic and Ridley,
2004).
1.4.4 Phosphorylation of Moesin
Introduction of negatively charged phophoryl group at threonine residue, po-
sitioned opposite to negatively charged FERMdomain, will destabilise it (Naka-
mura et al., 1995). Mutating the threonine residue to Aspartic acid does not
produce the same effect . This is due to the difference in steric effect, as there
is not sufficient room to accommodate phosphoryl group among the tight side
chains surrounding the threonine residue. Phosphorylation in moesin was ini-
tially noted in platelets at threonine 558 (T558) residue. This was found to re-
duce the affinity of C-ERMAD for the FERM domain. Phosphorylation of other
residues, in every ERM proteins, elicited a similar response. The significance of
this lies in the fact, that phosphorylated ERM proteins are found in cell-surface
structures . As a corollary, dephosphorylation has been found to breakdown
the microvilli due to anoxia or apoptosis, and the binding of phophorylated
moesin to actin is inactivated by purified protein phophatase 2C (Hishiya et al.,
1999; Niggli and Rossy, 2008; Ivetic and Ridley, 2004; McClatchey and Fehon,
2009).
There are other complexities involved in the regulation of ERM proteins.
FERMdomain binds to ATP, phosphatidylinositol 4,5-bisphosphate, phosphatidylser-
ine, calmodulin and P55 (Diakowski et al., 2006) . It is also found to mediate
attachment of protein 4.1 to the plasma membrane, by binding to the cyto-
plasmic domain of the transmembrane protein’s glycophorin A, glycophorin
C, band3 and CD44 (Marfatia et al., 1995; Nunomura et al., 2000), and also con-
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nect cell-surface transmembrane proteins such as CD44, CD43, ICAM-2 and
ICAM-3 to the actin cytoskeleton (Louvet-Vallée, 2000; OLSSON, 1999). Three
clusters of lysines, part of FERM domain are a requirement for ERM activation
via phophatidyl inositol-4-5-bisphosphate (PIP2) (Hamada et al., 2000). The
lysine residues of the FERM domain important for PIP2 binding has been in-
dicated to be K63,K64,K253,K254,K262 and K263. PIP2 is a requirement for
conformational change of ERM proteins, in synchronisation with phosphory-
lation (Barret et al., 2000; Blin et al., 2008). Cell survival in epithelial cells is
achieved by phosphorylation of the tyrosine residue (Tyr 353 in Ezrin), which
in turn activates the phophatidylinositol 3-kinase (PI3-K)/Akt pathway (Yeh
et al., 2009; Youn et al., 2009).
ERMproteins also seem to regulate each other. An evidence in this regard is
the C-ERMAD of merlin having a stronger affinity for the N-ERMAD of ezrin:
merlin-ezrin heterodimers thus have been detected (McClatchey and Fehon,
2009; Bretscher et al., 2002). Active Rho elicits a response from moesin, to form
focal adhesions. Rho kinase ROCK is seen to phophorylate ezrin. Also, for
Rho exchange factors Net and Dbl to be activated there is a requirement for the
activation of Ezrin (Kim et al., 2009; Tomar and Schlaepfer, 2009; Geiger et al.,
2009)
Merlin acts quite differently to the other ERMproteins, namely ezrin, radixin
and moesin. Hypo-phosphorylated merlin is found to be active as a growth
suppressing molecule, while phosphorylation of a C-terminal serine residue
(S518), weakens self-assocaition and inactivates the growth suppressing activ-
ity of merlin. Predominantly merlin is found in monomers. The role of other
ERM proteins in this regard, is to form stabler heterodimers/oligomer with
merlin (as mentioned earlier). (Hennigan et al., 2009; McClatchey and Fehon,
2009)
Rac1 is another activator of merlin, found upstream and downstream to
merlin activation. Rac1 is an important regulator of merlin, with active Rac1
found to activate merlin’s C-domain. As well, Rac1 and Rho GTPases interact
and RhoA GTPases phophorylates other ERM proteins (32). Thus there is a
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great amount of cross talk between ERM protein (including merlin) with var-
ious lipids, kinases and proteins and each other. Eliciting the interactions at a
molecular level will bring out the complexities at play. Functionally, this will
lead to better understanding in areas where cytoskeletal exerts influence (Shaw
et al., 2001; Hennigan et al., 2009).
1.4.5 Need for promiscuity; other partners & possible partners
Myo-x
It is the nature of things whereby evolution, universally has conferred specific
roles to proteins. Some of which provide molecular niche in regulating and
driving biological processes. Over the course of evolution redundancy is of-
ten common in proteins, especially in complex eukaryotic organisms, they still
confer uniqe roles in specialized cells and in specialized functions. When it
comes to the nature of things, rapid deployment, adaptablity is the nature of
ERMproteins, like most other adapter proteins. Anymolecule that has a FERM
domain, is potentially sticky to any molecule that has a C-ERMAD.
Thus an interesting molecule that has not been charactherised much with
respect to moesin, is Myosin-X or commonly referred to as Myo-10. An intra
filopodial molecule that is able to bind to both micotubules with its MyTH4
domain, and to actin. It is also found to bind to PIP2 by means of its FERM
domain (Wang et al., 2009a; Bennett et al., 2007). This is potentially a binding
partner for moesin due to the route it takes, making them plausible traveling
partners. It will be interesting to understand what roles they play due to their
interactions. (Berg et al., 2000; Berg and Cheney, 2002)
1.4.6 Dephosphorylation
Due to its regulation by phosphorylation, studies still need to be undertaken,
to understand more about the kinases that phosphorylate moesin and other
ERM proteins. There is also a need to understand the role played by phos-
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phatases that dephosphorylate moesin. The second event of dephosphoryla-
tion is often unappreciated but is important, as would be evident from some
of our results. Dephosphorylation, basically, leads to moesin lose its bind-
ing to actin (Figure 1.16)(Niggli and Rossy, 2008). The results obtained from
our experiments find the dephosphorylation mechanism an indispensable im-
mediate step, with both stretch and uPA induction. We discuss contextually
about plausible dephosphorylation in the discussion section. Furthermore we
demonstrate events that elicit dephosphorylation off moesin.
1.4.7 L-selectin
Expressed on leuckocytes wheremoesin is also heavily present, the finding that
this is a binding partner for moesin is important. This molecule tethers and al-
lows association between endothelial cells and leukocytes (Killock et al., 2009).
With its roles in cell adhesion, and the differential way in which it binds with
ezrin and moesin, L-selectin takes up a unique niche during pathways that
require their seperate role. The interaction with moesin meanwhile occurs at
the N-terminal domain. PMA stimulation allows only moesin and not ezrin to
bind to L-selectin. CD95/Fas also binds moesin and ezrin differentially (Ivetic
and Ridley, 2004).
1.4.8 Actin
The attention on moesin is due to its most important binding partner actin.
Ability to bind to actin, combinedwithmoesin’s ability to transiently phospho-
rylate/dephosphorylate, adapt and recruit other molecules provide plasticity
to the cell. This enable the cells to do various functions that depend on the
contractibility of the actin cytoskeleton.
The binding proteins of actin are classed into nucleation-promoting factors,
the severing proteins, motor proteins and the linker proteins. The nomencla-
ture is derived from the primary function that these proteins are involved in.
Experiments with antisense oligonucleotides inmouse thymoma cells (L5178Y)
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against the ERM proteins, has shown a dramatic disruption of its microvillar
structure. Thus moesin is considered as a linker protein. Far from being an
inert linker, moesin and other ERM proteins due to lipid interaction, also play
a role in receptor presentation or lack of it (McClatchey and Fehon, 2009).
Moesin with its ability to bind to PIP2 by means of its FERM domain at
the N terminus, is able to hold the membrane and the cytoskeleton. The mo-
tor central to this, is its ability to form heterodimer/oligomer with all ERM
proteins. This is controlled by its phosphorylation/dephosphorylation. Most
of its binding partners also associate with actin, and thus is choreographed
an elegant movement of cytoskeleton. Meanwhile, lack of merlin in mouse
keratinocytes lead to loss of junction-cortical actin interface between the cell
(Lallemand et al., 2003). Merlin as discussed earlier, has more affinity towards
other ERM molecules than to its own monomer. This is a powerful interfer-
ence, taking into respect merlin’s inability to bind to actin! Moreover merlin
is activated by Rac in contrast to other ERM proteins (Pearson et al., 2000a;
McClatchey and Fehon, 2009).
In areas of fine actin filaments devoid of surface structures, it has been re-
ported not to have not a heavy expression (Franck et al., 1993). This is not fully
appreciated in papers recently published. Studies inspired from these earlier
observations might pave way for myo-10, which is still not fully appreciated in
its versatility.
FERM domain containing protiens such as Talin, provide malleability to the
cell. Spectrin-actin complexes are tightly adhered to the erthrocyte membrane
via Protein 4.1, a member of the FERM-domain protein (this provides it with
its elliptical shape) (Sheetz et al., 2006). Though fully developed erythrocyte
lacks moesin, megakaryocyte has increasing moesin with the number of nu-
cleus it possess. ERM proteins provide an important linkage between PIP2 and
actin. Moesin also co-localise with the mitotic spindle, provides structural in-
tegrity via actin binding in a dividing cell. Phosphorylated moesin is thought
to provide the continuous cortical flow, which help the astral microtubules to
seperate the two asters of the spindle (Vilmos et al., 2009; Neisch and Fehon,
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2008). Moesin via phosphorylation by the Ste20 protein kinase S, lends its car-
boxy terminal for actin binding (Hipfner et al., 2004). This route is similar to
the classic Rho kinase effect on moesin, while Slik is thought to be the other
moesin mediator required for cell rounding prior to cell division (Rosenblatt,
2008).
Focal adhesion Kinase
With its FERMdomain, focal adhesion kinase like other FERMdomain contain-
ing molecules is a potential partner to moesin. This kinase which is involved
in focal adhesion formation, might latch onto the C-ERMAD of moesin. Irre-
spective of the kinase activity, this in itself might bring moesin to the loci of
focal adhesions. The FERM domain of FAK scores a score of 153 out of a max-
imum expected score of 158 when compared to moesin’s FERM domain. Thus
the FERM domain has an exceptionally high homology to moesin’s own FERM
domain (Dunty et al., 2004).
1.5 Molecular biology of the cell biomechanics &
intracellular force transduction
1.5.1 Shear stress
The dragging of blood on the endothelium is derived as shear stress (Fig-
ure 1.17). This is represented as frictional force per area. Unless injured, this
force is not experienced by vascular smooth muscle cells (VSMCs) (Haga et al.,
2007; Orr et al., 2006). Though due to the thin layer of endothelium, some
amount of this force could be transferrd to VSMCs.
There is still a co-operative paracrine exhange of information between en-
dothelium and VSMCs (Malek et al., 1999). The vascular vessels are elastic, big-
ger the vessels, greater being the elasticity. This elasticity maintains a uniform
flow of blood between the peaked pressure of (sytole) & deflation of pressure
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(dystole) in smaller arteries. The elasticity of large vessels, thus compensates
for lack of elasticity of smaller vessels (Hahn and Schwartz, 2009).
Endothelium in culture show some remarkable phenotype under flow and
without flow. It is an often noticed feature of endothelium, whereby cells of
endothelium aligns in the direction of shear stress with flow. Meanwhile pri-
mary cilia, a constituent of kidney cells which senses low shear levels, is seen
in endothelium under static conditions (Iomini et al., 2004). Blood flow once
established as parabolic, exerts laminar flow. This though requires, a straight
vessel and can then be expressed as
τ=4￿Q/πr3
( ￿ is viscosity, Q is the flow rate, r the vessel radius and τ being shear stress)
(Lehoux and Tedgui, 2003).
This always is not the case, due to the branched architecture of the vascula-
ture. These abnormal flow patterns give rise to non-laminar, low shear stress,
non-uniform flow pattern giving rise to chronic inflammation. This chronic in-
flammation due to these factors are even seen in newborns and is thus a basic
characteristic (Hahn and Schwartz, 2009). Meanwhile, physiological values of
shear stress is around 10-15 dynes/cm2 in most animals except mice (Lehoux
and Tedgui, 2003). Though there is variation depending on the arteries (high-
erst in small arteries (60-80 dynes/cm2) and veins, with large veins often at
being less than 1 dyne/cm2, while small venules at 20-40 dynes/cm2 (Baller-
mann et al., 1998).
1.5.2 Cyclic strain
Cyclic strain is the result of our pressurised blood pumping system, whereby
circumfrential cyclic strain is derived from the blood pressure (Figure 1.17).
Unlike hydrostatic pressure mentioned in the next section, blood pressure is
the highest in the aorta and decreases as it travels further. Blood pressure be-
ing hydraulic pressure, it is defined as force per area. The cyclic stretch is a
normal physiological aspect of both endothelium and vascular smooth muscle
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Figure 1.17: Hemodynamic Forces
Where τ is shear stress and P is pressure that results in circumfrential stretch-
ing, in all directions of the vascular circumference.
(Hahn and Schwartz, 2009)
cells (Haga et al., 2007). Wall tension is the force per unit length of the vessel.
Mathematically represented as
T=Pr
(where P is the blood pressure, r the radius of the vessel and T being wall
tension).
Meanwhile circumfrential strain can be expressed as
T=Pr/h
(where ’h’ represents the thickness of the vessel bearing the the circumfren-
tial strain).
Thus, strain is felt only partly by the various constituents of the vessel wall
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such as VSMCs and ECs (Lehoux and Tedgui, 2003).
1.5.3 Hydrostatic pressure
This is also a force sensed by endothelium, basically, the volume of blood on
top of the endothelium. In humans, lower limbs thus are exposed to higher
hydrostatic pressure than upper limbs. This is an area under investigation.
This force is also felt by cartilage, knee meniscus, temporomandibular joint
disc, intervertebral disc, bone (Elder and Athanasiou, 2008; Padilla et al., 2009).
At a cellular level fungi and plants utilise hydorstatic pressure based mech-
anism for protrusion (Harold, 2002; Messerli and Robinson, 2003; Money and
Harold, 1992). This is one of the major force intracellularly, whereby the cyto-
plasm exerts a certain pressure on the plama membrane. Here cytosol acts as
the conductor for hydrostatic pressure. There are locally acting pressure dif-
ferences on the membrane. This results in the contractile, elastic network of
membrane being infiltrated by cytosol (Charras et al., 2005). These differences
provide niche compartments for molecules, that then thrive in such circum-
stances. Hydrostatic pressure has to said, has been found to have much little
effect compared to shear stress or cyclic strain in terms of blood flow (Hahn
and Schwartz, 2009). Nevertheless, only further investigation into the molecu-
lar events will lead to hydrostatic pressure’s real significance.
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1.5.4 Molecular determinants & regulators of flow
1.5.4.1 Remodeling with flow
With flow, higher or lower blood pressure over long periods of time lead to
remodeling of our vasculature. The vasculature accomodates the change by
structural changes to itself. Vascular smooth muscle cells, play a major role in
directing this remodeling due to high flowwith increased blood pressure. This
leads to the thickening of vasculature due to constriction by VSMCs, eventually
leading to loss of elasticity. “Laplace’s law: This law states that tension in
the vessel wall equals the difference in pressure across the vessel times the
radius of the vessel, divided by the thickness of the wall. Thus, higher blood
pressure or vessels of larger radius require thicker walls to be mechanically
stable” (Hahn and Schwartz, 2009).
At the same instance, higher shear stress felt by endothelium induces NO
release, which then relaxes the VSMCs. VSMCs meanwhile, protect the en-
dothelium from NO-induced apoptosis by reducing bcl-2 activity in endothe-
lium (Haga et al., 2007).
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Figure 1.18: Progression to atheroscerosis
A)Endothelial cells normally align in direction of flow. The expression of adhe-
sion receptors, cytokines is kept to a minimum. The proliferation rate is quite
low, owing to quiescent nature of endothelium. Apoptosis is also at a mini-
mum at this stage. B) With susceptibility to atherosclerosis, owing to disturbed
flow, ECs get misaligned. Note that this misalignment is a prelude to further
disease. This results in inflammatory response. As the cause is disturbed flow,
the inflammation does not subside. Which would be the case with pathogenic
entry. Higher cell turnover, expression of leukocyte adhesion receptors (E-
selectin), vascular cell-adhesion molecule 1(VCAM1), intracellular adhesion
molecule 1 (ICAM1) and cytokines occur. The leukocytes, meanwhile migrate
into the vessel wall. C) Fatty streaks are formed in these regions with depo-
sition of lipoproteins (low density lipoproteins (LDL) and very low density
lipoproteins). Further to this, cholestrol, triglycerides are taken up. The reason
high density lipoproteins (HDL) is seen as the "goodmolecule", is becuase it es-
sentially, carry lipids away and oppose deposition (HDL in this circumstance is
considerably reduced, due to the earlier uptake of LDL). Macrophages mean-
while is laden with considerable amount of lipid (referred to as foam cells).
The activation of cells, meanwhile continues to increase resulting in secretion
of cytokines, enzymes. These rearrange the ECM, resulting in increased mi-
gration, thickening of the VSMCs. D) Finally, is formed atherosclerotic plaque.
Previously appreciated, modifiable risk factors determine, how fast this stage
is reached. (Hahn and Schwartz, 2009)
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Increase in stressmeanwhile, induces smoothmuscle cell hypertrophy. Also,
the wall undergoes atrophy when circumfrential stress is substantially reduced
(Bomberger et al., 1980).
Vascular cells shed extracellular matrix complimentary to the type of flow
that they experience. Collagen IV, laminin, nidogen and proteoglycans are the
normal constituents of ECM for endothelium. With injury, fibronectin, fibrino-
gen and thrombospondin are also incorporated. ECM also allow the cells to
sense stiffness. A decrease in substrate stiffness thus reduce formation of focal
adhesions and stress fibers. As well, they play a vital signaling role, allowing
the cells to sense, adapt and remodel (Chiang et al., 2009a; Wang and Tham-
patty, 2006; Hahn and Schwartz, 2009).
In situations with chronic hyperlipidaemia, an abuse of the modifiable fac-
tors over chronic period leads to atherosclerosis (Figure 1.18). Further long
term implications are calcification of the vasculature. Meanwhile, thrombus
formation is activated when these atherosclerotic plaques rupture, ending in
vessel occlusion (Hahn and Schwartz, 2009).
1.5.4.2 The transducers
Endothelial cells effect a range of signaling pathways with flow. Including
nitric oxide production, phosphoinositide 3-kinase (PI3K), extracellular signal-
regulated kinase 5 (ErK5/ MAPK7)) pathways. To sense the shear stress and
cyclic strain, endothelial cells are equipped with various receptors which in-
clude integrins, heterotrimeric G proteins, receptor tyrosine kinases, ion chan-
nels (Figure 1.19) (Malek et al., 1999; Hahn and Schwartz, 2009; Lehoux and
Tedgui, 2003).
Meanwhile the underlying cytoskeleton, relays the stimuli throughout the
cell. Mechanical stimuli is faster than chemically induced stimuli, reaching the
nucleus in less than 5￿s, while the latter takes ~5s (Wang et al., 2009b). This is a
huge difference, which enables faster gene expression. This allows the cells to
assert a finer control, with varying blood flow.
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Figure 1.19: Mechanotransducers
G-protein-coupled receptors (GPCRs), heterotrimeric G proteins, ion chan-
nels, glyocalyx, ATP channels transduce various mechanical stimuli. Laterally
cell membrane utilize PECAM-1, ECAM-1, VE-Cadherin to communicate to
nearby cells. Cytoskeleton spans inside transmitting force by means of corti-
cal actin cytoskeleton, actin stress fibers, microtubules. Integrins, meanwhile
connect the cell to ECM (Hahn and Schwartz, 2009).
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As well, the cells lying adjacent to each other are connected by means of
PECAM-1, VE-cadherin and vascular endothelial growth factor receptor 2 (VEGF2).
These cell-cell junctional proteins are also recruited for transmission of forces.
Glycocalix is a layer of carbohydrate-rich proteins generating a lot interest re-
cently, that can mediate shear stress (Jaalouk and Lammerding, 2009).
1.5.4.3 Flow dependent signaling
Cytoskeleton touches all areas of a cell, thus with actin and microtubules, it
enables the transmission of mechnanical forces. Actin-binding proteins play a
huge role bringing together different molecules. Actin stress fibers in BAECs
have shown to increase with stretch, aligning perpendicular to stretch (Kaunas
et al., 2006; Wang et al., 2002). Jnk is re-activated with realigning stress fibers,
due to stretch (Chien, 2007). Focal adhesion sites then recruit proteins, which
results in activation of MAPK. This downstream regulates transcription factors
AP-1, NF-B, Sp-1 and Egr-1. MicroRNA regulation has not been shown with
mechanotransduction. Changes in gene expression though have beenwell por-
trayed (Chien et al., 1998; Chien, 2007).
Rho GTPases regulate proteins that are critical to signaling via mechan-
otrasduction. They have been shown to cause cell contraction. This is achieved
by regulating myosin light chain and mDia incorporating Rho Kinase. Pro-
filin and Src-tyrosine kinase takes over, regulating focal adhesion turnover
and actin polymerisation. Stretch meanwhile is garnered by PECAM-1, re-
laying information to adjacent cells by activating respective Src-tyrosine ki-
nase (Chrzanowska-Wodnicka and Burridge, 1996; Satoh et al., 2000; Watanabe
et al., 1999; Newman, 1997). PECAM is also phosphorylated by Fyn, a tyrosine
kinase. This enables maintainence of a quiscent monolayer of endothelium
(Chiu et al., 2008). Hydrostatic pressure can also activate the Src family. FAK
is also activated downstream of hydrostatic pressure. This in turn phospho-
rylates α-actinin, this increases adhesion of the cells. Though the studies were
carried out in colon cells, the critical need of α5β1 integrin proved interesting
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for vasculature (Craig et al., 2007). Cyclic strain has been shown previously
to reorganise α5β1 in endothelium, parallel to FAK being phophorylated. This
tyrosine phosphorylation of FAK is similar to paxillin’s phosphorylation of the
tyrosine residues. The same group also noted α2β1 reorganising with cyclic
strain (Yano et al., 1997a).
The activation of FAK and Src occurs within ten minutes of stretch, which
leaves room for more rapid adapter proteins to bring together the big party
needed for focal adhesion. Vinculin, zyxin, talins (FERMdomawolfn), Kindlins
and as such yet to be identified components, are brought together in seconds.
The primary transducer for these are the integrins, which sense inside of the
cell, adjusting the adhesion to the ECM (Katsumi et al., 2005). In parallel, stretch
also opens up the cells to a calcium influx, via stretch activated cation chan-
nels. As well, nuclear factor kappa-B (NFkB), Ras, Rac-1 and the previously
mentioned RhoA are activated (Lehoux et al., 2006; Asparuhova et al., 2009).
Shear is found to activate the potassium channels (Lehoux and Tedgui, 2003).
There is increasing evidence for direction effecting change in gene expression.
The recently discovered sustained gene expression control by MAL (member
of myocardin-related transcription factor family (MRTF)), via serum response
factor with stretch is just one example. What about microRNA control? Inter-
estingly Rho A is the mediator of the MAL based pathway (Asparuhova et al.,
2009).
How do these molecules get transmitted to the nucleus with mechanotrans-
duction? The transmission lines are actin based cytoskeleton (Asparuhova
et al., 2009). Does that mean, the adapter proteins get translocated to the nu-
cleus with stretch? Zyxin, is an example of stretch, inducing a cytoskeletal
protein to translocate to the nucleus. This elegant study showed most of the
zyxin in the cell, in nucleus within 30 minutes of stretch induction (Cattaruzza
et al., 2004). This is a protein that also is an usual suspect in stretch induced
focal adhesions.
Another factor to note is that multiple pathways open up with mechan-
otransduction. There might be otherwise very useful mechano-transmission
51
proteins, which, might find itself redundant in this context. There are niche
mechano sensitive proteins such as in ear, that differ from endothelium (Orr
et al., 2006). The opening up of previously mentioned cation gates and the
influx of calcium activates calpain, which cleaves multiple proteins (Glading
et al., 2002). What about microparticle formation in this scenario?
Integrin linked kinase (ILK) can bind to Kindlins. This is antother stretch in-
duced transducer, activating Rho Awithin 5minutes (Schwartz and DeSimone,
2008). Kindlin binds to NPXY motif of the β integrin cytoplasmic tail. Though,
it has be noted that talin does not bind to the same NPXY motif, rather, utilizes
its FERM domain to bind with another NPXY motif. The binding of talin is
critical in inducing a conformational change to the integrin. This converts the
αβ heterodimer to a high affinity state from an inactive conformation. Kindlin
needs the co-operation of talin to activate integrins (Geiger et al., 2009). There
are other areas of functionality of a cell that provide insight into this. Osmotic
stress is shown to activate FAK and Src, where incidentally moesin is shown
to be activated (Di Ciano-Oliveira et al., 2006; Schwartz and DeSimone, 2008).
It has been demonstrated that chloride channels are opened when β1 integrins
are engaged mechanically. It is interesting to note that for calcium influx, un-
der similar conditions, a dependence on the type of ECM is seen. It has to be
noted that shear stress also shows similar activation of FAK and Src (Schwartz
and DeSimone, 2008).
This is but a slice of various signaling induced by shear, cyclic strain and
hydrostatic pressure. The shear volume though huge, is a fine interplay, with
every single molecule sensing each other regulating and adapting to the need
of the flow.
1.5.5 Migration of Cells
1.5.5.1 Cell migration
The cell is spanned by an extensive network of cytoskeleton with a large sur-
face area, connected to all the major organelles on which a large number of
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proteins can dock and regulate one another. Integrins give external cues to in-
side, by outside-in signaling and from the inside to the outside, by inside-out
signaling (Janmey, 1998).
Integrin cytoplasmic domain bind directly to many different cytoskeletal
proteins, which in turn act as adaptors to recruit signaling molecules (Liu et al.,
2000). It has been reported that theβ1A, β3 and β1D cytoplasmic domains bind
to talin, β1A tail bind to α-actinin, β1A,β2 and β7tails bind to filamin and the
α4 tail binds to paxillin. Of these filamin, paxillin associate with other adap-
tors, signaling molecules and effect migratory signaling (Stossel et al., 2001;
Turner, 2000).
1.5.5.2 Importance of cell migration
Under normal physiological conditions, directed movement of a cell is neces-
sary for processes like angiogenesis and leukocyte extravasation (Brakebusch
et al., 2002). Leukocytes are able to infiltrate into the tissues from a blood vessel
in case of infection. The infection promotes inflammatory signals, which then
attract the free moving leukocytes. These move to the endothelial cells, toward
the infected area. Then via integrin signaling, they are able to infiltrate into the
surrounding tissue and attack the infectious substance (Fujimi et al., 2002).
1.5.5.3 Understanding the movement mechanism
In studies conducted using green fluorescence protein tagged toβ3 subunit of
integrins, migration of cells is seen to be initiated by cell polarizations and
the formation of membrane protrusions to the ECM (Laukaitis et al., 2001;
Ballestrem et al., 2001)
At the cell front, adhesion sites containing αvβ3 integrin remain stationary,
whereas at the rear of the cell they slide inward (Ballestrem et al., 2001). At
the cell front, actin cytoskeleton is recruited which triggers the association of
many different signaling molecules at the focal contacts, and then, integrin sig-
nals stimulate cell contraction. While at the rear of the cell, it detaches from
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the substratum by integrin inactivation and the disassembly of the adhesion
complexes (Brakebusch et al., 2002; Brakebusch and FaÈssler, 2003).
Adhesion via integrins is dependent on its ligand binding property. Inte-
grins exist in high affinity and low affinity conformations. The high affinity
forms are necessary at the leading end of the cell, where they attach firmly
to the ECM. The high affinity binding, is regulated by the binding of regula-
tory intracellular molecules, to the cytoplasmic domains of the integrins. The
study to understand the binding partners and the regulatory mechanisms of
the cytoplasmic domains, thus has great significance. Huge array of different
proteins, are currently known to bind the intracellular domains of the integrin
molecules. And a lot more indirectly in the regulatory cascade (Brakebusch
et al., 2002; Brakebusch and FaÈssler, 2003; Rose et al., 2007)
Cell attachments not just regulate by “affinity regulation”, but also by avid-
ity regulation, whereby the integrins in low affinity increase adhesion because
of clustering. These clusters are seen in focal adhesions and readily detectable
cell-matrix contacts, studied extensively in fibroblast cells. Lateral mobility of
the integrins, also thus must have an important role in cell migration and ad-
hesion (Brakebusch and FaÈssler, 2003; Luster et al., 2005)
Experiments have shown that in leukocytes, where the integrin molecules
have been attached to actin cytoskeleton when released by proteolytic diges-
tion, results in increment of integrins resulting in lateral mobility. This also
increases the chances for integrins to meet specific ligands, which facilitates
integrin aggregation and high avidity clusters (Constanin, 2000).
1.5.5.4 Molecular basis of cell migration
Locking integrins into a high affinity state by mutations or activating antibod-
ies inhibit cell migration. Different studies have shown us, that detachment
of integrins at the cell’s rear is an important step in the process of cell migra-
tion. Detachment processes appear to be sensitive to the Ca+ levels. Migrating
fibroblasts have increased Ca+ levels in the rear. αvβ3 integrin is seen to de-
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tach by a Ca+ induced mechanism, whereby calcineurin is activated disrupting
the interactions between αvβ3 and cytoskeleton (Pierini, 2000). The unbound
integrins from the rear end or the trailing edge is transported to the leading
edge by endocytosis, which is probably needed to replace the fast depleting
amounts of integrins (Brakebusch and FaÈssler, 2003).
Matrix metalloproteinases (MMP) are important enzymes in the process of
metastasis, tumour invasion and angiogenesis. These zinc dependent endo-
proteases are important in partially destroying the surrounding ECM. Vari-
ous integrin dependent pathways, regulate these enzymes. One mechanism
is whereby, integrins bind to the ECM molecules and to MMPs, thus bring-
ing these molecules closer. This enzyme is also important in wound healing
(Hangai et al., 2002; Marshall et al., 2003; Xu et al., 2001; Brooks et al., 1998) Reg-
ulating proliferation of cells by integrins is also an important role that MMP
undertake. αvβ3 integrin and bFGF signaling is an important requirement of
the cell cycle progression (Roovers and Assoian, 2003; Welsh et al., 2001).
1.5.5.5 Regulatory mechanisms
Affinity and avidity of the integrins are regulated by growth factors and chemokine
signaling (Brakebusch et al., 2002). Phosphatidylinositol 3-kinase (PI3-K) is an
important regulator of the integrin signaling mechanism, and prior to migra-
tion increase integrin avidity (Trusolino et al., 2000).
In mast cells, PI3-K is activated by PDGF-R (Platelet derived growth factor-
R), which then increase the affinity of the α5β1 integrin. In breast cancer cells
also, PI3-K is seen to upregulate the increased metastatic properties and adhe-
sion (Salh et al., 2002; Brakebusch et al., 2002).
Extravasation process of leuokocytes require tight adhesion of itself to the
endothelium, and into inflamed tissues for which chemokines are an important
regulatory mechanism. Viruses affect the chemokine signaling and enter the
cells by evading the immune system (Brakebusch et al., 2002; Brakebusch and
FaÈssler, 2003; Poli, 1999).
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The Ras (small GTP binding proteins) and Rho (small GTP binding pro-
teins), GTPases though very specific to cell type and integrin, also regulate
the affinity of the integrins. In Chinese hamster ovary (CHO) cells, H-Ras (a
subset of Ras protein family) inhibits activation of β1 and β3 integrins. R-Ras
promotes integrin activation in the myeloid cells but has no effect in a lym-
phoid cell line (Kinashi et al., 2000). PI3-K is required for integrin activation by
both H-Ras and R-Ras (Mora et al., 2007; Yoshimura et al., 2006).
Rap1 meanwhile, regulate the integrin high affinity state in lymphoid and
endothelial cells (Nolz et al., 2008). Integrins also regulate each other, such as
when αIIβ3 downregulates α2β1, α5β1 mediated adhesion (Rose et al., 2007;
Brakebusch et al., 2002). Secreted molecules have been shown to reduce the
affinity of integrin β1 to other ligands, or by directly interacting with it, thus
producing a conformational change. An example of this is the Galectin-8, a
galactoside binding protein. Meanwhile Galectin-3 has been implicated with
β3 integrin (Diskin et al., 2009; Lei et al., 2009). Urokinase is another secreted
molecule, that laterally interact with integrins via its receptor uPAR (D’Alessio
and Blasi, 2009). This is a highly chemotactic mechanism, leading to cell mi-
gration (Degryse et al., 2001; Degryse, 2008).
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1.6 MicroRNA regulation
There is the constant wrestle between control and chaos, whose ratio in an
organism defines life or death. The classic studies by Rosalind Franklin, which
James Watson, Francis Crick and Maurice Wilkins confirmed, revealed DNA
as the information blue print of an organism (Maddox, 2003)
From initial postulation of the three letter codon by George Gamow, end-
ing in the pioneering work by Har Gobind Khorana revealed all the codons
(Nanjundiah, 2004). Since the advent of the genetic code, we have come to
understand other levels of control to the synthesis of the final building block
of an organism, the protein (Khorana et al., 1966). Post translational modifica-
tion, protein stability, transcription factors are all mutiple layer of control an
organism exerts.
MicroRNA is one such arsenal of control, that acts upstream at the level of
post transcription, on the mRNAs repressing translation of proteins. Though
called microRNA, the impact of microRNAs are quite global and macro in na-
ture (Filipowicz et al., 2008). This is because in animals each microRNA can
havemultiple protein targets, as long as they have 2-7 basepair seed region that
are complimentary. With one third of genes under regulation of microRNA,
we have considerable amount of work in front of us (Selbach et al., 2008; Lewis
et al., 2005). They also provide fodder to the saturated research of drug discov-
ery, bringing out new routes of drug targeting.
1.6.1 Biogenesis of microRNA
Fire and Mello were the pioneers in the field, with their studies in C. elegans
(Ambros, 2008).“According to the current convention, a miRNA is defined as
a singlestrandedRNA of ~22 nucleotides in length, which is generated by the
RNase-III-type enzyme Dicer from an endogenous transcript that contains a
local hairpin structure” (Kim, 2005). This being a rapidly advancing field, more
knowledge is bound to add to our understanding.
Small RNA molecules such as tRNA are transcribed by RNA polymerase
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III, while microRNAs are transcribed by RNA polymerase II (Lee et al., 2004).
The very long primary transcripts, pri-miRNAs that are kilobases long can-
not be transcribed by RNA polymerase III. The pri-miRNAs are located in in-
tergenic locations, introns as well as in exons. The pri-miRNAs can be gen-
erated using its own promoter region. They are polyadenylated and capped
(MGpppG) (Zhang, 2008; Kim, 2005). The resulting pri-miRNA contains a hair
loop structure and is cleaved by the nuclear RNase III Drosha. This sheds frag-
ments that are thought to be degraded in the nucleus. Drosha a large protein
~160 kDa, forms a large protein complex ~650 kDa for this process (Lee et al.,
2003). This complex referred to as the microprocessor complex, also contain
the DiGeorge syndrome critical region 8 (DGCR8) protein. This interaction is
postulated to be important in substrate recognition. DGCR8 ~120 kDa is re-
ferred to as Pasha in Drosophila melanogaster and Caenorhabditis elegans (Han
et al., 2004).
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Figure 1.20: Biogenesis of microRNA
The figure shows the various steps involved in microRNA biogenesis.
A) siRNA processing; siRNA do not exist in animal cells. Its processing uses
the common machinery as microRNA processing. B) microRNA processing.
(Ghildiyal and Zamore, 2009)
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From the microprocessor complex emerges the precursor of miRNA (pre-
miRNA). This pre-miRNA located in the nucleus, has to be critically trans-
ported to the cytoplasm. It is here that the final miRNA is generated. The ex-
port of pre-miRNA is carried out by Exportin-5 (Kim, 2004). This molecule, has
been previously implicated in tRNA transport when its primary export factor
exportin-t is overloaded (Bohnsack et al., 2002). Pre-miRNAs are transported
across nuclear pore complexes, in conjunction with Ran-GTP. Exportin 5 is also
found to increase the stability of pre-miRNA, without which it is highly unsta-
ble. The whole complex is referred to as the exportin complex (Murchison and
Hannon, 2004; Weis, 1998).
In the cytoplasm the Ran-GTP when hydrolyses to Ran-GDP, results in the
expulsion of the pre-miRNA (Murchison and Hannon, 2004). The final pro-
cessing is carried out by Dicer. Dicer is highly conserved in eukaryotes and
has been experimentally proven to dice the ~70-nucleotide pre-miRNAs to the
mature ~22-nucleotide miRNA (Bernstein et al., 2001). This ~200 kDa pro-
tein(Mallory and Vaucheret, 2009) shares the PAZ domain with argonaute pro-
teins. This domain binds to the 3’ end of small RNAs (Yan et al., 2003). Even
though dicer is known to interact with various proteins, including argonaute,
it is independent in its cleavage function. This was studied with purified Dicer,
which was analyzed for its function (Zhang et al., 2004; Kim, 2005).
The complex with the mature miRNAs are referred to as miRISC (miRNA-
containing RNA-induced silencing comples). This contains both the guide
strand and the passenger strand, where, the latter strand is degraded. In the
complex there is also the argonaute proteins and might have other unknown
proteins. Thermodynamic stability difference between the strands decideswhich
is the passenger strand (Ghildiyal and Zamore, 2009). Argonaute (Ago2) cleaves
the passenger strand wherein exists only the guide strand. This strand goes
through methylation in plants and flies which increase their stability. As well,
the guide strand is loaded on to the Ago complex. The RISC is referred to as
mature-RISC, while the former state is referred to as pre-RISC (Ghildiyal and
Zamore, 2009; Kim, 2005).
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Further to this occurs target selection, where only very few mammalian
miRNAs are fully complementary to the mRNAs, which is contrary to plants.
As mentioned previously, the target is selected based on the complimentarity
of the ’seed region’ which is the 5´ end of the miRNA to the mRNA (Grimson
et al., 2007). There is nothing micro about the global effect a single miRNA
can have. The ability to control many different genes are unmatched by any
other post transcription effector. As well, the actual repression can start at the
initiation step or the elongation step of the mRNA translation (Ghildiyal and
Zamore, 2009).
Argoanute (Ago) proteins number 1 in S.pombe to 27 in C.elegans and 8
in humans (Sasaki et al., 2003). The mature miRNA is loaded onto the Ago by
unknown helicase, and there is much speculation about the actual loading (Pe-
ters and Meister, 2007). Nevertheless we know, PAZ domain in Ago proteins
bind specifically to the 2 nucleotide 3’ overhangs of miRNAs. This domain, as
previously mentioned, is available in Dicer where it utilises the same mecha-
nism for specific binding (Kim, 2005). The thermodynamic instability of the 5’,
whereby the less stably paired strand (guide strand) is incorporated into Ago
(Ago1) complex while the other passenger strand is degraded. Ago proteins
are the final effectors in the miRNA mediated translational repression. Thus
there are variations in the actual effect it induces depending on a multitude of
factors, including which particular Ago protein was used. This Ago complex,
thus is referred to as the effector complex (Mallory and Vaucheret, 2009).
1.6.2 MicroRNA in cardiovascular system
The ~22 nucleotide tiny microRNAs might be dimunitive in stature, but con-
trols diverse areas such as developmental timing, haematopoiesis, organogen-
esis, apoptosis, cell proliferation,and metastasis. Vascular cells are controlled
at cell differentiation, growth, proliferation and apoptosis by microRNAs. An-
giogenesis is under microRNA guidance as well. All this advance took place
only in the last while, as people started to look into microRNA in cardiovascu-
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lar cells only from 2005 (Zhao et al., 2005).
MicroRNAs are highly expressed in vascular cells, and are tissue specific in
their expression (Lagos-Quintana et al., 2002). MicroRNA expression have been
found to differ between arteries and heart. mir-1 expressed in the heart while
not as much in the artery, plays a role in cardiac myocyte differentiation. This
microRNA is also a target of serum-response factors (SRFs), MyoD (myogenic
differentiation factor D) and Mef2 (myocyte-enhancing factor2) (Zhao et al.,
2005). It has been shown experimentally that miR-23a, miR-23b, miR-24, miR-
195 or miR-214 as well miR-1 to have roles in hypertrophy of the heart (van
Rooij et al., 2006). miR-21 has been shown to increase proliferation in vascu-
lar smooth muscle cells (VSMCs) (Zhang, 2008). Different miRNAs have been
shown to be also involved in endothelial migration eg:- miR-21, miR-221, let-7
and mIR-222 (Suarez et al., 2007; Poliseno et al., 2006; Kuehbacher et al., 2007).
In the case of angiogenesis, Dicer knock down mice proved miRNA to be
involved (Zhao et al., 2007). miR-17-92 is an miRNA that has has been shown
to increase tumour angiogeneis (Dews et al., 2006). miR-221, miR-222, miR-27b,
let-7f are othermiRNAs implicated in tube formation (Poliseno et al., 2006; Kue-
hbacher et al., 2007). Dicer knock out endothelial cells have been very useful
in understanding miRNAs roles in angiogenesis (Yang et al., 2005; Suarez et al.,
2007). It has been shown in endothelial cells that siRNA mediated down regu-
lation of drosha doesn’t affect angiogeneis. Meanwhile, Dicer downregulation
seems to prove thatmicroRNAsmediate angiogenesis (Kuehbacher et al., 2007).
It has been shown that there are drosha independent pre-miRNAs, and hence
Dicer is processing point that all miRNAs equally pass through (Ghildiyal and
Zamore, 2009). There are also endothelial specific miRNAs such as the miR-
126 that mediate developmental angiogeneis in-vivo. With this miRNA lack-
ing, there occurs leaky vessels, hemorrhaging and partial embryonic lethality
(Wang et al., 2008).
There are gaping holes in areas such as mechanotrasduction, with respect
to cyclyc strain, shear stress in microRNA research. We were the first to show
that an array of microRNA, was regulated by cyclic strain and shear stress.
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1.7 Endothelial derived Microparticles
Artheroprotective effects are enforced under physiological forces of blood flow,
under maintenance of an intact monolayer endothelial cell barrier. Release
of substances in-vivo that promote anticoagulation, that inhibit inflammation,
cause vasodilation are encouraged under such conditions. Activation or injury
of the endothelium leads to a variety of inflammatory disorders including the
release of microparticles (MP) (Chironi et al., 2008).
Cellular microparticles (MP) are sub-micron membrane vesicles that are re-
leased from cells upon activation, apoptosis, injury (Figure 1.21). They consti-
tute a heterogeneous population of submicron elements, differing in cellular
origin (such as platelets, leukocytes, endothelial cells), number, size, antigenic
composition and functional properties (Hugel et al., 2005; George, 2008).
Initially the MPs were considerd inert ’cell dust’, while recent evidences
suggest otherwise. They have been found to interact remotely, acquiring a
pathophysiological potential (Freyssinet, 2003). Peter Wolf et al, in 1967 using
ultracentrifugation and electron microscopy identified microparticles, while
referring to as “platelet dust”. He found these capable of facilitating throm-
bin generation, in the same manner as that of intact platelets (Wolf, 1967).
Found in the plasma of healthy subjects, they increase under pathogenic
conditions. Endothelial microparticles (EMP) not only constitute an emerging
marker of endothelial dysfunction, but are also considered to play a major bi-
ological role in inflammation, vascular injury, angiogenesis, and thrombosis
(Chironi et al., 2008).
As the name implies, endothelial microparticles are derived from endothe-
lial cells. MPs are widely considered as bi-layered membranes, with antigenic
composition very similar to the cell membrane of origin. There is this loss of
ability to maintain normal phospholipid architecture, which normally is assy-
metric (Dignat-George et al., 2004). The production of microparticles is very
stringent. There are MPs in circulation from necrotic cells with loss of mem-
brane integrity, originating from mechanical destruction of cells following in-
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jury (Hugel et al., 2005).
1.7.1 Structure and generation of microparticles
1.7.1.1 The assymetric plasma membrane
Generation of microparticles are effectively caused by the remodeling of the
plamamembrane under pro-coagulant, pro-inflammatory or apoptogenic stim-
ulation. Resting cell membrane exists in an assymetrical design with vari-
ous phospholipids. In this arrangement, phosphatidylserine (PS) and phos-
phatidylethanolamine (PE) are kept inside with phosphatidylcholine (PC) and
sphingomyelin kept externally. The enzymatic equilibrium between flippase,
floppase and scramblase maintain this assymetry. Sudden increase in cytoso-
lic calcium disturbs the transmembrane steady state. Basic mechanism of mi-
croparticle generation was studied in-vitro on platelets. This is similar in all
cells except for the differring antigenic composition (VanWijk et al., 2003; Hugel
et al., 2005; Boulanger et al., 2006; Piccin et al., 2007). Different antigenic turnover
and phospholipid content is clearly seen. This depends on the microparticle
lineage (Geo, 2008; Heijnen et al., 1999). The differing antigenic composition
also depends on the mode of initial activation. Such as whether its due to cal-
cium ionophore, ATP depletion, lipopolysaccharides, thrombin, complement,
cytokines or autoantibodies or similar mechanisms. Thus microparticles play
an important role in carrying slice of information that are locally important for
the attention of the cell remotely located (Piccin et al., 2007; Horstman et al.,
2009; Bertolini et al., 2006; Sabatier et al., 2009).
Activation of the cells results in release of calcium by the endoplasmic retic-
ulum, resulting in downstream calpain activation. The precise players in the
mechanism of microparticle release has not been fully elucidiated. The calpain
activation ensures cytoskeletal cleavage and further blebbing, shedding of the
MP. Loss of assymetry leading to the PS being externalized is a prelude to the
activation of the cytosolic enzymes including calpain (Piccin et al., 2007).
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Figure 1.21: A Microparticle
Sub-micron particles that are microparticles, are shed constantly. Under patho-
genesis, they increase. Different agonists induce microparticles with different
antigenic components. They play vital role in priming the an organism to the
state of affairs with every hear beat. The figure shows the arrangement of var-
ious proteins, associated molecules in a microparticle. Note that p-selectin is
a marker for microparticles, once isolated from plasma. Understanding of the
composition of MPs have profound diagnostic value. Though, molecules are
associated with different agonists, there are common structural components.
These could include cytoskeletal molecules, actin. Our knowledge ofmicropar-
ticles, its composition, activation pathways, enumeration with different ago-
nists are all limited. The image was taken from (Hugel et al., 2005).
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Figure 1.22: PlasmaMembrane plasmamembrane normally exists as an asym-
metric lipid bilayer. Proteins and lipids help architecturally with non-covalent
interactions. Sphingolipids, glycosphingolipids and phosphatidyl-choline are
decorated at the outer leaflet while glycerophospholipids exist in the inner
leaflet. Receptors such as the glycosylphosphatidylinositol (GPI)-anchored
proteins (shown in purple, such as uPAR) exist extracellularly doesn’t have
a transmembrane domain or a cytoplasmic domain. There are other recep-
tors such as integrins that span across, touching intracellularly and extracellu-
larly. There are nanodomains (less than 5nm) that organize the lipid rafts (they
are highly heterogeneous, highly dynamic, sterol− sphingolipid enriched do-
mains). Inside the plasma membrane, cytoskeletal proteins provide the neces-
sary adhesiveness by binding to proteins and lipids directly associatedwith the
plasma membrane. Loss of this asymmetry is leads to microparticle formation.
(Viola and Gupta, 2007)
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Figure 1.23: Flip Flop Scramble
The loss of assymetric composition of the plasma membrane leading to mi-
croparticle formation.
(Burnier et al., 2009)
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1.7.1.2 Flip, flop, scramble
Assymetry of the eukaryotic plasma membrane is ubiquitous. There is an ex-
ternal and internal leaflet maintained at the expense of energy. Adenosine
triphosphate (ATP) dependent amino phospholipid translocase transports PS
and PE from the external leaflet to the internal leaflet.This transport is much
faster for PS than for PE, as this is against the concentration gradient actively
spending energy. The transportation time is between 5 minutes to 10 minutes
half-time for PS (Zwaal et al., 1989). Mainainence of assymetry is achieved with
PS and PE in the inner leaflet with sphingomyelin and PC kept externally, and
is under the control of a couple of factors. ATP dependent amino phospholipid-
specific translocase also referred to as flippase is rapid and specific. There
is also the slower ATP-dependent nonspecific lipid floppase, responsible for
transportation from cell’s inner to external leaflet. There is also the scramblase,
Ca2+ dependent nonspecific lipid transporter randomly moving lipids across
both leaflets (Figure 1.23).
1.7.1.3 Loss of Assymetry and Microparticle Generation
Under physiological condition, the Flippase is the predominant player among
the three, enabling PS and PE to be continuously moved internally. While flop-
pase without specificity, and at a slower rate moves the phospholipid exter-
nally. Ca2+ concentration under normal physiological concentration, doesn’t
stimulate scramblase. The assymetry ismainly lost under stimulation of scram-
blase, under a sustained calcium increase externally with release from inracel-
lular stores. This also affect negatively the translocase or otherwise referred to
as the flippase. With the loss of the assymetry there occurs PS randomisation
across the plasma membrane, which is then decorated externally.
The assymetry loss can be experienced within one minute of “lipid scram-
bling”. Sustained calcium release is essential for functional scrambling. Cal-
pain activation is one of the essential preludes to the microparticle release, oc-
curring via blebbing by cytoskeletal breakdown (Figure 1.24). Calpain also ir-
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reversably degrade translocase, which otherwise can be restored, by removing
intracellular calcium that stop scrambling.
Figure 1.24: Distal elements in Microparticle formation
The cleavage of actin and its associated proteins, leading to microparticle for-
mation. (Burnier et al., 2009)
Such a controlled methodology for microparticle generation is not always
the case eg: microparticle release from necrotic cells. More importantly the
lack of assymetry, PS externalisation, encapsulation defines microparticles. Ex-
osomes are a subset of microparticles that are generated, not from the plasma
membrane, but rather from other internal membranes. Exosomes have highly
enriched tetraspaning molecules and also play significant role in antigen pre-
sentation (Thery et al., 2002). Each microparticle from even the same same cell
type, have differing protein composition. This is essentially due to the fact that
microparticles are a slice of information for the interest of remote cells, contin-
uously relaying information. "There is no news like bad news" and pathogenic
conditions increase the microparticle content.
1.7.2 Role of Proteins
Earlier experiments show the thermodynamic incompatibility of cytoskelal pro-
teins in maintaining the assymetric plama membrane (Frickenhaus et al., 1998).
Labs have been able to maintain the lipid distribution while lacking any cy-
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toskeletal proteins. This was maintained with no plasticity and as an inert
distribution (Bevers et al., 1999). In a dynamic cell, undergoing differerent pres-
sures plasticity is essential while at the same time maintaining the assymetric-
ity. To maintain the plasticity of the membrane help of cytoskeletal proteins
cannot be excluded (Sheetz, 2001).
Interplay between lipids and proteins is essential for membrane remodel-
ing. Like a dynamic fitting glove, these mechanisms are used by the cell to
generate, sense and stabilise local regions of membrane curvature. Areas of
highmembrane curvature frequently exist, but for only limited periods of time.
Surrounding proteins are utilized to change the morphology. Thus in the for-
mation of highly curved vesicles, the curvature is induced by the effects of
membrane-associated proteins, the ‘coat proteins’. The curvature is readily re-
versible when the coats dissociate, leaving the vesicle more fusogenic (as their
curvature is not stabilized) and the coat proteins can now be reused in a further
round of vesicle formation (giving an efficiency to protein usage) (Sheetz, 2001;
McMahon and Gallop, 2005).
Membrane curvature is no longer seen as a passive consequence of cellu-
lar activity, but an active means to create membrane domains and to organize
centres for membrane trafficking. Curvature can be dynamically modulated
by changes in lipid composition, the oligomerization of curvature scaffolding
proteins and the reversible insertion of protein regions that act like wedges
in membranes. On a larger scale, membrane curvature is a prime player in
growth, division and movement (McMahon and Gallop, 2005).
As discussed earlier the cell membrane bilayer leaflet interaction is more
than a brownian movement (Kusumi et al., 2005). The lipid properties ex-
ert a permissive state for membrane curvature. The properties of the lipids,
their headgroup binding to the membrane proteins aid in the recruitment of
proteins necessary to generate the curvature (Bi et al., 2002). Head group of
phophoinositides are easily modified and thus are key players in the lipid-
protein interaction in the membrane, leading to its curvature (Litman, 1973).
PtdIns(4,5)P2 (PIP2), the moesin phosphorylator is essential for budding, and
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so is PtdIns-3-OH kinase with which Hrs (hepatocyte growth factor-regulated
tyrosine kinase substrate) and other FYVE domain proteins interact (Fernandez-
Borja et al., 1999; Gruenberg and Stenmark, 2004). Clathrin, COPI and COPII
coat proteins, that interact with these lipids work in collaboration with other
proteins, as they do not have direct membrane associations (Ford et al., 2001;
Bi et al., 2002). Caveolin is another protein, but membrane associated, which
oligomerises to form the coat (Razani and Lisanti, 2001).
1.7.3 Cytoskeletal Influences
Reversible membrane curvature is either categorised as positive or negative.
Membrane that curve inwards towards the cytoplasm as positve (shallow pits,
ealy stages of vesicle budding) and budding out of the cell as negative cur-
vature (McMahon and Gallop, 2005). Of the many mechanisms involved in
the deformation of the membrane, actin and cytoskeletal protein’s also has a
role. Actin polymerisation and the pulling of the tubules by motor proteins
curve the membrane. Branching, bundling and treadmilling of actin filaments
are involved in the generation and remodeling of many areas of high mem-
brane curvature, including filopodia, pseudopodia, phagocytic cups and ax-
onal growth cones (McMahon and Gallop, 2005). There is a propulsive power
involved with the actin cytoskeleton mechanics due to the conductance of the
membrane tension, both contributing to it and affected by it. In-vivo and in-
vitro work have also implicated the microtubules, as well as implicating actin
mediated transport of vesicles via myosin (Buss et al., 2002). Curvature de-
pendent banana-shaped lipid-binding BAR domain proteins also have links to
actin and microtubule polymerization machinery (Peter et al., 2004). Curva-
ture induced localization of GAP or GEF activities leads to tight regulation of
small G-protein GTP/GDP status. This has been proposed to result in selective
actin polymerization or signaling pathway activation, as an molecular ecolog-
ical niche (McMahon and Gallop, 2005).
In terms of microparticle release, the loss of adhesion between the lipid bi-
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layer and the cytoskeleton, including the breakdown in the cytoskeleton is a
culminating event in the blebbing process (Sheetz, 2001). As mentioned earlier
the target of the calpain and other cytosolic enzymes is primarily the cytoskele-
ton (Chironi et al., 2008).
1.7.4 Exoskeletal Influence
On the exoskeleton, dynamin family sculpt the membrane topology into tubu-
lar shape from the outside (Hinshaw and Schmid, 1995). They also via GTP
hydrolysis, induce membrane fission (Marks et al., 2001). These are part of
the scaffolding proteins that form helical oligomers. Previously mentioned
coat proteins Clathrin COPI, COPII and Claveoli are also classed as exoskele-
tal proteins. On binding to phospho inositols they oligomerise scaffolding the
membrane into tubular shape. BAR domain proteins have preferential binding
to these curved membrane structures. This is due to their nature of binding,
which is electrostatic, leading to more avidity (multiple low strength bonds).
Dynamin (which is a dimer) binds to amphiphysin (a BAR domain protein)
more strongly when amphiphysin is a dimer (McMahon and Gallop, 2005; Pe-
ter et al., 2004).
Thus the shape of the membrane also drives downstream binding or not, of
other proteins. Other examples of these very important BAR domain contain-
ing proteins are endophilins, BRAPs and nadrins (Peter et al., 2004).
Other domains such as the PH or the PX act as important targeted domains,
that take them to specific compartments. BAR domain containing proteins are
a sensor for positive curvature, with BAR domain lipid-binding mutant even
with the PH domains, unable to bind to the membrane. Studies on the ex-
osekeletal proteins are more elucidiated due to the obviousness of these pro-
teins, but the cytoskeletal proteins though unappreciated, plays a significant
role (Peter et al., 2004).
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Figure 1.25: Microparticle formation
The plasma membrane is arranged in its normal asymmetric form by means of
"lipid rafts". Whereby, there is movement of lipids actively. There are proteins
both cytoskeletally and exoskeletally involved in maintaining this status quo.
Transient change in any of these proteins, would thus automatically lead to
formation of blebs, finally forming MPs. The image was taken from (Hugel
et al., 2005).
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1.7.5 PIP2 in the Membrane
1.7.5.1 Structure and Production
With respect to membranes, phosphoinositides are acidic phospholipids found
at the inner leaflet of cell membranes, primarily in the cytoplasmic leaflet. They
border the specific subcellular membrane compartments. Phosphoinositides
act as membrane recognition sites for specific cytoplasmic proteins, and act
from the membrane to modulate the activities of some membrane proteins.
They have myo-inositol in the head group and their parent compound is phos-
phatidylinositol (PI). PI can become phosphorylated on the 3, 4, and 5 positions
of the inositol ring in every combination. Seven low-abundance polyphospho-
inositides are possible in this manner, with very specific subcellular localiza-
tions such as plasma membrane, golgi complex, endoplasmic reticulum, late
and early endosomes (Suh and Hille, 2008; Di Paolo and De Camilli, 2006).
PIP2 is the most abundant poly-phosphoinositide in the plasma membrane.
Though constituting only 1% of the total acidic lipid in a cell, it is all primarily
found in the membrane. PIP2 with one phosphodiester linkage has a phos-
phate group and additionally two more phosphate groups (McLaughlin et al.,
2002). Classically PIP2 is cleaved by the enzyme phospholipase C (PLC), a
reaction that produces the two classical second messengers, soluble inositol
1,4,5- trisphosphate (IP3) and membrane-delimited diacylglycerol (DAG). IP3
and DAG go on to release Ca2+ from intracellular stores and recruit and acti-
vate protein kinase C (PKC), respectively. PIP2 is a primary product, that when
cleaved leads to two major signaling pathways (Hilgemann, 2007; McLaughlin
et al., 2002; Xu et al., 2003).
1.7.5.2 Implicating PIP2
The signaling role for PIP2 was not appreciated till the 1990s. PIP2’s ability to
serve as targeting anchor for proteins, that catalyze endocytosis and exocytosis
is now well known. So is its ability to anchor small molecular weight GTPases
and actin (Hilgemann, 2007; Suh and Hille, 2008). The significance of PIP2 in
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phosphorylating moesin has been discussed in depth earlier. When it comes
to microparticles, losing the membrane assymetry is a crucial factor, and PIP2
is significantly present in the membranes. It is an obvious candidate in these
circumstances, for example, red blood cells (RBC) exists as a biconcave discoid
body with the crenation of these cells holding unique functionality. PIP2 con-
verting to phophatidylinositol (this molecule has a smaller polar head group)
occurs at the same instance in accordance with the classic bilayer model pro-
posed in 1974 (Ferrell Jr, 1984; Sheetz and Singer, 1974).
Also, PIP2 specifically and not other phosphoinositides is essential in the
redistribution of the membrane lipids on addition of Ca2+ (or at ten times
more concentration Mg2+). The specificity of PIP2 when compared to other
phophoinositides is interesting, but they inferred that no protein to be involved
in the scrambling process. This was because both sides of the erythrocytemem-
brane could respond to Ca2+ provided they contained enough PIP2, (since then,
phospholipid scramblase (PLSCR1) has been cloned that exhibits Ca2+activated
PL scrambling activity in-vitro). There was also no increase in cytosolic Ca2+ on
addition of calcium externally (Sulpice et al., 1994). This is important as in-
crease in the cytoplasmic Ca2+ more than 1µM inhibits translocase (Bitbol et al.,
1987; Zachowski et al., 1986).
Indirect implication of PIP2 in microparticle release in unnecessary, with
both exocytosis and endocytosis directly influenced by PIP2. Membrane bleb-
bable particles are docked to the membrane, when levels of PIP2 is increased.
It acts in priming the vesicles and the plasma membrane by acting in cis to the
plasma membrane proteins, such as Ca2+ dependent activator protein (CAPS),
a priming factor in neuroendocrine cells. While it acts in trans on the vesicle
proteins such as synaptotagmin, a Ca2+ sensor for exocytosis (Martin, 1998; Bai
et al., 2003). The secondary products of PIP2 cleavage DAG and IP3 are impor-
tant in priming, regulating calcium response respectively. Endocytic proteins
are selective and PIP2 is an important co-receptor and regulator in their recruit-
ment. They bind to dynamin and to all known endocytic clathrin adaptors such
as epsin,AP-2, AP180/CALM (Wenk and Camilli, 2004; Owen et al., 2004).
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1.7.5.3 The Cytosolic Interaction
Regulation of integral membrane proteins or recruitment of membrane cy-
toskeletal and signaling components, is achieved through the binding of their
head groups to cytosolic proteins or cytosolic domains of membrane proteins.
The phosphate(s) on the inositol ring of these phosphoinositides have nega-
tive charge, thus electrostatic interactions modulate the interaction with cy-
tosolic proteins. In some cases, adjacent hydrophobic amino acids strengthen
the interaction through a partial penetration into the bilayer (Di Paolo and
De Camilli, 2006) .
Actin regulatory proteins like profilin, with clusters of basic residue and
folded modules such as the pleckstrin homology domain are ideal candidates.
FERM domain proteins, like moesin have these PH domain in their F3 lobe.
Myosin X (Myo X) is another protein with the F3 domain containing PH do-
main, in addition to the two more it has (Berg, 2000). The repertoire of phos-
phoinositide binding modules is rapidly expanding, thus increasing the un-
derstanding of the scale of signaling potential via phophoinositides (Lemmon,
2003; Balla, 2005; Hurley and Meyer, 2001; Di Paolo and De Camilli, 2006).
A wide range of actin binding proteins are recruited by the phosphoinsosi-
tides, they utilise small GTPases for these purposes (Hilgemann, 2007; Suh and
Hille, 2008). Actin polymerisation via ARP2/3-mediated nucleation of actin
networks is well studied, wherein PIP2, in cooperation with the small GTPase
Cdc42, binds N-WASP and triggers a conformational change that allows its
binding to and activation of the ARP2/3 complex (Rohatgi et al., 2000; Pollard
and Borisy, 2003). The PIP2 effects are further amplified by the recruitment of
N-WASP activators such as Toca in concert with CDC42 and other phosphi-
nositides (Ho et al., 2004). Even in the CDC42 independent mechanism of actin
nucleation via Nck-stimulation, PIP2 is synergestically required (Rohatgi et al.,
2001).
PIP2 also mediates the dissociation of capping proteins, such as gelsolin
and CapZ. This results in actin filament elongation via the addition of G-actin
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monomers at the plus end. For this pupose G-actinmonomers are pumped into
the reaction pool by PIP2 dissociating the actin-monomer–profilin complexes
via binding to profilin (Yin and Janmey, 2003), (Pollard and Borisy, 2003). Also,
adaptor proteins such as the FERM domain proteins, such as moesin, are re-
leased from their homodimer state into phosporylated active monomers by
PIP2. This also results in the important adaptor protein talin to strengthen its
binding to the integrins. Type I phosphatidylinositol phosphate kinase iso-
form g661 (PIPKIg661), an enzyme that makes PIP2, is targeted to focal ad-
hesion by binding to Talin at its FERM domain. This is an instance of ensur-
ing spatial specificity in phosphoinositide signaling (Ling et al., 2002; Di Paolo
et al., 2002). Pathogens sometimes inject a protein similar to mammalian in-
ositol phosphatase (eg: Shigella and Salmonella), which eases its entry, due to
the loss of adhesion between the membrane and the actin cytoskeleton. This
results from the phosphoinositide imbalance as noted from the depletion of
PIP2, from the base of membrane ruffles in the proximity of the bacterial inva-
sion (LeBrasseur, 2002).
PIP2 and the Microparticle
Figure 1.26: PIP2 and intracellular adhesion of actin
PIP2 by means of its actin binding proteins, maintain cell membrane adhesion
to actin. Loss of this, leads to bleb formation. This is utilized in endocytosis,
exocytosis and microparticle formation.
(Sheetz, 2001)
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PIP2 contributes to the strengthening of adhesion between the membrane
and the cytoskeleton, as noticed by the directly proportional increase inmembrane-
cytoskeleton adhesion energy. While, Cytochalasin a potent inhibitor of actin
polymerization, as well as overexpression studies using PH domain (binds
specifically to PIP2) results in reduction of the membrane-cytoskeleton adhe-
sion energy. Expression studies using PH domains result in PIP2 being se-
questered (Raucher et al., 2000). Transfection studies using IpgD, a potent PIP2-
phosphatase IpgD (virulence factor from Shigella flexneri), also results in simi-
lar reduction in adhesion via dephosphorylation of PIP2 (Niebuhr et al., 2002).
Numerous studies have looked into membrane-cytoskeletal loss of adhesion
(Sheetz, 2001). As loss of cortical actin is associated with protrusions of the
plasma membrane. This is then followed by vesicle formation which is pre-
ceded by reduction of membrane-cytoskeleton adhesion (Flaumenhaft, 2006).
Actin binding proteins such asα-actinin, ezrin, radixin, and moesin bind
with high affinity to PIP2 (Flaumenhaft, 2006). Membrane and cytoskeleton
adheres mostly via avidity (more numbers than the strength of the binding)
than affinity, especially with PIP2 present at a concentration of 1,000–10,000
molecules per µm2 of membrane (Sheetz, 2001; Flaumenhaft, 2006). Spectrin
and talin also contribute to the adhesion process this way, with studies show-
ing difficulty in extracting them frommembranes enriched in phosphatidylser-
ine (Manno et al., 2002; Shiffer and Goodman, 1984).
The loss of adhesion betweeen cytoskeleton and membrane results in bleb
formation. Studies with PIP2 depletion, PIP2 sequestration, ATP depletion, all
results in loss of membrane-cytoskeletal adhesion resulting in blebs (Sheetz,
2001). PIP2 on addition to RBC promotes Ca2+ dependent transbilayer move-
ment of phosphatidyl serine with subsequent redistribution in the phospho-
lipids (Sulpice et al., 1994).
Clear evidence so far is the reduction of microparticle formation in platelets
pre-incubated with PIP2 via the thromin-collagen or Ca2+ ionophore pathway
with upto 90% reduction, with other phospholipids lacking a similar effect.
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1.8 The Urokinase System
Other receptors, unlike integrins, that lack a transmembrane domain and cy-
toplasmic domain also play important roles in adhesivness. These molecules
though less well characterized, are also integrators of focal adhesion dynamics.
Molecules such as syndecan-4, uPAR (urokinase plaminogen activator recep-
tor), layilin, transmit their niche signals by utilizing integrins among various
other molecules, as well adapters which act to stablise this information pas-
sage between extracellular matrix and the membrane and inward into the cell
(Geiger et al., 2001).
Similarly specific internal cues are transmitted outward utilizing the inside
out signaling of integrins. This is effected using adapters that might have
unique roles in effecting a change in these receptors. These rapid exchange
of information is regulated by cleavages of molecules, phosphorylation / de-
phosphorylation and recruitment of scaffolds (Ragno, 2006). Existence of these
molecules in evolutionary terms have roles concurrently to their uniqueness.
One of the best characterized receptor of this kind is the uPAR. Binding
integrins, EGF receptor, high molecular weight kininogen, caveolin and the G-
protein-coupled receptor FPRL1, uPAR orchestrates various functions of a cell
(D’Alessio and Blasi, 2009). uPAR is a critical component of the plasminogen
activation system (Blasi and Carmeliet, 2002). This receptor was identified 24
years ago in monocyte like cells, being able to sense and accumulate its lig-
and urokinase-type plasminogen activator (uPA) on the membrane. Though
famous for its enzymatic and thus proteolytic properties, last decade has shed
new light on this versatile molecule, found overexpressed during inflamma-
tion and in most metastatic cells. Its importance in angiogenesis comes down
to ECM remodeling utilizing downstream matrix-metalloproteases (MMPs) to
remodel tissues. Its ability to exert control over integrin binding to fibronectin,
collagen as well the innate ability to bind to vitronectin, lends regulatory func-
tion of adhesivness of cells (Madsen and Sidenius, 2008).
Urokinase (uPA) is the most well characterized ligand of uPAR, together
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with tPA (Tissue plasminogen activator) they activate plasminogen. Combined
uPA / tPA-deficient mice havemore profound effect resulting in severe sponta-
neous thrombosis, the effect similar to plasmin deficient mice. Plasminogen is
present in plasma and extracellular fluids and the plasminogen cascade remod-
els the ECM extensively. Cleavage of plasminogen at the Arg561-Val562 bond,
generates the serine-protease plasmin, able to degrade various ECM such as
fibrinogen, fibronectin and vitronectin. uPA and tPA, the physiological activa-
tors of the plasminogen, both yield two chains held together by a disulphide
chain. They are both released from the endothelium while plasminogen is pro-
duced in the liver (O’Rourke et al., 2006). Initially released as a single chain,
uPA in this form is a zymogen. In this form uPA is inactive and differs from
tPA . tPA activity is potentiated on binding to fibrin resulting in fibrinolysis,
while uPA’s differing roles are cell migration, tissue invasion, such as inflam-
mation angiogenesis and tumor invasion.
1.8.1 Structure of uPAR
uPAR is attached to the cell surface sensing the extracellular space via a pe-
ripheral glycosyl-phosphatydil-insositol (GPI) tail at the Gly 283 residue of the
uPAR, at the C terminus. This tail doesn’t span cell membrane and only pe-
ripherally anchors the uPAR.
This necessitates collaboration with receptors that bore deep into the cy-
toplamic regions of a cell (Ploug et al., 1991). uPAR is a single polypeptide
chain of 313 amino acid residues decorated with a 21-residue signal peptide.
Gly 283, the site of GPI attachment is exposed on removal of 30 C-terminal
residues. This removal is by a postranslational mechanism. GPI-anchor con-
sists of phophatidylinositol attached to a carbohydrate chain via the C-6 hy-
droxyl of the inositol, connected to the protein through and ethanolamine phos-
phate moiety (Blasi and Carmeliet, 2002). uPAR is arranged into folded homol-
ogous with almost globular structures referred to as D1,D2 and D3 from the be-
ginning of the N-terminus respectively. Each of these folded regions have im-
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portance when binding to various ligands and in peripheral association with
other receptors. These structures are members of Ly-6/uPAR/α-neurotoxin
protein domain family consisting of 90 amino acids with 4 to 5 disulphide
bonds (Ploug et al., 1993; Behrendt et al., 1991a).
These three domains individually fold as three finger structures, similar to
other proteins of the same family (Llinas et al., 2005). Previous evidences have
shown it to contain as well multiple structures, similar to metastasis-associated
C4.4A (Ploug et al., 1993; Behrendt et al., 1991a). D1,D2 and D3 domains exist as
β-pleated sheets arranged into the three finger structures, ending with a small
C-terminal loop (Llinas et al., 2005).
There is a 19 Å, central ligand docking cavity tapering towards the D3 re-
gion. Topology/structural preference due to the cavity, as well the existence of
the ligand peptide here, draws in the ligand to this void of attraction with half
of it binding to the D1. The ligand peptide provides multiple anchorage to the
ligand, while the linker regions between D1, D2 is especially proteolytically
sensitive, thus is exposed to the large outer surface. Additionally uPAR incor-
porates five N-linked glycosyation sites (N52,N162,N172,N200 and N233), also
in the large outer surface. This enables it to bind multiple ligands while hold-
ing uPA inside the cavity (Blasi and Carmeliet, 2002; Llinas et al., 2005; Illemann
et al., 2009)
Observations in-vitro has shown the sensitivity of uPAR to enzymes such
as trypsin, chymotrypsin, elastase, cathepsin G, metalloproteases as well by
plasmin and uPA. These enzymes generate varying products. Truncated forms
lacking D1 is referred to as c-uPAR, with the varying differences at the N-
terminus amino acid region 88-92. c-uPAR has also been found in-vivo, in
both normal and cancerous cell types, with evidence to show uPA can be sim-
ilarly proteolytic in-vivo. The 88-92 amino acid region that is affected is espe-
cially pertinent to cell migration (Illemann et al., 2009; Mondino and Blasi, 2004;
Ragno, 2006)
The full length as well the cleaved form also exists as soluble uPAR and is
often shed from a cell. In this form its referred to as suPAR or c-suPAR cor-
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responding to the existence of D1 or not. The full length uPAR form is gener-
ated by the juxtamembrane cleavage in-vivo by glycosylphosphatidyl-inositol-
specific phospholipase C or D (Ploug et al., 1991; Wilhelm et al., 1999; Beaufort
et al., 2004b,a). There is evidence to this soluble full length suPAR’s ability to be
cleaved further, to produce c-suPAR. The enzymes implicated in this process
are metalloproteases, cathepsin G and elastase (Montuori et al., 2005b).
1.8.2 Genetic regulation of uPAR
The human uPAR gene is at the locus 19q13 (long arm of chromosome 19) with
seven exons spanned by six introns, all together 23 kb in size (Casey et al., 1994;
Suh et al., 1994). A GC rich region lacking TATA and CAAT boxes with con-
sensus elements for SP, AP1, AP2, PEA3 and NFkB has been identified as the
major transcription start site (Soravia et al., 1995; Wang et al., 2000). This region
within 188bp from the major transcription start site of the uPAR gene between
-141 and +47 bp relative to the transcription initiation site is implicated as a
silencing agent. Experimental evidence has shown the deletion of PEA3/Ets
motif, to impair the β3-integrin mediated downregulation of uPAR expression
(Hapke et al., 2001). In colon cancer cells uPAR receptor is overexpressed by
transcrptional regulation via Kruppel-like transcription factor, utilizing multi-
ple sites in the uPAR promoter (Wang et al., 2004). Post transcriptional regu-
lation, is another level of control over uPAR expression with several sequence
elements identified. AU-rich elements (AREs) in the 3’ untranslated region
(UTR) of the uPAR transcript, functioning to make it significantly unstable
(Ragno, 2006). Meanwhile, ELAV protein HuR and heterogeneous nuclear ri-
bonucleoprotein C (hnRNPC) bind uPAR ARE, stabilising uPAR mRNA (Tran
et al., 2003; Shetty, 2005). In small lung carcinoma a stabilising factor binds,
upregulating the uPAR, while this factor is not hugely present in normal cells
(Montuori et al., 2001, 2003). Meanwhile, phosphoglycerate kinase (PGK) in
bronchial epithelial cells drive uPAR mRNA degradation by binding specifi-
cally to a regulatory element in the coding region (Shetty et al., 2004; Shetty
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and Idell, 2000). Urokinase (uPA) upregulates uPAR expression in MDA-MB-
231 breast carcinoma cells by increasing SP1 binding activity, while in lung car-
cinomas cells by increasing uPAR mRNA stability (Montuori et al., 2003; Zan-
netti et al., 2000). Thus the major ligand of uPAR, uPA regulates the uPAR’s ex-
pression both transcriptionally and post-transcriptionally. Unidentified rapid
cytoskeletal elements, recruited by uPA, obviously has implications.
1.8.3 Structure of Urokinase (uPA) and its association to uPAR
Urokinase, the pro-enzyme is a 54 kDa single chain, and is inactive referred
to as pro-uPA or sc-uPA. This is converted into the active form by a single
proteolysis at Lys158-Ile159. This active form is commonly referred to as uPA,
now consisting of two chains.
Urokinase both in the form of pro-uPA and uPA folds into three parts. There
is an amino terminal fragment (referred to as ATF, residues 1-135) in which ex-
ists the first two domains (Behrendt et al., 1991b; Llinas et al., 2005). Epidermal
growth factor (EGF)-like domain (residues 4-43,GFD) exists in the noncatalytic
amino-terminal A chain, after which lies the tripledisulphide containing struc-
ture called kringle domain (residues 47-135) (Vassalli et al., 1985; Stoppelli et al.,
1985). The ATF has strong specificity to the uPAR . The last part of the folding
topology is a βchain with serine-protease domain, which doesn’t bind to the
uPAR. This is the C-terminal domain, referred to as the low molecular weight
uPA (Behrendt et al., 1991b; Llinas et al., 2005).
As disucssed earlier uPA binds to D1 andwith decreasing affinity to D2 and
D3. Thus a full length uPA (active) has been found to be significantly more
specific (1500 times) than to just D1 alone (Behrendt et al., 1996). Further to
these factors there seems to be a need for D1 and D3 to be proximal for strong
binding to uPA, which enhances affinity of the multiple binding site (Ploug,
1998). In the uPA EGF domain is the receptor binding part of uPA, thus ATF, as
well pro-uPA and uPA, all have high affinity to uPAR (Ploug and Ellis, 1994).
The association of uPA to uPAR monomers also results in uPAR dimers which
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then preferentially moves into the lipid rafts (Ragno, 2006).
1.8.4 The other ligands of uPAR
Vitronectin (VN) was identified as another binding partner to uPAR in 1994
(Wei et al., 1996). VN concentrates and stabilises active PAI-1 which inhibits
the plasminogen activation system. VN is well known as being able to bind
and interact with the integrin family (αvβ1, αvβ3,αvβ5,αIIβ3) (Hynes, 1992;
Preissner, 1991) via the RGD motif (Pytela et al., 1985). As the plasminogen
system took importance with respect to uPAR, uPA was increasingly consid-
ered incorrectly to be the only ligand. Including vitronectin, it also binds to
high molecular mass kininogen (HKa). HKa as well as VN both require a full
length uPAR for efficienct binding, differing with uPA over binding sites be-
ing in D2 and D3 (Ragno, 2006). Another aspect in which uPA binding differs
to vitronectin binding is in its more efficient binding to uPAR dimers, as well
association with lipid raft (Cunningham et al., 2003). uPAR binds VN at the
somatomedin B domain (SMB) of vitronectin (Binder et al., 2007). uPA induced
binding to VN requires the extracellular protein kinase casein kinase-2 (CK2),
to phosphorylate vitronectin.
uPAR is abe to adhere to vitronectin possibly as part of the initial adhesive
mechanism, but cannot spread or migrate without the integrins. Specific abol-
ishment of CK2 was found to totally abolish uPA induced vitrnoectin binding
to uPAR (Stepanova et al., 2002; Madsen and Sidenius, 2008)
Hka and VN due to theire similar binding regions in uPAR is competitive,
with Hka binding inhibiting VN binding (Chavakis et al., 2000). PAI 1 (Plas-
minogen acitvator-inhibitor 1), an important regulator of uPA-uPAR associa-
tion also inhibits VN binding to uPAR. This is due to similar association areas
of PAI1 on VN as uPAR, also proximal to the integrin binding site (Dellas and
Loskutoff, 2005). Vitronectin circulates the blood as a monomer, but on stabi-
lizing as ECM turns multimeric. Similar to uPAR, VN plays functional roles
in regulating cell adhesion, migration and proliferation (Hayman et al., 1983;
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Figure 1.27: Vitronectin binds to uPAR
Casein kinase-2 (CK2) by phosphorylating vitronectin (Vn) regulates uPA-
uPAR association with vitronectin. Integrins are recruited to effect cytoskeletal
changes as uPAR lacks cytosolic domains.
(Blasi and Carmeliet, 2002)
Reilly andNash, 1988; Blasi and Carmeliet, 2002; Ossowski and Aguirre-Ghiso,
2000).
1.9 Transducers of uPAR signals to the cytoplasm
The extracellular receptors that has the cytoplasmic domain, such as integrins,
caveolin and G-coupled receptors can interact with uPAR (Blasi and Carmeliet,
2002). These interactions utilize the need for information transmission inwards,
into the cytoplasm of the cells. These outside-in signaling mechanisms inter-
nally recruit adapters specific to the cues transferred, and transmembrane re-
ceptors used (Figure 1.28).
85
1.9.1 Integrins and uPAR interactions
Integrins have been discussed previously in great detail and are cell surface
receptors that bind to ECM and pass information bidirectionally. The associ-
ation of integrins and uPAR, has led to considerable excitement in the field
(Figure 1.28). This has brought to focus other signaling molecules associated
with integrins and plausible effect on uPAR of these molecules. Different tech-
niques have proven the the interaction of uPAR with the β1, β2, β3 and β5 inte-
grins. Experiments such as FRET (Fluorescence resonance energy transfer an-
alyzis), co-immunoprecipitation, immunolocalization, uPAR binding peptides
from phage libraries, have all gathered evidence in this regard (Ragno, 2006;
Blasi and Carmeliet, 2002; D’Alessio and Blasi, 2009). The ability to transduce
signals to the internal compartment of the cell from outside the cell membrane,
resulted in the nomenclature "integrin" (Giancotti and Ruoslahti, 1999). Inte-
grin signaling is now well established regarding its bidirectionallity i.e, the cy-
toplasmic domain interactions of the integrins being able influence interaction
of its extracellular domains as well as vice versa.
Migration due to uPA-uPAR interactions and other ligand-uPAR interac-
tions have been found to recruit integrins. Antibodies against uPAR has been
found to block cell adhesion, migration as well as proliferation, whilst inter-
acting with various ligands. This effect is similar to when antibodies targeting
integrins are used (Wei et al., 1996; Yebra et al., 1996; Degryse et al., 2001). Be-
yond proving uPAR-integrin signaling leading to migration, the complexities
are still left to be eliucidiated. These include understanding the induction of
all cytoplasmic and transmembrane adapters. The need to stabilize them tran-
siently and reversibly bring back the machinery that continue migration (May
et al., 1998; Waltz et al., 2000).
Leukocytes in uPAR -/- mice were extensively limited in their migration ca-
pacity via a β2 integrin pathway to inflamed peritoneum (May et al., 1998). Sim-
ilarly, other integrins have been implicated in uPA-uPAR mediated migration,
such as α5β1 in Chinese hamser ovary cells (CHO). Interestingly they showed
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temperature sensitivity, as well a requirement for activation ofmitogen-activated
protein kinase (MAPK) activation. Epithelial cells, endothelial cells, myeloid
cells have all been shown to be similarly responsive to uPA induced cell migra-
tion (Busso et al., 1994; Odekon et al., 1992; Waltz et al., 1993; Gyetko et al., 1994).
With respect to uPA, the non-proteolytic domain and the Kringle domain have
been found to not affect migration.
The integrins that interact with uPAR include integrin β2 members, uPAR
in fact, was first identified bound to these integrins in resting neutrophils (Xue
et al., 1994). Spontaneous migration led uPAR to dissociate from Mac-1(αMβ2)
with uPAR staying in lamellipodiawhileMac-1 polarised into uropods (Kindzel-
skii et al., 1996). Mac-1 also known as CR3, CD11b/CD18 is an integrin het-
erodimer, which is also a receptor for fibrinogen (Kindzelskii et al., 1996). In-
tegrins have also been shown to be associated with signaling complexes with
uPAR (Bohuslav et al., 1995). αvβ5 and αvβ3 are other heterodimer integrins im-
plicated to associate with uPAR, which are also receptors for vitronectin (Mon-
tuori et al., 1999). α4β1, α6β1, α9β1, αvβ3 are integrin heterodimers shown to as-
sociate with suPAR (Binder et al., 2007). In their work, interestingly they have
proven the specific binding between glycosyl phosphatidylinositol-anchored
uPAR on the cell surface. This binding was to integrins on the apposing cells.
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Figure 1.28: uPA-uPAR transducers
The various transducers of uPA-uPAR interactions and their functional signif-
icance. Note the interaction with integrins and G-coupled proteins.
(Binder et al., 2007)
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This adds new evidence suggesting that uPAR-integrin interactionmayme-
diate cell-cell interaction (trans-interaction) (Binder et al., 2007; D’Alessio and
Blasi, 2009).
These interactions that control migration or proliferation have roles in an-
giogenesis in which the associated integrin is αvβ3 (Brooks et al., 1998; Nykjaer
et al., 1997; Prager et al., 2004). Details of this process have been discussed
previously. Though able to bind many different integrins, “uPAR has the high-
est affinity for the bondafide fibronectin receptors α3β1 and α5β1” (Blasi and
Carmeliet, 2002).
Figure 1.29: α5β1 integrin interacts with urokinase increasing ERK activation
uPA-uPAR as well as promoting α5β1 integrin activity, it also leads to phos-
phorylation of EGF receptor (EGFR). The EGFR association with α5β1 integrin
is also tightened. The EGFR phosphorylation in this circumstance is indepen-
dent of other EGFR ligands.
(Ragno, 2006)
1.9.2 G-coupled receptors
FPR (N-formyl-peptide receptor) and its homolgues FPR-like 1 (FPRL1) and
FPR-like2 (FPRL2) are seven transmembrane domain G-coupled receptors. N-
formyl- methionyl-leucyl-phenylalanine (fMLP), is a peptide which is formy-
lated and of bacterial origin. This peptide stimulate chemotaxis, activating the
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FPR and its homogues. The fMLP receptors initially identified in leukocytes
has a broad expression pattern, including in endothelial cells (Carriero et al.,
2009; Degryse, 2008)
FPR has the highest affinity for fMLP among its homologues, while FPRL2
doesn’t bind and FPRL1 has very low affinity. FPRL1 can be activated by
lipoxin A4, serum amyloidA, the prion peptide PrP106–126, human immunod-
eficiency virus-type 1 (HIV-1) envelope peptides. Helicobacter pylori Hp(2–20)
peptide and certain synthetic peptides can bind both FPRL1 and FPRL2 (Le
et al., 2002; Nedellec et al., 2009)
In monocytes it was discovered that FPRL1 is activated by c-suPAR (Fig-
ure 1.28) (explained under structure of uPAR, is the cleaved soluble form of
uPAR with a role in migration in-vivo and shed in fluids from diseased sub-
jects) (Resnati et al., 2002b; Montuori et al., 2005a). There is infact a specific
peptide that activates FPRL1 referred to as SRSRY representing S for serine, R
for arginine and Y for tyrosine. This peptide is exposed when uPAR is cleaved
and is part of the linker region connecting D1 domain of uPAR to the D2 (Blasi
and Carmeliet, 2002).
Figure 1.30: Urokinase induce cell migration
The cleaved uPAR exposes the SRSRY sequence of amino acids from the D1-D2
linker region. This region interacts with fMLP receptors inducing cell migra-
tion.
(Ragno, 2006)
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This peptide sequence provides directionality to cell. With cells moving
towards uPA, pro-uPA and ATF gradients (Resnati et al., 1996). This active
D2D3 fragment with the exposed SRSRY goes on to bind FPRL1 (Resnati et al.,
2002b). Downstream to binding to FPRL1, different signaling molecules are
recruited. This plausibly involves some adaptor proteins utlilising the inside
out signaling route to elicit chemotaxis via integrins. Full length uPAR has
been demonstrated not to bind to FPRL1, even though it can bind to integrins
and vitronectin (Resnati et al., 1996; Fazioli et al., 1997; Resnati et al., 2002b).
The SRSRY linker region between D1 and D2 though commonly referred to
as “exposed eliciting a chemotactic resonse”, there is another reason as well.
This region differs in conformation between full length uPAR and c-suPAR.
This was understood from differential antibody binding to this region (Høyer-
Hansen et al., 2001)
1.10 The effect on cyoskeleton
1.10.1 uPAR, integrins and the cytoskelton
Internally, in the cell different adaptors and signaling kinases, phosphatases
and molecules are recruited to effect specific directed change. Integrin as de-
scribed in detail earlier recruits a whole slew of adaptors, the list of which is
still growing. uPAR lacks a transmembrane domain and a cytoplasmic domain
requiring its lateral association with various receptors including integrin.
Corneal fibroblast were used to study wound healing, where the authors
have found evidence of αvβ3 associating with uPAR. Here they discovered that
uPA-uPAR ligation leading to its association with F-actin, along the length of
the actin filament. They also found focal adhesions localised with uPA-uPAR
and αvβ3. This association, still requires αvβ3 to recruit its own set of adapters
to link to F-actin (Bernstein et al., 2004). Experimental evidence has proven
integrin binding proteins such as vinculin and FAK to be present in focal adhe-
sions and to localise with uPA-uPAR complex (Myöhänen et al., 1993)
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A characteristic of uPAR, which it shares with tPA, uPA and PAI-1 is the lack
of mRNA production in quiescent endothelial cells (Reidy et al., 1996). uPAR,
uPA is expressed heavily in migrating cells though. This feature is shared by
FERM-domain containing F-actin binding protein moesin, though moesin is
still expressed at basal levels (Batchelor et al., 2004). This protein is amain focus
of our study. Moesin has been found to induce stress fiber assembly, cortical
actin polymerization and focal complex formation in response to activation of
Rho and Rac (Mackay et al., 1997). In the results section we show howmoesin is
a downstream target of uPA-uPAR interaction and a functional trasducer. Fur-
thermore, mechanotransduction has been shown to increase uPA in otherwise
quiescent endothelial cells (Sweeney et al., 2004; Von Offenberg Sweeney et al.,
2005). It will be interesting if moesin is similarly increased with mechanotrans-
duction.
Lim and SH3 protein 1 (LASP-1) is another protein studied extensively in
our lab. This protein is associated with actin cytoskeleton. This protein has
been shown to be mechanically sensitive (personal communication Paul Fitz-
patrick). Meanwhile, Salvi et al in Italy have shown recently LASP-1 and uPA
to have a coordinated expression pattern in human hepatocellular carcinoma
(HCC) derived cells (Salvi et al., 2009). Lasp-1 is also implicated by Han Zhang
et al to be involved in cell migration and tumour formation. They have pro-
posed focal adhesion protein lipoma preferred partner (LPP) to be involved in
this process (Zhang et al., 2009).
uPA activates a number of tyrosine kinases involved in cytoskeletal regu-
lation. Src, Hck, FAK, Gardner Rasheed feline sarcoma viral oncogene homo-
logue (Fgr) as well serine/threonine kinases (ERK/MAPK) are all shown to be
activated downstream of uPA (Resnati et al., 1996; Degryse et al., 2001, 1999;
Nguyen et al., 2000). uPA activates Rac (member of Rho family GTPases) a
major regulator of cytoskeletal changes and an effector of moesin and LASP-1.
uPA is also able to effect membrane translocation of Rac as well Raf, Src and
FAK. This happens while localizing ERK/MAPK1/2 to the nucleus (Degryse
et al., 2001, 1999; Nguyen et al., 2000; Webb et al., 2000; Kjøller and Hall, 2001).
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The functional importance of this has to be appreciated as there seems to be
an array of kinases dowstream of uPA. Activation of Ras, Myosin light-chain
kinase (MLCK) , Protein Kinase C (PKC) and PI3k are some other kinases in-
volved (Nguyen et al., 2000, 1999; Busso et al., 1994; Degryse et al., 2001). There
is also evidence towards molecules, such as α-actinin and JAK-STAT (pathway
pertinent to haematopoesis), to co-immunoprecipitate with uPAR (Koshelnick
et al., 1997; Dumler et al., 1998). uPA induces cell shape changes, reorganises
the cytoskeleton, ruffles the membrane, forms actin rings, induces laemellipo-
dia and extends uropodia (Degryse et al., 1999). Functionally, cells deficient in
the kinases listed above, will prove difficult to effect their function dowstream
of uPA. As, experimental evidence has proven Src, MAPK and ERK kinase in
these (Resnati et al., 1996; Degryse et al., 2001, 1999; Nguyen et al., 2000).
With respect to ERK, increased firbronectin adhesion correlated with in-
creased uPAR expression due to α5β1 integrin.
Figure 1.31: α5β1 integrin interacts with urokinase increasing ERK activation
uPA-uPAR has been shown to promote α5β1 integrin activity, wherein uPAR
is able to bind both α5 and β1 subunit via its D2 subunit. This also leads to
formation of insoluble fibronectin fibrils and ERK 1/2 activation.
(Ragno, 2006)
This was shown to be controlled by ERK phosphorylation levels. It was
able to block this increased adhesion by the uPAR peptide P25, which inhibits
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uPAR – integrin interactions (Aguirre-Ghiso et al., 2003; Aguirre Ghiso et al.,
1999; Aguirre-Ghiso et al., 2001).
1.10.2 uPAR, G-coupled receptors and the cytoskeleton
FPRL1 was found to act upstream in similar fashion to integrin in signaling.
FPRL1 induces signaling pathways involving cytoskeletal molecules. This reg-
ulaton is necessarry as FPRL1 effects a chemotactic response on binding to c-
suPAR. This requires regulation, contraction of the actin cytoskeleton. FPRL1
acts upstream to integrin as shown with experimental evidence with regard to
Hck and ERK/MAPK 1/2 (Resnati et al., 1996; Degryse et al., 2001; Fazioli et al.,
1997).
FPRL-1 receptor couples to Gαi/Gα0 proteins and generally found to mo-
bilise calcium and generate reactive oxygen species with induction of chemo-
taxis upon activation and calcium mobilization (Elagoz et al., 2004; Bae et al.,
2003). Calciummobilisation is an aspect where it differs, with respect to FPRL1.
Normally the ligands for FPRL1mobilise calcium including the first such chemo-
tactic ligand identified for FPRL1 serum amyloid A (SAA) as well as fMLP
among other ligands (Su et al., 1999). While this is not the case with the SRSRY
exposedD2D3 upar (c-suPAR) also a chemotactic ligandwhen it binds to FPRL1
(Resnati et al., 2002a; Furlan et al., 2004). uPA can induce calcium moblisa-
tion but at higher concentration requiring initially for uPAR to cluster together
(Resnati et al., 2002a; de Paulis et al., 2004; Blasi and Carmeliet, 2002). uPA and
the ATF of uPA can also induce cell migration mediated by FPRL1 (Resnati
et al., 2002a; de Paulis et al., 2004). This still requires uPAR to be present, as
shown by experiments with uPA in cells lacking uPAR (Resnati et al., 2002a).
FPRL1 based signaling with respect to uPAR is still not fully elucidiated.
A study utilizing proteomics, Karsten Boldt et al identified in polymor-
phonuclear neutrophils cytoskeletal changes downstream of FPRL1 (Boldt et al.,
2006b). They did not study the effect of uPAR based effect on FPRL1, rather
used the ligands such as the synthetic ligand W-peptide and sCK8-1. Groups
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have shown extracellular-regulated kinase 1/2 (Erk1/2), phospholipase D (PLD),
c-JUN N-terminal kinase (JNK), and mitogen-activated kinase p38 (p38) to be
activated in neutrophils mediated by FPRL-1
Boldt went on to show L-plastin was phosphorylated while moesin, cofilin,
and stathmin was dephosphorylated in neutrophils utilizing proteomics based
2-D Fluorescence Difference Gel Electrophoresis (2-D-DIGE)method. This work
was pioneeringwith its usage of 2-D-DIGE. There are limitations to thismethod,
as listed by Alberto Paradela et al. Testing by western blotting would be an
ideal confirmation (Paradela and Albar, 2008).
These studies were important in our understading with regard to FPRL1.
There needs to be further studies that put this in perspective, with c-suPAR
based association with FPRL1. Further understanding in this matter pertains
to integrin signaling and whether these pathways are linked. There is also a
lack of understanding in other cell types, such as in the vascular system in
endothelial cells. It will be interesting to know if these changes produce a mi-
gratory response, instigating the inside out signaling with respect to integrins.
1.10.3 Other receptors for uPAR
LDLR family
uPAR is a ligand, receptor, member of supramolecular complexes and an im-
portant player at the extracellular domain with ability to effect multiple targets
(D’Alessio and Blasi, 2009).
There are other molecules to which it is associated, such as the low-density
lipoprotein receptor-related protein (LRP-1). This protein is able to bind and
mediate endocytosis and can activate Rac1. This Rac1 activation is also shown
to be uPAR dependent. Endocytosis involves dynamic actin movement with
the involvement of clathrin (Binder et al., 2007). Here clathrin coated pits are
changed into clathrin coated vesicles and is involved in the internalisation of
receptors including G-coupled receptors (Slepnev and De Camilli, 2000; Mer-
rifield et al., 2005). Moesin, one of the cytoskeletal proteins discussed earlier, is
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involved in this process. With experimental evidences, it has been proposed
that moesin is a clathrin-coated vesiclelinker acting on rab5-clathrin-coated
vesicle pulling at the actin, while bound to phosphatidylinositol (4,5)- bis-
phosphate and actin cytoskeleton (Barroso-Gonzalez et al., 2009). Previous to
this paper ezrin was also implicated in clathrin mediated endocytosis of α1β-
adrenergic receptor (Stanasila et al., 2006). There is a reciprocal modulation
of uPAR dependent biological responses, which can simultaneously involve
EGFR and integrins, GPCR, members of the LDLR-family and integrins or ma-
trix metalloproteases (Ragno, 2006).
1.10.4 The uPA-uPAR system in angiogenesis
Kaposis’s sarcoma is is a well known pathological condition in which uPAR
plays a role in the angiogenesis (Morris et al., 2008). This disease is usually
prevalent concurrently to AIDS and is caused byHuman herpesvirus 8 (HHV8)
(Casanova et al., 2009). Experimental evidences has also characterized the role
of uPA-uPAR interaction in angiogenesis. Antibodies against uPAR clearly
blocks angiogenesis (Gondi et al., 2007). In the section covering endothelial
cells are listed pro-angiogenic factors and anti-angiogenic factors. The balance
between these molecules are tightly controlled. Increase in angiogenesis leads
to a dramatic increase in urokinase, thus the mechanisms, interactions required
to recruit cytoskeletal molecules, is important to our understanding of angio-
genesis itself (Rao et al., 2005; Basire et al., 2006).
VEGF is clearly one of the more potent pro-angiogenic factors and on as-
sociation with its receptor VEGF-2, induces pro-uPA on endothelial surface. It
acts initially to allow the crossing of plasma proteins (Linderholm et al., 2008).
This lays scaffold for endothelial cells to adhere to. Meanwhile release of VEGF
results in transcriptional activation of also many other proteolytic enzymes
(Prager et al., 2006; Conn et al., 2009; D’Alessio and Blasi, 2009). Then prote-
olysis ocurrs whereby MMPs, chymase and heparanse families play a role in
degradation. uPAR thus plays an initial role in this. There is a seemingly para-
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dox role played by PAI-1 in these steps. The logical conclusion should be, with
more PAI-1 less angiogensis occurs, due to its inhibition of uPA-uPAR asso-
ciation. Clinically a poor prognosis is conferred to patients that have cancer
with increasing PAI-1 and tissue inhibitor of MMPs 1 (TIMP-1). The paradox is
explained by increased expression of uPA and uPAR at the leading migratory
front (Labied et al., 2008; Blasi and Carmeliet, 2002; Basu et al., 2009). This is
supposed to overcome the inhibition by PAI-1 of uPA-uPAR mediated prote-
olytic breakdown of the vessel wall. There are as such unknown mechanisms
which might also explain this paradox. This degradation results in PAI-1 be-
ing removed from the vitronectin rich matrix. Initially LDL receptor family is
involved in internalising uPA-PAI-1-uPAR complex, which is then degraded.
Another interesting aspect is the requirement of PAI-1 for this internalisation
process (Dass et al., 2008; Ha et al., 2009; Binder et al., 2007; Diebold et al., 2008)
Integrins, as explained earlier in the section covering angiogenesis is a ma-
jor player in angiogenesis. Whereby, uPA-uPAR complex correctly positions
the integrins to high affinity binding site in the matrix (Kreidberg, 2008). This
is because the degradation exposes integrin binding regions, to which it has
high affinity. Thus, it actually encourages integrin-dependent endothelial ad-
hesion andmigration. Focal contacts that are established by this integrin medi-
ated event is continuously re-established. At the trailing edge, integrins allow
the cells to continue moving by being internalised due to endocytosis. Inte-
grins are then re-distributed thus continuing the process. uPAR is recycled
back to these focal contacts. There are still answers needed to understand the
full mechanism with respect to integrins. NPXY motif found in β subunits via
clathrin coated endocytotic machinery is understood to be the major mecha-
nism in place (Binder et al., 2007; van Hinsbergh and Koolwijk, 2008; Blasi and
Carmeliet, 2002).
The underlying mechanism involves cytoskeletal proteins. There is a need
to better understand these proteins, that can then be regulated by integrins,
uPAR and in processes such as endocytosis.
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1.11 Rationale
Moesin with ezrin and radixin is an highly redundant ERM protein. It is highly
expressed in the endothelial cells compared to its cousins ezrin and radixin. We
want to investigate how this protein is affected by the hemodynamic force, gen-
erated by the blood conducting through the arteries. We elucidate if moesin is
translocated to nucleus with cyclic strain and if this protein is phosphorylated.
Our investigations here lead us to suspect moesin regulation bymicroRNA.We
see if this is the case, meanwhile elucidating an array of microRNAs regulated
by hemodynamic forces. Moesin’s role in endothelial microparticle release is
also investigated. We investigate if this is in conjunction with microRNA reg-
ulation. Studies previously carried out in the lab has shown uPA increase with
cyclic strain and its effects on both migration and angiogenesis. From our
knowledge of moesin expression with cyclic strain, we investigate if moesin
and uPA interact. Furthermore we elucidate their synergy inmigration, wound
healing, angiogenesis and also its possible implications in endothelial barrier
upkeep.
Chapter 3
Aim of this chapter is to elucidate if and how moesin is affected by hemodynamic
forces.
Chapter 4
Aim of this chapter is see if moesin is regulated by microRNA with cyclic strain,
as well to elucidate microRNAs regulated by shear stress and cyclic strain.
Chapter 5
Aim of this chapter is to investigate moesin’s role in pathogenesis of endothelial
cells, with regard to endothelial microparticle release. We also investigate microRNA
regulation’s need for endothelial microparticle release.
Chapter 6
98
Aim of this chapter is to investigate moesin and uPA interaction in a slew of arterial
functions, with primary focus on migration and angiogenesis.
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Chapter 2
Materials & Methods
2.1 Materials
All reagents used in this study were of the highest purity commercially avail-
able and were of cell culture standard when applicable. Specific materials, not
shown below is listed with corresponding methods.
Materials
AGB Scientific (Dublin, Ireland)
Whatmann Chromatography paper
Abcam (Cambridge, UK) ab3196 mouse anti-Moesin antibody [38/87]
ab6728 secondary antibody, anti-mouse IgG-HRP
Amersham Pharmacia Biotech (Buckinghamshire, UK)
ECL Hybond nitrocellulose membrane
ECL Hyperfilm
BD Biosciences (Oxford, UK)
BD FACSflow™
FACS Caliber Flowcytometer
100
BioRAD (Alpha Technologies, Dublin)
iScript™cDNA Synthesis Kit
Bio-Sciences Ltd (Dun Laoghaire, Ireland)
DEPC-treated water
Trizol® Reagent
Cell signaling (Boston, US)
3363S mouse anti-Dicer antibody
Dako Cytomation (UK)
Dako mounting media
Dunn Labortechnik GmBH (Asbach, Germany)
6-well Bioflex® plates
Flexcell International Corp. (Hillsborough, NC)
Flexercell® Tension Plus™- FX-4000T™- system
Invitrogen (Groningen, Netherlands)
Vybrant™CFDA SE Cell Tracer Kit
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Lonza, Cologne, Germany
Basic Nucleofector® Kit for Primary Smooth Muscle Cells (SMC)
MWG Biotech (Milton Keynes, UK)
Moesin forward primer 5’-ATC ACT CAG CGC CTG ATC TT-3’
Moesin reverse primer 5’-GAT ATT CCA GGA CAG CAT CC-3’
Ezrin forward primer 5’-GTT TTC CCC AGT TGT AAT AGT GCC-3’
Ezrin reverse primer 5’-TCC GTA ATT CAA TCA GTC CTG C-3’
Radixin forward primer 5’-CGA GGA AGA ACG TGT AAC CGA A-3’
Radixin reverse primer 5’-TCT TGG TTT CAT CTC TGG CTT G-3’
GAPDH forward primer 5’-TGC TGA CTA TGT CGT GGA GT-3’
GAPDH reverse primer 5’-GCA TTG CTG ACA ATC TTG AC-3’
Pierce Chemicals (Cheshire, UK)
BCA protein assay kit
Supersignal West Pico chemilumescent substrate
Roche (West Sussex, UK)
Complete Protease Inhibitor Cocktail Tablets
Santa Cruz Biotechnology, Inc (Santa Cruz, US)
sc-12895 goat anti-p-Moesin antibody (Thr 558)
sc-2304 secondary antibody, anti-goat IgG-HRP
Sarstedt (Drinagh, Wexford, Ireland)
1.5 ml eppendorf tubes
T25 tissue culture flasks
T75 tissue culture flasks
T175 tissue culture flasks
6-well tissue culture plates
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5,10 and 25ml serological pipettes
15 and 50ml falcone tubes
cryovials
Imaging software, (Image J)
Image J (Abramoff et al., 2004)
Sigma Chemical Company (Poole, Dorset, England)
β-glycerophosphate
β-mercaptoethanol
Acetic Acid
Acetone
Agarose
Ammonium Persulphate
Acrylamide/Bis-acrylamide
Bovine Serum Albumin
Brightline Haemocytometer
Chloroform
DMEM
DMSO
DPX Mounting Media
EDTA
EGTA
Ethidium Bromide
Foetal Calf Serum
Glycerol
Glycine
Hematoxylin
Hydrochloric acid
Isopropanol
Lauryl Sulphate
Lithium Chloride
Methanol
PBS tablets
Penicillin-Streptomycin (100x)
Phosphatase Inhibitor Cocktail
Ponceau S
Potassium Chloride
Potassium Iodide
Protease Inhibitor Cocktail
RPMI-164040
SB216763
Sodium Acetate
Sodium Chloride
Sodium Doecly Sulphate
Sodium Hydroxide
Sodium Orthovanadate
Sodium Phosphate
SYBR Green Taq Ready Mix ™
TEMED
Tris Base
Tris Chloride
Tween 20
Triton X-100
Trypsin-EDTA solution (10x)
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2.2 Methods
2.3 Cell culture methods
2.3.1 Cell culture
Cell culture was conducted in highly sterile environment using a Bio air 2000
MAC laminar flow cabinet. Cells were visualized using an Olympus CK30
phase contrast microscope unless otherwise stated. RVSMCs was purchased
from Cell Applications Inc.(CA, USA). BVSMCs was purchased from Coriell
Cell Repository, New Jersey, USA. BAECs were obtained from Coriell Cell
Repository, New Jersey, USA. These cells were maintained in RPMI-1640 sup-
plemented with 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin and
100 µg/ml streptomycin. HAECs was purchased from Promocell, Germany.
HAECs were grown in proprietary low serummedia (C-22020 Endothelial Cell
Growth Medium MV), obtained from Promocell, Germany.
All cells were adherent cells and required trypsinisation for subculturing
and harvesting. For trypsinisation, growth media was removed from the flask
and the cells were gently washed two times in Hanks buffered saline solution
(HBSS)/Phosphate buffered saline solution (PBS) to remove macroglobulin,
a trypsin inhibitor present in FBS.A suitable volume of trypsin / ethylenedi-
amine tetracetic acid (EDTA) (1% v/v trypsin EDTA in HBSS/PBS) was added
to the flask and incubated for 5 min or until all the cells were removed from
the flask surface. Trypsin was inactivated by the addition of growth medium
and the cells were removed from suspension by centrifugation at 700g for 5
min (eppendorf centrifuge). Cells were then resuspended in culture medium
and typically diluted 1:4 for HAECs/VSMCs and 1:5 for BAECs into culture
flasks, or cryogenically preserved. Cells were incubated in a humidified at-
mosphere 5% v/v 37oC humidified atmosphere of 5%CO2/95% air in a Hera
water jacketed cell culture incubator.
Cells were cultured in T175 cm2, T75 cm2, T25 cm2 flasks and 6 well plates.
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In the case of cyclic strain experiments, cells were grown on Bioflex® series cul-
ture plates which have a flexible, pronectin bonded growth surface. Bioflex®
plates were coated with fibrnonectin at 50 µg/ml for all cyclic strain experi-
ments unless otherwise stated (Liu et al., 2007). In the case of dextran perme-
ability studies, cells were grown on 24mm round polyester filters, (0.4 µmpore
size, 6 well format). Cells between passages 5–10 were used in experiments.
2.3.2 Cryogenic Cell Storage and Recovery of Cells.
The cells were maintained long-term in liquid nitrogen in a cryofreezer unit.
Cells to be frozen were trypsinized from the flask, centrifuged down in serum-
containing media for 5 min at 700g, and the pellet was resuspended in 20%
(v/v) FBS containing dimetylsulphoxide (DMSO) at a final concentration of
10% (v/v). HAECs were resuspended in serum free proprietary solution from
Promocell (Germany). This solution contains DMSO and methylcellulose and
is referred to as Cryo-SFM® .
A ml of suspension was then transferred to sterile cryovials and frozen at -
80oC freezer at a rate of−1oC/minute using a Nalgene cryo freezing container.
Cells were recovered from longterm storage by rapid thawing at 37oC and re-
suspension in 5ml of growth medium followed by centrifugation at 700g for
5 min. The resultant cell pellet was resuspended in fresh medium and trans-
ferred to a culture flasks. The following day the media was removed, the cells
were washed in PBS and fresh culture media added.
2.3.3 Cyclic Strain
For cyclic strain studies, cells were seeded into 6-well Bioflex plates (Dunn
Labortechnik GmBH - Asbach, Germany) at a density of 105 cells/cm2 to reach
confluency in 24 h. For sub-confluent studies, cells were seeded at a density
of 104 cells/cm2. When the cells had reached full confluency, the cells were
exposed to cyclic strain. For experiments requiring sub-confluence, cells were
allowed to reach 50% confluency. Bioflex™plates contain a pronectin-coated
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silicon membrane bottom that enables precise deformation of cultured cells by
microprocessor controlled vacuum (Figure 2.1). The plates were also coated
with fibronectin at 50 µg/ml for all cyclic strain experiments, unless otherwise
stated (Liu et al., 2007). A Flexercell Tension Plus™FX-4000T™system (Flexcell
International Corp., Hillsborough, NC) was employed to apply different cyclic
strain regimen to each plate (0-10% strain, 60 cycles/min; 0-7.5% strain, 60 cy-
cles/min; 0-4% strain, 60 cycles/min; 8-10% strain, 60 cycles/min) providing
equibiaxial tension using the Heartbeat™simulation protocol. The strain was
employed for different time frames specified for each experiment. For cyclic
strain stasis, cells were strained for 4 h after which it was maintained in stasis
for 6 h. Cells were also acutely stretched to 20% non cyclically and equibiax-
ially, the stretch was induced slowly in 3 s. This reduced the flow velocity to
less than 2.5 mm/s (Chiu et al., 2008). Th Flexercell system used for stretching
and biaxially straining cells is shown in (Figure 2.1).
Figure 2.1: Flexercell system used for cyclic strain and stretching vascular
cells
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Control cells remained unstrained or unstretched. Following strain/stretch,
the cells were washed twice in I x PBS, and protein, RNA or microRNA sam-
ples were isolated. For cell fractionation studies cells were harvested accord-
ing to either Biovision™or Calbiochem™methodology. Where the experiments
looked into cell cycle, cells previously stained with Edu (commercial nucleo-
side stain) at 10µMwere harvested by trypsinization for monitoring by FACS.
For proliferation studies cells previously stained with CFSE was trypsinized
andmonitored by FACS. For chemotaxis studies, cells were harvested by versene
® to avoid cleavage of extracellular domains. These were then monitored for
migration over a boyden chamber to full serum media. Detailed experimental
methodology of all experiments from this paragraph is described under respec-
tive sections.
2.3.4 Shear Stress
2.3.4.1 Orbital shaker methodology
HAECs were seeded at 1 x 105 cells/cm2 in 6 well plates and allowed to come
to confluency. Following this, media was removed and replaced with 4 ml of
fresh media. Cells were then sheared at 10 dyne/cm2 for 24 h on an orbital
shaker (Stuart Scientific Mini Orbital Shaker) set to the appropriate RPM as de-
termined by the following equation. Control cells were not sheared. Post shear-
ing the cells were harvested for their protein after washing in 1x PBS twice.
shear stress=α
￿
η(2πf)^3
Where α = radius of rotation (cm), = density of liquid (g/l), η = 7.5 x 10-3
(dynes/cm2 at 37oC), f = rotation per second
Control cells were not sheared. Post shearing the cells were harvested for
their protein after washing in 1x PBS twice. The method of shearing is illus-
trated in (Figure 2.2). As well, as per requirement of the experiment images
were obtained using microscope (Olympus BX50).
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Figure 2.2: Orbital shaker used for shear stress
The figure shows the orbital shaker used for shear stress resulting in the cells
experiencing 10dynes/cm2. Six well plates with 4 ml of media was used at
150 rpm to generate the particiular shear stress according to the equation shear
stress=α
￿
η(2πf)^3.
2.3.4.2 ibidi®
This is an innovative flow system that continuously flows media at precisely
controlled shear stress over the flow surface. This allows for cultivation of cells
under flow conditions, inside an incubator in long term assays. The system
also provided microscope friendly system which allows for live imaging. Ini-
tially optimization was required to grow cells without coating with adhesive
extracellular matrix. Matrix free enviroment was sought, as our current shear
stress parameters used non-matrix coated system. Coating with extracellular
matrix would introduce other variables in the system. Also, all our western
blotting conducted for shear stress was conducted in the non-matrix coated
system. The optimization provided the optimum shear stress that could be ap-
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plied without affecting cell adhesiveness. This was found to be 8.2 dynes/cm2
both unidirectionally as well as oscillating for HAECs. The system is capable
of applying high shear stress of 40 dynes/cm2, which is useful for acute studies
without application of extracellular matrix.
The air pump component of the system is controlled by means of a com-
puter. The pump is capable of generating pressure ranging from −100 to 100
mbar with +/− 1 mbar accuracy. The system was controlled by means of soft-
ware, which allows for precise control of the shear stress taking into account
the density of media used.
There are two reservoirs for the cell media, a slide holder which holds the
µ-slide. Additionally there are tubes that connect the reservoirs and µ-Slides.
ibidi® , refers these reservoirs and the connecting tubes as perfusion sets which
come in different diameters and lengths.
With optimization µ-Slide VI 0.4, was found to be themost user friendly. The
specific slide µ-Slide y-shaped also had the same ease of use, and was useful
to understand flow mediated responses in areas of arteries that are bifurcated.
µ-Slide I was not very easy to use, and had leakage issues with media. Re-
cently, the company has discontnued this slide for flow based system. Thus for
the experimental setup µ-Slide VI 0.4 was used. The slides used are shown in
(Figure 2.3)
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Figure 2.3: ibidi® slides
The figure shows the slides that were used for various shear stress studies. Ac-
cording to manufacturer’s protocol, slides were seeded with HAECs. Further
to full confluence the slides were connected by means of tubes to the perfu-
sion system. Using software, shear stress regime was selected taking into ac-
count the type of slide, perfusion system used. The manufacuturer’s website
is http : //www.ibidi.de
Due to the design, perfusion sets allowed for varying the flow rates as well
as placing the fluidic unit on the microscope stage. With flow, there was slight
disruption of the stage which blurred the video capture with higher shear
stress. Due to these reasons, with respect to video capture with flow, shear
stress of 5.1 dynes/cm2 was applied acutely for 10 min. As the shear applied
is acute, it would show protein translocation (Hahn and Schwartz, 2009). For
video capture studies, µ-Slide VI 0.4 was used. For extraction of total RNA after
24 h of shear stress (8.2dynes/cm2), µ-Slide VI 0.4 was used. RNAwas extracted
with RNAeasy® (Qiagen) according to the manufacturer’s protocol. The red
perfusion set was used in all experiments.The control unit is connected to the
fluidic unit by a thin, low-voltage electric cable and a tube which shifts the air
pressure, driving the flow. The air tube and the electric cable was mounted into
the incubator through a hole in the black wall. The principle of ibidi® based
flow is shown in (Figure 2.4)
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Figure 2.4: Principle of ibidi® flow system
The pressure generator utilises negative pressure. State 1 supplies negative
pressure at reservoir 1. This causes media to be sucked from reservoir 2 into
reservoir 1. When all of reservoir 1 is filled, all valves switch and the liquid
gets sucked from reservoir 1 in the same way and thus in the same direction
filling reservoir 2. The manufacuturer’s website is http://www.ibidi.de
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2.3.5 Transformations
DH5α chemically competent cells were purchased from invitrogen. A volume
of 50µl of the competent cells were placed in a sterile eppendorf. Following
quantification of plasmid DNA, 50ng of DNA was added to the cells and the
contents of the tube were mixed gently. The tube was then placed on ice for 30
min, before being heat shocked at 42oC for 90 s. The tube was then placed on
ice for 2 min. 1ml of sterile SOCmedium (20% tryptone, 5% yeast extract, 0.5%
NaCl, 1% 0.25M KCl, 2% 1 M glucose) was then added to the tube, and the
tube was incubated at 37oC for 1 h. The tube was then centrifuged for 2 min at
100 x g and the pellet then resuspended in 100µl of SOC medium. The culture
was then plated out on LB agar plates containing 100µg/ml ampicillin and in-
cubated overnight at 37oC. Non-transformed competent cells were also plated
out as a negative control. Only transformed colonies contain the ampicillin re-
sistance gene, and therefore grow on the ampicillin-containing agar plates. A
single colony, therefore, was transferred to a 50ml sterile tube containing 5mls
of LB broth (1% tryptone, 0.5% yeast extract, 1.0%NaCl). This primary culture
was then incubated at 37oC with agitation of 200 rpm for 8h. 400µl of the cul-
ture was transferred to a 250ml sterile conical flask containing 50mls broth and
incubated overnight at 37oC with agitation of 200 x g. DNA minipreparation
were then carried out on this secondary culture as described in.The remainder
of the 5ml primary culture was used for glycerol stocks.
2.3.6 Plasmid purification protocol
Plasmid DNA was purified using the QIAGEN-tip HiSpeed® system from Qi-
agen, according to the manufacturer’s instructions for plasmid purification of
animal cells. DNA was then quantified by spectrophotometric analyzis.
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2.3.7 DNA Quantitation and Storage
To determine the amount of DNA in a sample obtained from the Qiagen plas-
mid midi kit, the sample was analyzed using a NANODROP 1000 Spectropho-
tometer (Thermo Scientific) blanked with TE. The sample was read at wave-
lengths of 260 and 280 nm, and the concentration of the DNA in the sample
was calculated out as follows;
Abs260nm x dilution factor x 50 = concentration of DNA (µg/ml)
The purity of the DNAwas determined by calculating the ratio of absorbance
at 260 nm to 280 nm, the value of which should be greater than 1.6. All samples
were tested in triplicate andwere kept on ice at all times during the experiment.
DNA samples were then stored at −20oC for use in transient transfections.
2.3.8 Transient Electroporation (Transfections)
2.3.8.1 Nucleofection™
Nucleofection™is a transfection method based on the physical method of elec-
troporation. Nucleofection™uses a combination of optimized electrical param-
eters, generated by a special device called Nucleofector® , with cell-type spe-
cific reagents. Cells were transiently electroporated using a Basic Nucleofec-
tor® Kit for endothelial cells. Cells were electroporated with plasmid DNA
at no greater then 80% confluency. Cells were trypsinized as previously de-
scribed in section and counted to determine the cell density. A volume con-
taining 1 x 106 cells was used per transfection. The cells were centrifuged at
700g for 5 min, The pellet was resuspended in room temperature in the Basic
Solution to a final concentration of 1 x 106 cells/100µl. 100µl of cell suspension
was mixed with a total of 3µg DNA. The nucleofection sample was then trans-
ferred to an amaxa cuvette. The cuvette was inserted into the cuvette holder of
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the Nucleofector and the appropriate Nucleofector program selected.After the
programme was finished, the cells were transferred from the cuvette, into an
eppendorf tube and 500µl of pre-warmed culture medium containing serum
and supplements was added. The eppendorf tube was then incubated at 37oC,
until all transfections were completed. The samples were then transferred from
the eppendorf tubes into 6-well plates containing 1ml of culture medium with
serum and supplements (3 wells/sample). The cells were then incubated at
37oC and the medium changed 16-18h post nucleofection.
2.3.8.2 Microporator™
Cells were also electroporated with Microporator™, based on electroporation
method. Similar to Nucleofection™, Microporator™uses a combination of op-
timized electrical parameters, generated by a special device called Micropora-
tor™. Cells were transiently electroporated using Microporator™kit. 1 x 106
cells were electroporated in 95µl solution R. The solution was made upto 100µl
solution with DNA (3µg).
Importantly, stock volume of all DNA used in an experiment was equalised
before addition. Solution E2 (3ml) was used as per the manufacturer’s proto-
col. The cells were electroporated as per the manufacturer’s protocol. This was
optimized for HAECs (voltage: 1000V, pulse width: 30ms, pulse number: 3)
and BAECs (voltage: 1300V, pulse width: 20ms, pulse number: 2).
Prior to transfection the media was pre-warmed and acidity regulated by
equilibriating in the incubator under the same conditions used for cell culture.
Post transfection, cells were plated in this media whereby a third was added
per well of a 6-well plate (9.6 cm6).
BothNucleofection™andMicroporator™programswere optimised to yield
approximately 95% transfection efficiency with respect to RNA and greater
than 65% for the final protein. This was assessed by RT PCR and FACS.
Cells were routinely co-electroporated with green fluorescent protein (GFP)
encoding plasmid as a means to determine approximate levels of transfection.
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2.3.9 Rho A Inhibition
C3 Transferase (catalog number CTO4 from Cytoskeleton, Inc) was obtained.
This is a highly purified C3 Transferase which is covalently linked to the manu-
facturer’s proprietary cell penetrating moiety via a disulfide bond. The moeity
allows for C3 Transferase to move into plasma membrane rapidly. Inside the
cell only the C3 Transferase is released, discarding the moeity. C3 Transferase
inactivates RhoA, RhoB, and RhoC, but not related GTPases such as Cdc42 or
Rac1.
The exoenzyme C3 Transferase is derived from Clostridum bolulinium. It is
commonly used to selectivley inactivate the GTPases RhoA, RhoB, and RhoC,
both in-vivo and in-vitro. The inhibition involves ADP-ribosylation on asparagine
41 in the effector binding domain of the GTPase. Traditional usage of this pro-
tein required expensively high concentrations of 100µg/ml. The incubation
time was also too long with overnight incubations required. This was fraught
with difficulty when studying with transiently electroporated genetic material.
Researchers had to often use less specific inhibitors.
The inhibitor was prepared according to the manufacturer’s directions. The
inhibitor was dissolved in sterile water to obtain 100µg/ml. As per their direc-
tion, 1µg/ml was added into each well of the 6-well fully confluent bioflex®
plates. This was fulfilled as follows.
HAECs were electroporated with siRNA against Dicer and scrambled and
seeded on bioflex® plates previously coatedwith fibronectin. The seeding den-
sity was 105 cells/cm2 to reach confluency in 24 h Post transfection, cells were
allowed to recover over 12 h after which the cells were fed with full serumme-
dia and left undisturbed for a further 12 h. The cells were serum starved for 12
h, after which they were treated with C3 transferase at 1µg/ml for 6 h to obtain
maximal robust inhibition according to the manufacturer’s scale of Rho activ-
ity in 1.2 ml serum free media. Further to this the cells were acutely stretched
to 20% non cyclically and equibiaxially, the stretch was induced slowly in 3 s.
This reduced the flow velocity to less than 2.5 mm/s (Chiu et al., 2008). The
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protein lysate was harvested.
2.3.10 Small-interfering RNA
All siRNA were obtained from Applied Biosystems. Non-specific sequence re-
ferred to as scrambled was used as control and also obtained from Applied
Biosystems. Different siRNA against the same target was checked. This was
verified by RT-PCR (only for GAPDH and moesin) further confirmed by west-
ernblotting ( for all siRNAs). The canditate siRNA that produced most knock
down of target proteins was used for experiments. 4µg of siRNA was utilized
for 106 cells. Transfection efficiency for each cell type was determined and op-
timised with siRNA against GAPDH.
The following siRNA IDs (used by Applied biosystems) correspond to the
target proteins in humans. They were chosen for their high transfection effi-
ciency. These were used for downstream experiments.
GAPDH
Moesin
Dicer
Scrambled
AM4624
11593
s23754
4390825
2.4 Analytical Methods
2.4.1 SDS-PAGE and Western Blot Analyzis
2.4.1.1 Preparation of Whole Cell Lysates
Cells were washed in 1 x PBS and then 100µl/cm2 1X RIPA lysis buffer (20mM
Tris, 150mMNaCl; 1mMNa2EDTA; 1mMEGTA; 1% Triton X-100 (v/v); 2.5mM
sodium pyrophosphate; 1mM β-glycerophosphate; 1mM sodium orthovana-
date; 1µg/ml leupeptin) supplemented with protease-phosphatase inhibitor
cocktails (1/100 dilution of stock, Sigma Aldrich)was added to the cells. The
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cells were then scraped into the lysis buffer using a cell scraper and transferred
to an eppendorf. The lysates were centrifuged for 1hr or o/n at 4oC and cen-
trifuged at 10,000rpm for 20min. Samples were stored at -20oC for short-term
storage or -80oC for long-term storage.
2.4.1.2 Bicinchoninic Acid (BCA) Protein Microassay
The bicinchoninic acid protein microassay utilizes the biuret reaction, the re-
duction of Cu++ to the cuprous cation (Cu+) by protein under alkaline condi-
tions, with the selective colourimetric detection of Cu+) using a reagent con-
taining bicinchoninic acid. Bicinchoninic acid, sodium salt, is a stable, water-
soluble compound capable of forming an intense purple complex with cuprous
ion (Cu+) in an alkaline environment. This water-soluble complex exhibits a
strong absorbance at 562 nm that is linear with increasing protein concentra-
tions over a broad working range of 20-2000 µg/ml. The two separate reagents
used were supplied in the commercially available assay kit (Pierce Chemicals):
A, an alkaline bicarbonate solution and B, a copper sulphate solution. A work-
ing solution was prepared by mixing 1 part reagent B with 50 parts reagent A.
On a microtitre plate 200µl of the working solution was added to 10 µl of the
whole cell lysate or bovine serum albumin (BSA) protein standard. The plate
was then incubated at 37oC for 30 min. The absorbance of each well was then
read at 560 nm using a Tecan Spectra plate reader. All samples and standards
were tested in triplicate. Quantification was carried out by interpolation from
a BSA standard curve (0-2 mg/ml).
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2.4.1.3 Western Blotting
SDS-PAGEwas performed as described by Laemmli using 10% polyacrylamide
gels (Laemmli et al., 1970). 10% resolving and 5% stacking gels were prepared
as follows:
Resolving Gel:
2.5
3.3
4.0
100µl
100µl
4µl
Buffer A (1.5M Tris pH8.8)
30% acrylamide stock
distilled water
10% (w/v) SDS
10% (w/v) ammonium persulphate
TEMED
Stacking Gel:
1.26ml
0.83ml
2.77ml
50µl
50µl
5µl
Buffer B(0.5M Tris pH6.8)
30%acrylamide stock
distilled water
10%(w/v) SDS
10%(w/v) ammonium persulphate
TEMED
For analyzis of cell lysate protein concentration was determined by BCA
assay and a equal amounts of protein were resolved on the gel. Samples were
mixed with 4X loading buffer (8% SDS, 20% β-mercatoethanol, 40% glycerol,
Brilliant Blue R in 0.32M Tris pH6.8) and boiled at 95oC for 5 min, then imme-
diately placed on ice. The gel was electrophoresed in reservoir buffer (0.025M
Tris pH 8.3; 0.192M Glycine; 0.1% (w/v) SDS) at 100V per gel using bio-rad
® gel electrophoresis system until the dye front reached the bottom of the gel.
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Following electrophoresis the gel was soaked for 15 min in cold transfer buffer
(0.025M Tris pH8.3; 0.192M Glycine; 15% v/v methanol). Nitrocelluose mem-
brane and 12 sheets of Whatmann filter paper were cut to the same size as the
gel and soaked in transfer buffer.
Proteins were transferred to the membrane overnight at 50V in a Bio-rad
transfer cell with magnetic agitation. Following transfer, membranes were
soaked in Ponceau S solution to confirm transfer of protein to the membrane
and also to normalize for variations in protein loading. Ponceau stains all
transfered bands of proteins red. Membranes were blocked for a minimum
of 1h in blocking solution (5% BSA- PBS-1%Tween). Membranes were then in-
cubated overnight at 4oC with the appropriate dilution of primary antibody
in blocking solution (Table 2.3). The blots were then vigorously washed in
three changes of PBST and then incubated for 2 h at room temperature with
a suitable HRP linked secondary antibody diluted in PBST. Following incuba-
tion in secondary antibody, the blots were again washed in three changes of
PBST. Antibody-antigen complexes were detected by incubation in West Pico
Supersignal reagent (Pierce Chemicals).
The blot was previously cut precisely isolating the GAPDH area. This was
subjected to similar procedure to detect GAPDH antibody-antigen complex.
Briefly, an equal volume of solution A and Bwere mixed and the blot was incu-
bated for 5 min at room temperature. Blots were exposed to autoradiographic
film (Amersham Hyperfilm ECL) to visualize bands present on the blot and
developed (Amersham Hyperprocessor Automatic Developer).
Alternatively the blot was not exposed to autoradiographic film, rather was
exposed to a high sensitivity camera G:Box ® from Syngene® . In certain exper-
iments that required detection of phosphorylated moesin, initially total moesin
was detected. This was then subjected to stripping over 10 min at 37oC to re-
move primary antibody against moesin including the secondary antibody at-
tached. This was achieved using commercial stripping buffer from pierce ®.
The blot was then subjected to incubation with secondary antibody against to-
tal moesin and developed after the prescribed washes (explained earlier) . This
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was to control for removal of primary antibody against total moesin. Further
to this confirmation, primary antibody against phosphorylated moesin was in-
cubated with the blot for 2 h. The blot was subjected to washes described ear-
lier, and then incubated with the secondary antibody against phosphorylated
moesin. The blot was subjected to washes and developed as described earlier.
Bands of interest were identified by use of molecular weight markers. Ex-
posure times varied depending on the antibody being used and the developer
used. The photograph was then processed for the value of the bands using
Image J software. (Abramoff et al., 2004).
2.4.2 Subcellular Fractionation
Biovision® Method
BAECs were exposed to cyclic strain of 7.5%, the cells were then fractionated to
cytosolic and nuclear fractions according to the manufacturer prescribed pro-
tocol K266-100 (from Biovision ® ). The protocol derived nuclear and cytosolic
fractions. From the total volume of each fractions, half was used for western
blotting using the standard procedure previously described. This allowed us
to control for proportionate equal loading.
This was immunoblotted for moesin, similarly, the other half of the fraction
was utilized to detect phosphorylated moesin. The studies were conducted to
five independent experiments.
Acetone precipitation of proteins
Acetone precipitation is conducted to remove interfering contaminants from
protein samples for downstream processing. It is also useful to concentrate
the proteins. The procedure was applied in our experimental methodology for
concentrating the protein. The disadvantage was the phosphorylation status
of the proteins could be lost.
Pre-chilled acetone (at−20o) was utilized for this procedure. Four times the
sample volume of the cold acetone was added. The mixture was vortexed very
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well and incubated at −20o. The mixture was vortexed after every 10 minute
incubation at −20o for a total of 60 minutes. The vortexing was conducted at
maximal speed vigorously ensuring robust mixing.
After the incubation and vortexing, the suprernatant was decanted and dis-
posed without disturbing the pellet. The acetone was allowed to evaporate
from the uncapped tube for 30 min on ice. Care was taken not to overdry the
pellet, as it will render it not dissolvable. The pellet was then dissolved with
20µl sample buffer. Further to which, it was separated using western blotting
procedure described earlier.
Calbiochem®Method
BAECs were exposed to cyclic strain of 7.5%, the cells were then fractionated
to cytosolic, nuclear fractions, membrane and cytoskeleton according to the
manufacturer prescribed protocol The entire volume of each fraction was pre-
cipated using Further to this, it was reconstituted in laemmli buffer 15 µl. This
was used to confirmmoesin’s presence in nucleus using standard western blot-
ting described previously.
This was immunoblotted for moesin, similarly, the other half of the frac-
tion was utilized to detect phosphorylated moesin. This method was used to
confirm biovision derived results, and was repeated to one independent exper-
iment.
2.4.3 Polymerase Chain Reaction (PCR)
2.4.3.1 Preparation of Total RNA
The reagents were obtained fromQiagen® andwas commercially referred to as
RNeasy mini kit® . Total RNA was isolated using the manufacturer’s method-
ology. Whereby, after washing the adherent cells with 1x PBS, the total RNA
was isolated using RLT buffer. This was stored at -80oC after lysing the cells or
processed immediately. Post processing the RNA was stored at -80oC.
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Alternatively, total RNA was isolated from cells using Trizol® reagent ac-
cording to the method of (Chomczynski and Sacchi, 1987). The reagent, a
mono-phasic solution of phenol and guanidine isothiocyanate, maintains the
integrity of RNA while disrupting cells and dissolving cell components.
Growth media was removed and cells were washed with 1XPBS twice.
Cells were then lysed directly by adding trizol reagent to the flask, 1 ml per
10 cm2. The lysate was transferred to a sterile falcone tube and incubated for
5 min at 15-30oC to permit the complete dissociation of nucleoprotein com-
plexes. Chloroform was added at a concentration of 0.2 ml of chloroform per 1
ml of trizol, the tube was then shaken vigorously for 15 s and then centrifuged
down at 12,000 x g for 15 min at 2 to 8oC. The resulting aqueous phase was
then transferred to a fresh tube. RNA was then precipitated by mixing with
isopropyl alcohol, 0.5 ml per 1 ml of trizol. The samples were then incubated
at 15oC to 30oC for 10 min and centrifuged down at 12,000 x g for 10 min at 2 to
8oC. The RNAwas then visible as a gel like pellet on the side and bottom of the
tube. The supernatant was then removed and the pellet washed with at least
1ml of 75% ethanol per 1 ml of trizol used. The sample was then mixed by vor-
texing and centrifuged down at 7,500 x g for 5 min at 2 to 8oC. The supernatant
was removed and the pellet washed again in ethanol. After washing the pellet,
it was air-dried and the RNA re-suspended in 30-50µl of RNase free water and
incubated at 60oC for 10 min. All total RNA preparations were stored at -80oC.
2.4.3.2 in-silico analyzis of microRNA targets
Target analyzis was performed using the bioinformatic software tool available
in the internet at http : //microrna.sanger.ac.uk
2.4.3.3 Preparation of microRNA in Samples
Preparation of microRNA was performed using the manufacturer’s protocol
utilizing the ABI basedmirVANA® kit. There is a significant loss of microRNA
if harvested using commercially available kit for total RNA. It has to be noted
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that Trizol® based extraction method does harvest microRNAs. The process-
ing to microRNA was performed immediately from cells using mirVANA®
kit. Further processing included assessing the quality of the microRNA by
means of Nanodrop 1000 spectrprophotometer (Thermo Scientific) and Agi-
lent Microfluidic Bio-analyzer (Agilent technologies). This included synthe-
sizing cDNAwith 20µg of extracted microRNA. Towards this purpose thermal
cycler was set to 9600 Emulation mode. Program according to the manufacurer
was 30 min at 160C, 30 min at 420C, 5 min at 850C for a total volume of 10µl.
The cDNA was diluted 62.5 fold and 50µl of this was mixed to 50µl of Taq-
Man Universal PCR master mix (2X). This 100µl was loaded onto the side port
of TLDA v1.0 chip. After brief centrifugation according to the manufacturer,
the card was run on the thermocycler (Applied Biosystems 7900HT Fast Real-
Time PCR system). Loading controls included RNU44 and RNU48 while the
primers were proprietary stem-loop (Chen et al., 2005). The chip is shown in
(Figure 2.5). The actual list of microRNAs are given with the results in the
microRNA chapter. Data was analyzed
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Figure 2.5: TLDA v1.0 Chip cDNA is loaded onto the right side of the chip.
The cDNA runs over the proprietary stem-loop primers (Chen et al., 2005), after
which it is sealed and RT-PCR conducted. The card is a representation and the
actual microRNAs analyzed are listed in the results section in the microRNA
chapter.
2.4.3.4 Quantification of Total RNA in Samples
To determine the amount of total RNA in samples, the sample was analyzed
using a Nanodop 1000 spectrophotomoter (Thermo Scientific) blanked with
RNase free water. 1.5µl of sample was measured at wavelengths of 260 and
280 nm, and the concentration of the RNA in the sample was determined as
follows;
Abs260nm x dilution factor x 40 = concentration of RNA (µg/ml)
The purity of the RNAwas determined by calculating the ratio of absorbance
at 260nm to 280nm. A ratio of 1.9 to 2.0 was indicative of a highly purified
preparation of RNA. A ratio lower than this was indicative of protein contam-
ination. Absorbance at 230 nm reflected contamination of the sample by phe-
nol, while absorbance at 325 nm suggests contamination by particulates. All
samples were tested in triplicate and were kept on ice at all times during the
experiment. RNA samples were then stored at -80oC.
2.4.3.5 Design of PCR Primer Sets
A number of web based programs, "Primer 3 Output" and "NCBI/BLAST"
were utilized to design the primer sets used in this study. The Primer 3 pro-
gram picks primers from the given sequence, and the BLAST program allows
multiple sequence alignment, which allows primers to be designed from highly
conserved areas. Primers were designed with 50% GC content so the anneal-
ing temperature for all sets was 55-60oC. The primers also spanned high length
intron to avoid genomic DNA contamination prone products in qRT PCR.
2.4.3.6 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
All total RNA samples were prepared by the Trizol method as previously. RNA
preparations were then quantified by absorbance spectroscopy as described in
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Section 2.6.2. Reverse transcriptase was carried out using an iScript™cDNA
Synthesis Kit according to the manufacturer’s instructions. Briefly, 2µg of RNA
was added to 1µl of reverse transcriptase enzyme and 4µl of 5x buffer in a
PCR tube. RNase and DNase free H2O was then added to make a total of 20µl
sample volume. The tubes were centrifuged briefly, and placed in a PCR Sprint
thermocycler (Thermo Hybaid) and the following programme was run: 25oC
for 5 min, 42oC for 30 min, 85oC for 5 min. The samples were then stored at
-20oC and used for real-time PCR.
2.4.3.7 Real-Time PCR
Quantitative PCRwas carried out using a Real-time PCR. The principle of real-
time PCR amplification detection is that the amount of fluorescence is propor-
tional to the concentration of product in a reaction. Higher fluorescence indi-
cates a higher concentration of a product. Each PCR reaction was set up as
follows:
SYBR-Green
RNAse free water
cDNA
Forward primer(10µM)
Reverse primer(10µM)
12.5µl
8.5µl
2.0µl
1.0µl
1.0µl
Each sample was assayed in triplicate, and the program used for the differ-
ent primer sets was as follows;
Denaturing Phase
Annealing Phase
Elongation Phase
95oC - 20s
55-60oC - 30s (55 cycles)
72oC - 30s
The Comparative Ct method was used for quantitative analyzis while Melt
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Curve analyzis was carried out for qualitative analyzis.
2.4.3.8 Agarose Gel Electrophoresis
All DNA gel electrophoresis was carried out utilizing GibcoBRL Horizon 20.25
Gel Electrophoresis Apparatus. Before use the gel boxwas cleanedwith ethanol
and the gel cast was set up as described in the manufacturers instruction man-
ual. A 2.5% agarose gel stock was made up by dissolving 2.5 g of agarose in
100 ml of 1x Tris Acetate EDTA (TAE) (40 mM Tris-Acetate, 1 mM EDTA). The
agarose was dissolved by heating in a microwave (700 mHz) at full power for
5 min. The agarose was then poured into the cast, the comb put into place and
the gel allowed to set. Once it solidified, the comb was removed and the appa-
ratus filled with 1x TAE buffer. Loading dye was added to the sample (17µ of
loading dye to 6µl of sample). 10µl was then loaded to each well in duplicate.
The gel was run at 80 V, 110 mA and 150W until the dye front hadmigrated the
length of the gel. The gel was stained in a 2mg/l ethidium bromide staining
bath for 10-15 min, and then placed on an Ultra Violet Products UV transillu-
minator for visualization. A picture was taken using a Kodak DC290 digital
camera. The gel was then disposed of in the appropriate EtBr waste container.
2.4.4 Immunocytochemistry
Cells cultured as described previously were washed in PBS and fixedwith 0.3%
formaldehyde for 15 min at room temperature. Cells were washed twice in
PBS and permeabilised with 0.025% Triton-X-PBS. Cells were washed twice in
PBS and blocked in 5% BSA- PBS-1% Tween for 1 h at room temperature and
incubated overnight with the appropriate primary antibody at 4oC. Cells were
washed twice for 15 min in PBS-1%Tween and incubated in the appropriate
secondary antibody for 30mins in the dark. Following, two 15 min washes in
PBS, cells were visualised using the Olympus DP-50 fluorescent microscope.
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Constructs Charachteristic Vector Antibiotic
Ezrin-GFP wild type ezrin pEGFP-N1 Kanamycin
Moesin-GFP wild type moesin pEGFP-N1 Kanamycin
plc-δ-RFP wild type plc-δ pEGFP M6BP Kanamycin
Ezrin-FLAG wild type ezrin pEGFP-N1 Kanamycin
Moesin-FLAG wild type moesin pEGFP-N1 Kanamycin
T558D-GFP phosphomimetic moesin pEGFP-N1 Kanamycin
T558A-GFP Moesin that cannot be phophorylated pEGFP-N1 Kanamycin
GFP-Moesin Moesin unable to bind to PIP2 pEGFP-N1 Kanamycin
N1-GFP Control for contructs with pEGFP-N1 pEGFP-N1 Kanamycin
Table 2.1: Plasmid Constructs
Constructs Source Verification
Ezrin-GFP Richard Lamb, Cancer Research UK (Lamb et al., 1997)
Moesin-GFP Ronan Murphy, DCU Sequenced
plc-δ-RFP Tamas Balla, NICHD, (Varnai and Balla, 1998)
Ezrin-FLAG Made the construct Sequenced
Moesin-FLAG Made the construct Sequenced
T558D-GFP Ronan Murphy, DCU Sequenced
T558A-GFP Ronan Murphy, DCU Sequenced
GFP-Moesin Ronan Murphy, DCU Sequenced
Table 2.2: Source & Verification of the Plasmid Constructs
2.4.4.1 GFP protein visualization and FLAG tag plasmids used
Transient transfections were utilized as detailed before with the plasmids given
in the table below. The concentration and volume of the construct was kept
same for all constructs between each set of experiments. Each plasmid was
electroporated with 3µg for 106 cells. The various constructs used are illus-
trated in the following figure (Figure 2.6). The constructs have been previously
verified for its expression and localization.
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Figure 2.6: Constructs used in experiments Representation of all constructs
used in the experiments. The illustration shows where the GFP/FLAG was
cloned into. T558D is a constitutively phopho-mimetic form of moesin (Threo-
nine 558 to Aspartic Acid, T558D). T558A is constitutively nonphopho-mimetic
form of moesin (Threonine 558 to Alanine). Inactive moesin has GFP cloned
into N-terminus, at the F1 domain, while FERM domain alone is created by re-
moval of the C terminus tail at position 382 (GFP is cloned here). FLAG tag has
been cloned into the C-terminus for both moesin and ezrin, availing functional
full length. Similarly GFP is cloned into moesin C-terminus for functional full
length.
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2.4.5 Endothelial Microparticle Assay
2.4.5.1 Isolation of Endothelial Microparticles for Western Blotting
BAECs were grown in five 1752 tissue culture flasks to confluency. These were
then stiumulated/non-stimulatedwith TNF-α overnight. The supernatant was
centrifuged at 2000xg for 10 min to clear debri. The supernatant was then col-
lected undisturbed and ultra-centrifuged at 70,000g for 1 h. The pellet was then
acetone precipated. This was immuonblotted for moesin after seperation of the
proteins by gel electrophoresis
2.4.5.2 Calcein AM Staining of Microparticles
For ionophore activation C5149-5MG (A23187) from Sigma was prepared ac-
cording to the manufacturer’s guidelines. According to this, 15.9mM stock
solution was prepared by addition of 5mg in 600µl of DMSO and stored in
aliquots of 10µl at -20oC.
Fully confluent cells were in 6 well plates were stained with 2µl (in 1ml
media) in each well for 20 min with calcein AM (Falati et al., 2003). Calcein
AM stock solution was previously prepared by dissolving 50µg of the same to
100µl DMSO (Falati et al., 2003).
The cells were then incubated with fresh media (1.1ml media and 0.7µl of
15.9mM ionophore) and ionophore to obtain 10µM ionophore solution for a
period of 4 h. Cells were also left untreatedwith ionophore for the same period.
The supernatant was harvested or the cells utilized for visualizing under the
microscope. The harvested supernatant was centrifuged at 2000xg for 10 min.
800µl of the supernatant was then obtained and the rest including cell debri
discarded. This was assayed utilizing FACS for microparticles (Falati et al.,
2003).
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Figure 2.7: Fluorescence of Calcein AM, whenmembrane bound Calcein AM
is a non fluorescent dye and readily diffuses across the plasma membrane of
cells. This dye fluoresces on cleavage of its calcein AM (cleaved at the ester
bonds), by endogenous esterases inside the cell. With this transformation, it
becomes highly hydrophilic and intensely fluorescent but is retained inside
the membranes. Microparticles then formed, contain membrane and thus en-
capsulates the now fluorescent dye. After removal of cells, cell debri by cen-
trifugation microparticles (under 1 micron) can be gated using FACS. Particles
and cell debri under 1 micron that are still present won’t fluoresce due lack of
intact membrane.
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Instead of ionophore, microparticles were also induced by thrombin. For
this purpose initially thrombin stock solution was prepared. Thrombin (lot
number 087k7570 ) was obtained from Sigma. From Sigma, the amount of
thrombin units were found to be 195 units. As per the manufacturer’s direc-
tions thrombin was dissolved in de-ionoised water to obtain 1 unit per µl.
According to literature, confluent cells were serum starved for 12 h. The
cells were then induced for microparticles with thrombin (1 IU/ml) and with-
out (Sap, 2006). Prior to this the cells were stained with calcein AM in serum
freemedia, otherwise as stated before. Microparticles were also harvested from
the supernatant as stated before for analyzis with FACS.
For studies that utilized calpeptin (which is a a cell-permeable calpain in-
hibitor) final concentration according to literature was kept at 50µM. Stock so-
lution was prepared to 27.5 mM by addition of 500 µl DMSO. Calpeptin was
added together with media and ionohphore/thrombin towards obtaining final
concentration of 50µM. If added together with thrombin the media was main-
tained without serum.
2.4.6 Microparticles analysis in-vivomodel
Blood was drawn from participants using a 19C needle into 0.32% final con-
centration citrate. Anti-coagulant was utilized, after which samples were cen-
trifuged at 1550g for 20min. Plasma was subjected to 18890g centrifugation for
30min at 20o. 225µl from the supernatant was mixed with 225µl 1xPBS/citrate.
This was centrifuged for 30min at 18890g at −20o. 225µl was taken, mixed
with 75µl 1XPBS/citrate. After incubation in dark for 15min it was subjected
to FACS
2.4.7 Permeability assay
Following transfection and recovery of cells in fresh media, cells were serum
starved for 12 h. The cells were then trypsinized and replated into Transwell-
Clear plates at high density of 106cells/cm2. After 24 h when cells were con-
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fluent, transendothelial permeability was measured. At t=0, 4 ml of media was
added to the subluminal chamber. Following this at t=0, fluorescein isothio-
cyanate (FITC)-labelled dextran (40 kDa, Sigma-Aldrich) was added to the ab-
luminal chamber (to give a final concentration of 250 µg/mL) and diffusion of
dextran across the monolayer allowed to proceed at 37oC for 2 h. 10nM uPA in
final concentration was added to the abluminal chamber at t=0 for experiments
that monitored acute effect of uPA on barrier integrity.
Media samples (28 µl) were collected every 30 min from the subluminal
compartment. This was diluted with 372µl media and monitored in tripli-
cate for FITC-dextran fluorescence at excitation and emission wavelengths of
490 and 520 nm, respectively (Perkin-Elmer Luminescence Spectrometer LS50B
with microplate reader attachment). 100µl was loaded per well of a 96 well
plate for this purpose. Trans Endothelial Exchange (%TEE) of FITC-dextran
40 kDa is expressed as the total subluminal fluorescence at a given time point
(from 0-180 min) expressed as a percentage of total abluminal fluorescence at
t=0 min.
2.4.8 Chemotaxis
A filter (8 µm pore size) for microchamber unit was treated with 100 µg/ml
Collagen I (rat tail, Roche) for 2h at 37oC. For this purpose initially the filter was
washed in serum-free cell culture medium for a few seconds (10 ml of medium
in a 10 cm Petri dish). After drying the filter it was immersed completely in 1.5
ml of the 100 µg/ml collagen I solution in a 10 cm Petri dish. Further to this 1.5
ml of collagen I solution was applied on the top of the filter in order to have
both side treated. The Petri dish was placed at 37oC for 2 h.
The solutions at appropriate final concentration of reagents (to be tested
for their efficacy in enticing chemotaxis in cells) in serum-free media was pre-
pared. The final concentration of the reagents used is given below.
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uPA
SRSRY
D2A
D2A-Ala
VN
10nM
1pM
1pM
100pM
1µg/ml
After the 2 h incubation, the filter was dried. Meanwhile the solutions
prepared was added in bottom well at a volume of 25µl. The filter was cen-
tered correctly onto the apparatus containg the lower wells. The upper part of
the microchamber unit was immediately positioned and tightened with screws
whilst holding tightly. The cells were then prepared by washing the cell mono-
layer with 1x PBS after removal of media. The cells were trypsinzed. Critically
after trypsinization cells were subjected to two washes with 14 ml of serum-
free medium. This was to remove any factors that might interfere with chemo-
taxis. Further to centrifugation cells were resuspended in 1 ml of serum-free
medium. 5 x 105 cells were then seeded at 50 µl volume on the upper well.
This entire procedure was performed expediently to avoid evaporation in the
lower well. The cells were then allowed to migrate overnight in a tissue cul-
ture incubator. At the end of the migration period, the filter was fixed in 20%
methanol (w/v). The cells were then stained in 10% (w/v) crystal violet in
20% methanol (w/v) for 10 min at room temperature. Further to this the filter
was washed in distilled water and mounted on glass slide. Cells were counted
under the microscope using 20X lens. For each well five fields were taken into
account for counting. Each independent experiment conducted had at least
three duplicates for each condition.
2.4.9 Wound Healing
Wound healing measures the ability of the cell to migrate and close introduced
gap between cells. Ibidi® provide a 35mm dish (µ-slide35mm, high wall) with high
walls that enable to grow cells in precise chambers. These chambers are inserts,
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which when removed introduce defined gaps. Cells were seeded according to
the manufacturer’s protocol. Post seeding, cells were allowed to achieve full
confluence in full media. The inserts were washed with 1 x PBS twice and
serum starved overnight. Following this, the insert was removed introducing
the gap. Immediately following this petridish was washed twice with serum
free media and image captured (t=0). The dish was incubated in the tissue
culture incubator. Every 1 h image was captured upto 8 h, image was captured
after overnight incubation. Due to the lack of serum, proliferation was avoided
but migration occurred, resulting in closure of the gap was measured. The
images were measured by means of a simple ruler using CELL software to
quantitate. The mean measurements was plotted against control to generate
fold difference.
2.4.10 Angiogenesis
2.4.10.1 Angiogenesis in Collagen I
Acetic acid 0.1M was used to prepare Collagen I 1.5 mg/ ml (rat tail, Sigma
Aldrich). This preparation was mixed in the following preparation.
Collagen I 1.5 mg/ml
full serum media
1M NaOH
84.5%(w/v)
8.45%(w/v)
7.04%
The media for uPA based study in collagen gel was titrated to yield the
most stringent result. This was 1.5% serum for HAECs in collagen gel. Less
serum was detrimental to invasion while too much serum drowned the effects
of uPA. The other area where stringency was evident was the number of cells
to be seeded. Collagen gels typically required more cells, while Matrigel re-
quired much less cells. The cells required for stringency was even less, if the
experimental situation required full serum media. Collagen solidifies at neu-
tral pH and when in solution with acetic acid, it remains in liquid due to its
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low pH. NaOH is utilized to neutralize the pH allowing collagen to solidify.
It is also possible to use NaOH vapours to solidify collagen. Studies in colla-
gen provided a one dimensional system to analyze with stringency, effects of
overexperssion of various moesin plasmids.
100µl of the above mix was added per well of 96 well plate, which then
solidified in 1 h. The above plate was then incubated with 100µl of treat-
ment media in tissue culture incubator. The following day 20,000 cells were
seeded onto this plate with fresh media. The following day, the matrix was ob-
served for tube formation/elongation. Images were taken with 10x objective,
four different fields were obtained per duplicate conditions. Each indepen-
dent experiment constituted at least three different duplicates. As well, at least
three independent experiments were conducted (Von Offenberg Sweeney et al.,
2005). Further to image capture, tube length was measured using CELL soft-
ware, which calculated tube length of each tube. Graphs were plotted as fold
difference in mean tube length.
2.4.10.2 Angiogenesis in Matrigel™
Studies in Matrigel™is much easier to conduct compared to collagen gel. Ma-
trigel™, (BD Biosciences) is derived from Engelbreth-Holm-SwarmMouse Tu-
mor. Matrigel is widely used to study angiogenesis (Suarez et al., 2007). This
provides a mechanism to study angiogenesis, simulating tumour like condi-
tions. An array of titrations were carried out to gain optimum serum concen-
trations to use with this batch of Matrigel™. Titration also took into account
the optimum serum concentration that enabled to discern differences between
various conditions used. Further to this, optimum incubation period that en-
able discerning differences between various conditions was validated. Gel was
prepared according to the manufacturer’s protocol. Prior to solidifying the gel,
the plates were centrifuged at maximum speed for 10 s to even the meniscus
and remove any air bubbles. Further to this, 8000 cells in media (0.5% serum)
media was seeded onto the Matrigel. Cells were adjusted to equal stock vol-
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ume for each condition prior to addition. In case addition of uPAwas required,
media added with the cells had uPA in final concentration of 10nM.
Otherwise the experiment was conducted according to manufacturer’s pro-
tocol. Further to which, images were taken using 4x objective. The images
were qualitative in nature. For discerning the difference, images were looked
for web like formation which constitute angiogenesis. As well the ability of the
webs to interconnect each other (Suarez et al., 2007).
2.4.11 Cell Count
To analyze HAEC proliferation post transfection, cells were seeded at equal
density of 103 cells per well after serum deprivation for 24 h. Cells were then
counted using ADAM automatic cell counter® 24 h after. The technology uses
propidium iodide based dye to intercalate nuclear DNA. This is thenmeasured
and processed by the machine giving a more precise count (Herrmann et al.,
1994). Similarly for routine cell count the same methodology was used.
2.4.12 Alamar Blue® methodology for proliferation
Alamar Blue® is a non toxic dye used to measure cell proliferation and health.
The dye consists of resazurin (a non-fluorescent and blue in colour) which
is converted to resorufin (fluorescent and bright red in colour) by the cells.
The change is directly proportional to the number of metabolically active cells.
Cells are plated at equal density in 96-well tissue culture plates post serum
starvation. The media added with the cells contain 10% of the dye. As a
control the same preparation is taken into account without cells. The cells
are incubated for the period that the cells are monitored for cell prolifera-
tion. Following this, 200µl of the media is loaded onto a 96 well plate and
absorbance of alamarBlue measured at 600nm and 570nm. The measurement
is conducted using a spectrophotometer. Post measurement data were ana-
lyzed using www.abdserotec.com/antibodies/−705.html (Ahmed et al., 1994).
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2.4.13 Click-iT ® EdU Cell Proliferation Assays
This method is an alternative to the commonly used BrdU based cell cycle an-
alyzis. BrdU uses nucleoside analog bromo-deoxyuridine (BrdU) while EdU
uses 5-ethynyl-2´-deoxyuridinewhich is a nucleoside analog to thymidine (Lee
et al., 2008; Yu et al., 2009; Buck et al., 2008). This is then incorporated into
DNA during the synthesis of DNA. For detection a copper catalyzed covalent
reaction between an azide (Alexa Fluor® 488 dye) and an alkyne (which is
the Edu) is utilized. The main difference in contrast to BrdU based method is
the non necessity of DNA denaturation. Edu based method utilizes standard
aldehyde-based fixation and detergent (saponin) permeabilisation. Further to
this 7-AAD (7-Aminoactinomycin D) was incubated according to Click-iT ®
protocol. 7-AAD binds with high affinity to GC region in DNA and is useful
for monitoring cell cycle.
Due to their high sensitivity, EdU based method is useful for detection of
cell cycle progress at an early stage (Buck et al., 2008). The cells further to pro-
cessing according to the manufacturer’s protocol was monitored by FACS. For
the detection of EdU with Alexa Fluor® 488 azide we used 488 nm excitation.
Prior to starting the experimental procedures, compensation with various con-
trols were done and a template created, validated for accurate measuerment of
the cell cycle.
Cell synchronization to Go for various experiments
For cell cycle analyzis for static cells, HAECswere seeded equally at 105 cells/cm2
and allowed to reach confluence over 24 h. The cells were then synchronized
by serum starvation for 24 h to Go phase. The cells were labelled with EdU
containing the full media 12 h prior to harvestation by trypsin. For cell cy-
cle analyzis of cells subjected to cyclic strain followed by stasis, HAECs were
seeded equally at 105 cells/cm2 and allowed to reach confluence over 24 h.
The cells were then synchronized by serum starvation for 24 h to Go phase.
The cells were labelled with EdU containing the full media prior to straining.
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The cells were then strained for 4 h. The strain was stopped and the cells main-
tained in stasis for 6h following which the cells were trypsinized. HAECs were
seeded equally at 105 cells/cm2 and allowed to reach confluence over 24 h.
The cells were then synchronized by serum starvation for 24 h to Go phase.
The cells were labelled with EdU containing the full media prior to straining.
The cells were then strained for 12 h. The cells were harvested post strain by
trypsinization. Following trypsinzation all cells were monitored by FACS post
processing according to the Click-iT® .
2.4.14 Carboxy-fluorescein diacetate succinimidyl estermethod
Carboxy-fluorescein diacetate succinimidyl ester (CFDA-SE) is a colorless and
nonfluorescent dye which passively diffuses into cells. Its acetate groups are
cleaved by intracellular esterases to yield highly fluorescent, amine-reactive
carboxyfluorescein succinimidyl ester. The succinimidyl ester group reacts
with intracellular amines, forming fluorescent conjugates that are well-retained
and can be fixed with aldehyde fixatives. Excess unconjugated reagent and
by-products passively diffuse to the extracellular medium, where they can be
washed away. The dye - protein adducts that form in labeled cells are retained
by the cells throughout development, mitosis, and in-vivo tracing. The label is
inherited by daughter cells after cell division or cell fusion, and is not trans-
ferred to adjacent cells in a population (Hodgkin et al., 1996).
For proliferation analyzis, 12 h post transfectionHAECswere fed. A further
12 h later the cells were seeded equally at 104/cm2 to bioflex plates. 8 h post
seeding, they were stained with CFDA-SE. For staining the cells were washed
once with PBS and 1 ml of 5 µMCFDA-SE, prepared in PBS, was added to each
well for 5min at 37oC. Following incubation, CFDA-SEwas replacedwith fresh
media and the cells allowed to recover for 1 h. Cyclic strain was applied after
this for 24 h. Cells were harvested after, by trypsinization and centrifugation
and washed twice with 1 ml ice-cold PBS (containing 0.1% BSA). Cells were
then placed on ice and immediately analyzed using flow cytometry.
139
The concentration of the dye in the cells, which is inversely proportional to
the rate of proliferation, was measured by flow cytometry (Becton Dickinson
FACSCaliber) at an excitation peak of 492nm and emission peak of 517nm.
2.4.15 Flow Cytometry
Flow cytometry is a method for counting, and sorting microscopic particles
suspended in a stream of fluid. FACS™(Fluorescent Activated Cell Sorting) is
a specialised type of flow cytometry that measures the amount of light emitted
by fluorescent molecules associated with individual cells. Lasers are used to
excite the fluorescent molecules, which are excited at one range of wavelengths
and emit at a second range. Filters in front of each of a series of detectors re-
strict the light that reaches the detector to only a small range of wavelengths
(Tung et al., 2007). Examples of the fluorescent molecules that can be detected
are calcein AM, used with microparticle studies. This is used to measure the
number of microparticles in supernatant suspension and carboxy-fluorescein
diacetate succinimidyl ester (CFDA-SE), which can be used to measure prolif-
eration. This is also used to measure Click-iT ® EdU based cell cycle analyzis.
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Chapter 3
Haemodynamic regulation in
the vasculature; the need for
moesin
3.1 Introduction
Vascular cells are subjected to various stimuli such as the mechanical forces
of cyclic strain and shear stress. This induces numerous molecular responses,
which are still not fully characterized. The vasculature fine tuned by evolu-
tion has been purpose built, for the flow of blood, thus carrying vital nutrients
to the far reaches of the body. The flow of blood and the associated haemo-
dynamic forces induce the necessary functional responses, allowing self repair
and remodeling according to the specific needs and challenges.
Functionally, it has been demonstrated that proliferation is increased by
cyclic strain in endothelial cells. Research labs (including ours) have previously
shown enhanced migration of endothelial cells previously subjected to cyclic
strain. Cyclic strain is transduced across the vasculature and thus smooth mus-
cle cells also experience cyclic strain. Proliferation in smooth muscle cells show
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the opposite effect from endothelial cells and thus is decreased with cyclic
strain. Inflammatory signals such as in areas with irregular cyclic strain (such
as turbulent, oscillatory, low flow) would induce a differential proliferation re-
sponse.
The in-vitromodel that we use to subject cells to cyclic strain has been char-
acterized extensively and is well published in the literature. The model has
been extensively characterized with respect to migration, proliferation, angio-
genesis and eNOS production, induced with cyclic strain. As endothelial nitric
oxide synthase (eNOS) is increased by cyclic strain, the model is frequently
assessed for this response. These functional responses due to cyclic strain, de-
tailed in the introduction, has been published extensively.
It has been shown that integrins and their associated adapter proteins, in-
cluding the FERM domain containing protein talin, have roles associated with
cyclic strain. The forces are transmitted and modulated by these cytoskele-
tal proteins. Other FERM domain containing proteins such as, moesin, ezrin,
radixin have not been studied to date. Though difficult to study due to high
level of redundancy in mammalian cell model, the ERM proteins still might
have roles specifically suited to the adaptive nature of the vasculature.
Moesin is highly expressed in endothelial cells compared to ezrin, while
radixin is expressed at the lowest level of all three ERMs. Thus, moesin might
have specific and key regulatory roles suited to the function of the vascula-
ture. Rho kinase is activated in smooth muscle cells experiencing stretch, while
conversely Rac is activated in endothelial cells. Rho kinase activates moesin
by phosphorylation while Rac might dephosphorylate moesin.Furthermore,
other research groups (including our lab) have recently noticed the presence
of moesin in the nucleus.
This chapter looks into biochemically elucidating moesin with cyclic strain
and shear stress mainly in endothelial cells and also in smooth muscle cells
(cyclic strain). It is investigated whether moesin is translocated to the nucleus
with cyclic strain. Further more, we look into mRNA, protein and also look
into their correlation.We characterize if fibronectin coated plates or the widely
142
used synthetic derivative pronectin, coated plates are a better inflammatory
model for cyclic strain. Functionally, we profile cell cycle soon after induction
of cylic strain in endothelial cells. We see if our cyclic strain model induces
migration as seen in literature. As well, moesin and actin is checked to see if
indeed it does co-localise in the flexible membrane.
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3.2 Results
3.2.1 Biochemical profile of moesin under cyclic strain mRNA,
protein, phosphorylation status (endothelial cells).
In order to investigate sensitivity of moesin to mechanical stimuli, bovine aor-
tic endothelial cells (BAECs) were subjected to cyclic strain (7.5%, 24 h) follow-
ing which the cell’s RNA and protein was harvested. The cDNAwas analyzed
using RT-PCR which showed increased mRNA of moesin with cyclic strain
(60% fold) (Figure 3.1). Moesin protein though increased at amuch higher level
post cyclic strain (2.5 fold). The protein levels were confirmed to be similar in
HAECs with moesin increasing hugely with cyclic strain. The phosphorylation
state of moesin is upregulated with chronic strain over 24h (370% difference
compared to static).
Similar investigation into sub-confluent cells, show an increase of moesin/
phosphorylated moesin with cylic strain in BAECs (50% difference for total
moesin and 70% difference for phosphorylated moesin), albeit not to huge lev-
els seen in confluent cells. The actual phosphorylation levels were also higher
in static cells in sub-confluent cells.
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Figure 3.1: Effect of cyclic strain on Moesin in endothelial cells
Endothelial cells were exposed to cyclic strain (7.5% for 24 h ) in (50 µg/ml) fi-
bronectin coated bioflex® plates (HAECs) (Liu et al., 2007). BAECs were grown
on pronectin coated bioflex® plates. mRNA changewasmonitored by RT-PCR,
while protein change was monitored by western blotting. Studies A to D were
conducted on fully confluent cells seeded at 105 cells/cm2. Studies E and F
were conducted on subconfluent cells seeded at 104 cells/cm2 (Liu et al., 2007).
A) Moesin mRNA change in BAECs. B) Moesin protein change in BAECs.
C) Moesin protein change in HAECs. D) Phosphorylated Moesin change in
HAECs. E) Moesin protein change in subconfluent BAECs. F) Phosphorylated
Moesin change in subconfluent BAECs. Histograms represent fold change in
band intensity relative to unstrained controls and are averaged from three
independent experiments ± SEM; All values were controlled for equal load-
ing by equalising for corresponding GAPDH. Representative blots are shown.
∗P<0.05 Statistically significant compared to static control.
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3.2.2 Moesin translocated to the nucleus with cyclic strain
BAECs exposed to cyclic strain (24h) showed increase in moesin expression
previously. The flexible membrane used for cyclic strain proved to be difficult
in viewingwith fluorescencemicroscopy. This was due to the silicone lubricant
applied on the base. Thematerial was not also very conductive to viewingwith
microscopy. We thus employed two different biochemical kits to fractionate the
cells post cyclic strain (7.5%, 24 h) (Figure 3.2) (Cattaruzza et al., 2004; Batchelor
et al., 2004).
Using Biovision based extraction method the cells were harvested into sub-
cellular fractions. Simlarly to be conclusive, another kit from Calbiochem was
utilized. The cells were fractionated post cyclic strain. There was clear translo-
cation using both methods to the nucleus. The cells were fully confluent prior
to the application of cyclic strain. We found no bands for moesin in the nucleus
when no strain was applied at this concentration of protein.
The cytosolic fraction using Biovision based method yielded, increase (35%
difference) in cytosolic fraction due to cyclic strain.
The group that published moesin’s presence in nucleus used calyculin A at
300 nM for 30 min before harvesting the cells. This was to preserve the phos-
phorylation status of moesin with downstream processing. We followed the
same protocol in terms of addition of 300nM calyculinA for 30 minutes prior
to harvesting the cells. Thus cyclic strain was stopped very briefly for addition
of calyculin A. Otherwise same method as was utilized for fractionation post
cyclic strain (7.5%, 24 h, BAECs).
The results also clearly indicate moesin translocated to the nucleus, is phos-
phorylated. While there was no moesin present from these in confluent cells
in the nucleus. Calbiochem method couldn’t be used as acetone precipitation
was found to affect the phosphorylation state of moesin.
The results from cytosolic fraction found moesin increased (25% difference)
with cyclic strain to be phosphorylated.
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Figure 3.2: Moesin is translocated to nucleus with cyclic strain BAECs were
exposed to cyclic strain (7.5% for 24 h) in pronectin coated bioflex® plates, the
cells were then fractionated to cytosolic and nuclear fractions. Two different
methods were employed for this purpose. Thirty minutes prior to harvesting
the cells, it was treated with 300 nM calyculin (Batchelor et al., 2004). This was
to preserve the phosphorylation status of moesin with downstream process-
ing. When, (representative blots labelled i, or not labelled) Biovision® based
extraction method was utilized equal volume of each fraction was monitored
by western blotting for Moesin and Phosphorylated Moesin. Further to (rep-
resetnative blots labelled ii) Calbiochem® based extraction method, each frac-
tion was acetone precipitated, mixed in equal volume of sample buffer. Fur-
ther to which, the fractions were monitored for Moesin by western blotting.
A) Cytosolic fraction monitored for Moesin. B) Nuclear fraction monitored for
Moesin. C) Cytosolic fraction monitored for Phosphorylated Moesin. D) Nu-
clear fraction monitored for Phosphorylated Moesin. Equal loading was mon-
itored by ponceou staining. The fractions were verified for nuclear or cytosolic
fraction bymeans of antibodies against GAPDH (positive for cytosolic fraction,
negative for nuclear fraction); TATA binding protein (postive for nuclear frac-
tion, negative for cytosolic fraction). Histograms represent fold change in band
intensity relative to unstrained controls and are averaged from at least three
independent experiments ± SEM; representative blots are shown ∗P<0.05 Sta-
tistically significant to static
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3.2.3 Moesin protein change associated with cyclic strain in
smooth muscle cells.
Smooth muscle cells were also investigated to understand moesin expression
pattern with mechanical stimuli. Cyclic strain (7.5%, 24h) on bovine aortic
smooth muscle cells reduced moesin protein expression (50%). There was
no disparity between mRNA change and protein change (Figure 3.3). Protein
change thus reflected the mRNA change in smooth muscle cells.
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Figure 3.3: Effect of cyclic strain on Moesin in BASMCs
BASMCs were exposed to cyclic strain (7.5% and 4% for 24 h) and monitored
for A) Moesin Protein expression by western blotting and B) Moesin mRNA
change using Real-Time PCR. Histograms represent fold change in band inten-
sity relative to unstrained controls and are averaged from three independent
experiments± SEM; All values were controlled for equal loading by equalising
for corresponding GAPDH. Representative blots are shown. ∗P<0.05 Statisti-
cally significant, ∗∗ not statistically significant
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3.2.4 Effect of shear on moesin expression
Moesin expression was also investigated with respect to shear stress in en-
dothelial cells. Shear stress measured in dyne/cm2 was subjected on HAECs
at 10dynes/cm2. This resulted in reduced moesin protein expression (60%)
(Figure 3.4). The reduced expression pattern was in contrast to the previously
studied cyclic strain, wherein moesin expression increased. There was a simi-
lar paradigm with respect to mRNA. Where there was a considerable increase
in moesin mRNA (140%).
mRNA expression profile of the highly redundant ERM proteins provide
interesting insights. Moesin mRNA expression was substantially increased un-
der shear stress (10 dynes, 24h) using microfludic ibidi® system. Meanwhile
ezrin mRNA did not change significantly with shear. This was in contrast to
the huge shift in moesin and radixin (300%).
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Figure 3.4: Moesin protein change associated with shear stress
HAECs were exposed to 10 dynes/cm2 shear stress for 24 h using ibidi® mi-
croslide vi for mRNA and orbital methodology of shear for protein. Following
this it was monitored for A) (moesin, ezrin, radixin) mRNA and B) (moesin)
protein by RT-PCR and western blotting respectively. Histograms represent
fold change in band intensity relative to unsheared controls and are averaged
from three independent experiments ± SEM ; All values were controlled for
equal loading by equalising for corresponding GAPDH. All values are con-
trolled for equal loading by equalising for GAPDH under same conditions.
Representative blots are shown. ∗P<0.05 Statistically significant.
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3.2.5 Moesin-GFP distribution under shear stress
In order to understand shear stress induced moesin translocation, using stan-
dard fluorescencemicroscopyMoesin-GFP arrangement post shear (10dynes/cm2,
24 h) was monitored in BAECs. Moesin-GFP and GFP (on control cells) was
transfected in using lipofectamine. Under static conditions there is an uneven
distribution adhering to no particular pattern (Figure 3.5). There is a higher
localization of moesin across the cell. Compared to this, there is a an even dis-
tribution of moesin post shear. Moesin takes on a brushed distribution aligning
in the direction of the flow. GFP control cells meanwhile show no change be-
tween static and shear.
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Figure 3.5: Moesin-GFP showing peripheral alignment with shear
BAECs were exposed to constant laminar shear of 10 dynes/cm2 for 24 h fur-
ther to transfecting in Moesin-GFP and GFP control with lipofectamine A)
MoesinGFP (no shear, 1000X magnification). B) MoesinGFP (sheared, 1000X
magnification). C) GFP control (no shear, 1000X magnification). D) GFP con-
trol (sheared, 1000X magnification). Images are representatives of three inde-
pendent experiments.
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3.2.6 Moesin-GFP redistribution under shear stress
Using microfluidic ibidi® flow system HAECs were subjected to shear at 5.1
dynes/ cm2. Prior to this, Moesin-GFP was electroporated in, utilizing the
high efficiency electroporator amaxa. The cells were subjected to shear stress
for 10minutes. With fastprocessing of the videograph, redistribution of moesin
due to shear stress can be clearly noted. The force of 5.1 dynes/cm2 was
used to reduce the distortion on the microscope. The video can be viewed at
(www.youtube.com/watch?v=BcOC7PZrK1U). Alternately, the video can be
viewed at http : //www.youtube.com/user/mishanv. The figure representing
this, is Figure 3.6.
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Figure 3.6: Live visualization of Moesin-GFP peripheral alignment with
shear
HAECs were exposed to constant laminar shear of 5.1 dynes/cm2 for 24 h fur-
ther to electroporating in Moesin-GFP and grown on ibidi® microslide Y . The
region of the slide that undergoes laminar shear was subjected to videography.
Moesin-GFP rearrangement in cells were monitored by live microscopy for 10
minutes. The magnification is 1000X. The video in actual time can be viewed
at (www.youtube.com/watch?v=BcOC7PZrK1U). Alternately, the video can
be viewed at www.youtube.com/user/mishanv
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3.2.7 Comparison of cell cycle profile Fibronectin versus Pronectin
coated flexible plates
This study compares the cell cycle profile between cells grown on fibronectin
and pronectin. Changes in cell cycle in HAECs was compared when grown
on different matrices fibronectin and pronectin (Figure 3.7). The coated plates
were made of the silicone membrane, referred to as Bioflex® plates . An im-
proved method to Brdu referred to as Click it® was used to monitor this with
FACS.
The data is expressed as fold difference compared to cells grown on pronectin
coated plates. This showed no significant difference in apoptosis, G0/G1, S
phase between cells on fibronectin and pronectin. There was a significant dif-
ference in the G2/M phase between the two.
The effect of a pathogenic cyclic strain was also monitored, wherein we
introduced cyclic strain for 4h followed by stasis (Shown in the same figure;
(Figure 3.7). Six hours after stasis, the cells were analyzed with FACS. The
effect of a denuded cyclic strain was used as a model to compare cell cycle
differences between fibronectin and pronectin coated plates.
The cell cycle trend of cells grown on fibronectinwhen compared to pronectin
is similar with exception of apoptosis. The differences aremore profoundwhen
pronectin plates are used, except for G2/M phase. With cells grown on fibr-
noectin plates, effect on G2/M phase of cell cycle is profound.
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Figure 3.7: Cell cycle progression due to fibronectin and pronectin
HAECs were seeded equally at 105 cells/cm2 and allowed to reach confluence
over 24 h on either pronectin coated bioflex® plates or fibronectin( 50 µg/ml)
coated bioflex® plates. The cells were then synchronized by serum starva-
tion for 12 h to G0 phase. The cells were labeled with EdU® (according to
the "Click-iT® EdU" manufacturer’s guidelines) containing the full media 24 h
prior to harvestation by trypsin. For experiments requiring cyclic strain, label-
ing was done prior to the application of strain for 4 h. The strain was stopped
and the cells maintained in stasis for 6h. The cells were then monitored for
cell cycle change by FACS. A) Representative of cell population selected. B)
Representative FACS analysis. C) 12 h cell cycle change due to fibronection
coated plates controlled to pronectin coated plates. D) Strain versus Static
in fibronectin coated plates E) Strain versus Static in pronectin coated plates
Histograms represent fold change and are averaged from three independent
experiments ± SEM ∗ P<0.05 Statistically significant compared to pronectin
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3.2.8 Effect of cyclic strain on cell migration
This study was conducted to understand the effect of cyclic strain on the mi-
gratory apparatus of a cell. HAECs grown to confluency on fibronectin coated
plates were subjected to cyclic strains of 5% and 10% for 24h. These cells post
harvestation, was monitored over night across membrane in boyden chamber.
The data is expressed as fold change compared to static.
Cyclic strain increased themigration of cells (Figure 3.8). As well, it showed
a dose based increase in cell migration. Thus, 10% cyclic strain regime com-
pared to 5% (3 fold change) moulded the cells to migrate at a much higher rate
(17 fold change).
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Figure 3.8: Cyclic strain increase migration of HAECs
HAECs were seeded equally at 105 cells/cm2 and allowed to reach confluence
over 24 h in (50 µg/ml) fibronectin coated bioflex® plates. Cyclic strain was
then applied for 24 h after which cells were harvested with versene ®, washed
and seeded in serum free media. The cells were then allowed to migrate over
boyden chamber to full serum media. Histograms represent fold change in
mean migration measured by counting number of endothelial cells that has
migrated. Atleast five different fields were counted, and the experiment re-
peated at least three times. The cells were visualized by means of crystal violet.
∗P<0.05 Statistically significant compared to static
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3.2.9 Effect of acute cyclic strain on cell cycle
In this study different parameters of acute cyclic strain (12 h) are compared.
HAECs were grown to confluency on fibronectin plates. The flexible mem-
branes were subjected to different cyclic strain regimes. The study profiled
the effect of 10% and 8-10% regimes, on cell cycle with induction of cyclic
strain (Figure 3.9). The effect of cyclic strain on proliferation in endothelial
cells grown on fibronectin was analyzed.
8-10% showed no significant differences when compared to static cells. 10%
cyclic strain induces a very different profile compared to static cells immedi-
ately on induction of cyclic strain.
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Figure 3.9: Effect of acute cyclic strain (12 h) on cell cycle HAECs were
seeded equally at 105 cells/cm2 and allowed to reach confluence over 24 h
in (50 µg/ml) fibronectin coated bioflex® plates. The cells were then synchro-
nized by serum starvation for 24 h to G0 phase. The cells were labelled with
EdU® (according to the "Click-iT® EdU" manufacturer’s guidelines) contain-
ing the full media prior to straining. The cells were then strained for 12 h. The
cells were harvested post strain and monitored for cell cycle by FACS. His-
tograms represent percentage change and are averaged from three indepen-
dent experiments ± SEM ∗ P<0.05 Statistically significant compared to static
control ∗∗P<0.05statistically significant compared to 0-10%
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3.2.10 Conclusion
In this chapter the studies clearly demonstrate that moesin is sensitive to me-
chanical stimuli. In addition, there is a differential regulation of moesin with
shear stress and cyclic strain.
Furthermore, similar mechanical stimuli (cyclic strain) regulates moesin
differentially in different vascular beds. Moesin is also translocated to the nu-
cleus with cyclic strain. We also characterize proliferation, migration induced
by various cyclic strain.
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Chapter 4
microRNA regulation of
moesin under
mechanotransduction
4.1 Introduction
In the previous chapter, we found a disparity between moesin expression at
the mRNA and protein levels in cells that were mechanotransduced via cyclic
strain and shear stress. There could be many different reasons for this lack of
correlation between the mRNA and proteins. These could involve either post
transcriptional or post translational modifications. As explained in depth in
the introduction, moesin is a likely candidate for both scenarios.
We nevertheless decided to investigate the possibility thatmicroRNAmight
interfere with moesin expression. It is known that at least a third of human
genes could be under the conrol of microRNA (Selbach et al., 2008). Suarez et
al’s classic study into Dicer down regulation has unearthed diverse functions
affected with respect to vasculature (Suarez et al., 2007).
In-silico analysis was conducted to generate microRNAs that shared the 7
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nucleotide seed region with moesin. As explained in the introduction unlike
conventional importance for nucleotide paring, microRNAs need only a 7 nu-
cleotide complimetary region to repress (or even activate) (Vasudevan et al.,
2007). This is the widely held view, though increasingly the proximity of the
microRNA is found to be of importance as well. Further to this we exploited
a proprietary new technology by Applied Biosystems ®. This lets you analyze
an array of microRNA relevant to vascular cells and profile their expression
using RT-PCR.
Wewanted to see if moesin expression changes with Dicer downregulation.
We also wanted to investigate whether RhoGTPases control moesin dephos-
phorylation with cyclic strain. Further to this there will be interesting implica-
tions if we find dephosphorylation status of moesin was under microRNA con-
trol. With respect to proliferation, Suarez et al has shown endothelial cell pro-
liferation reduced with dicer down regulation(Suarez et al., 2007). We wanted
to elucidate if proliferation and also endothelial microparticle release, with
mechanotransduction is under microRNA regulation. Detailed investigation
into endothelial microparticles and moesin’s role in EMP release is detailed in
the next chapter.
Aim:
To profile micrRNAs affected and their change with shear stress and cyclic
strain in HAECs. To investigate whether moesin expression is affected with
chronic cyclic strain. To investigate moesin’s phosphorylation status and reg-
ulation with acute cyclic strain. Similarly confirm moesin’s expression pattern
with chronic shear stress. See if endothelum is able to sense shear stress, and
take on the charachteristic physiological arrangement i.e, in the direction of
flow. To investigate what other functions were under the control of microRNA
regulation.
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4.2 Results
4.2.1 Insilico analyzis ofmicroRNAs for determination ofmoesin
as a target
Here we explore the microRNAs that potentially regulate moesin. Using in-
silico analyzis using the bioinformatic tool at http : //microrna.sanger.ac.uk
provided the microRNAs hsa miR 489, hsa miR 221, hsa miR 215, hsa miR-542-
3p, hsa miR-767-5p. Their seed region’s alignment and p value are significant
towards moesin mRNA. This is shown in (Figure 4.1).
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Figure 4.1: MicroRNAs with moesin as probable target
In silico analyzis was carried out using data from http://microrna.sanger.ac.uk
A) MicroRNAs predicted to target moesin with high probablity, their align-
ment to moesin mRNA (note that microRNAs don’t align fully but, rather tar-
gets themRNAutilizing a few complimentary seed region). B) Their alignment
with respect to moesin and evaluation of their interspecies conservation.
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4.2.2 microRNAs of interest regulated with mechanotrasduc-
tion
Here we investigate the mechano-regulation of the microRNAs complimen-
tary to moesin mRNA. Previously identified microRNAs that possibly target
moesin were found to be regulated with mechanotransduction. There are other
microRNAs listed thatmight be of interest, which is also regulatedwithmechan-
otransduction. We find here that hsa-miR-221 (4.4 fold) and hsa-miR-489 (2.9)
are both increased with cyclic strain. With shear stress hsa-miR-221 increase
(1.5 fold), while hsa-miR-489 is not present anymore. The figure also shows
the methodology used for isolation of microRNA, verification and expression
analyzis. This is shown in (Figure 4.2).
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Figure 4.2: MicroRNA change with shear stress and cyclic strain
HAECs were exposed to laminar shear of 10 dynes/cm2 and cyclic strain
(10%) for 24 h. Cyclic strain was carried out using pronectin coated bioflex
plates. Further to microRNA being extracted it was subjected to quality con-
trol using a Nano drop 1000 spectrprophotometer and Agilent Microfluidic
Bio-analyzer 2100 (Agilent technologies). TLDA v1.0 card was loaded with
prepared cDNA and analyzed utilizing RT-PCR using AB 7900HT Fast RT-PCR
system. In silico analyzis was carried out using http://microrna.sanger.ac.uk.
Data was analyzed using RT-PCR StatMiner. A) Change in a selection of mi-
croRNAs(including the previously identified microRNAs with moesin as pos-
sible target) with shear and cyclic strain (fold difference to static). B) Outline of
the process utilizing TLDA v1.0 card.
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4.2.3 microRNAs upregulated with cyclic strain
Our investigation also led to the identification of an array of microRNAs up-
regulated with cyclic strain. This is shown in (Figure 4.3).
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Figure 4.3: Upregulated microRNAs under cyclic strain.
HAECs were exposed to cyclic strain (10%). Cyclic strain was carried out us-
ing pronectin coated bioflex plates. Further to microRNA being extracted it
was subjected to quality control using a Nano drop 1000 spectrprophotome-
ter and Agilent Microfluidic Bio-analyzer 2100 (Agilent technologies). TLDA
v1.0 card was loaded with prepared cDNA and analyzed utilizing RT-PCR us-
ing AB 7900HT Fast RT-PCR system. In silico analyzis was carried out using
http://microrna.sanger.ac.uk. Data was analyzed using RT-PCR StatMiner.
Values are expressed as positive fold change compared to static control. This
corresponds to upregulation of microRNAs.
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4.2.4 microRNAs upregulated with shear stress
The investigation also led to the identificatin of an array of microRNAs upreg-
ulated with shear stress. This is shown in (Figure 4.4).
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Figure 4.4: Upregulated microRNAs under laminar shear
HAECs were exposed to laminar shear at 10 dynes/cm2. Further to microRNA
being extracted it was subjected to quality control using aNano drop 1000 spec-
trprophotometer and Agilent Microfluidic Bio-analyzer 2100 (Agilent tech-
nologies). TLDA v1.0 card was loaded with prepared cDNA and analyzed
utilizing RT-PCR using AB 7900HT Fast RT-PCR system. In silico analyzis was
carried out using http://microrna.sanger.ac.uk. Data was analyzed using RT-
PCR StatMiner™. Values are expressed as positive fold change compared to
static control. This corresponds to upregulation of microRNAs.
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4.2.5 microRNAs downregulated with cyclic stain
Majority of microRNAs investigated meanwhile was found to be downregu-
lated with cyclic strain. This is shown in (Figure 4.5) and (Figure 4.6).
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Figure 4.5: Down regulated microRNAs under cyclic strain
HAECs were exposed to cyclic strain (10%) for 24 h. Cyclic strain was car-
ried out using pronectin coated bioflex® plates. Further to microRNA being
extracted it was subjected to quality control using a Nano drop 1000 spectr-
prophotometer and Agilent Microfluidic Bio-analyzer 2100 (Agilent technolo-
gies). TLDA v1.0 card was loaded with prepared cDNA and analyzed uti-
lizing RT-PCR using AB 7900HT Fast RT-PCR system. In silico analyzis was
carried out using http://microrna.sanger.ac.uk. Data was analyzed using RT-
PCR StatMiner™. Values are expressed as negative fold change compared to
static control. This corresponds to downregulation of microRNAs.
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Figure 4.6: Down regulated microRNAs under cyclic strain
HAECs were exposed to cyclic strain (10%) for 24 h. Cyclic strain was carried
out using pronectin coated bioflex plates. Further tomicroRNAbeing extracted
it was subjected to quality control using a Nano drop 1000 spectrprophotome-
ter and Agilent Microfluidic Bio-analyzer 2100 (Agilent technologies). TLDA
v1.0 card was loaded with prepared cDNA and analyzed utilizing RT-PCR us-
ing AB 7900HT Fast RT-PCR system. In silico analyzis was carried out using
http://microrna.sanger.ac.uk. Data was analyzed using RT-PCR StatMiner.
Values are expressed as negative fold change compared to static control. This
corresponds to downregulation of microRNAs.
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4.2.6 microRNAs downregulated with shear stress
Simiarly, majority of microRNAs investigated was found to be downregulated
with shear stress. This is shown in (Figure 4.7).
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Figure 4.7: Downregulated microRNAs under laminar shear
HAECs were exposed to laminar shear at 10 dynes/cm2. Further to microRNA
being extracted it was subjected to quality control using aNano drop 1000 spec-
trprophotometer and Agilent Microfluidic Bio-analyzer 2100 (Agilent tech-
nologies). TLDA v1.0 card was loaded with prepared cDNA and analyzed
utilizing RT-PCR using AB 7900HT Fast RT-PCR system. In silico analyzis was
carried out using http://microrna.sanger.ac.uk. Data was analyzed using RT-
PCR StatMiner™. Values are expressed as negative fold change compared to
static control. This corresponds to upregulation of microRNAs.
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4.2.7 Moesin and dicer are downregulated robustlywith siRNA
Further to optimization with different siRNAs against Dicer and Moesin, two
of them were chosen that provided robust downregulation of both proteins.
In comparison to the control (scrambled sequence) siRNA, they both provide
upto 60% downregulation. We find levels of moesin and dicer remain dowreg-
ulated even after 48 h. (Figure 4.8).
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Figure 4.8: Moesin and dicer are downregulated robustly with siRNA
HAECs at 106 cells were electroporated with siRNA against dicer and moesin
and controlled with scrambled. This was seeded onto three wells of a six well
plate. Cells were fed after 24 h, and further grown to 48 h for dicer and 72 h for
moesin. Protein was then harvested and monitored for both dicer and moesin
utilizing western blotting.
Histograms represent fold change in band intensity relative to scrambled con-
trols and are averaged from three independent experiments ± SEM; All values
are controlled for equal loading by equalising for GAPDH under same con-
ditions. Prior to this it was also controlled for poncoue staining immediately
after protein transfer. Representative blots are shown.∗P<0.05 Statistically sig-
nificant compared to static
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4.2.8 Moesin protein expression with cyclic strain is regulated
by microRNA system
Here we investigate whether moesin is regulated by microRNAs (directly or
indirectly) during cyclic strain. Moesin’s protein expression previously found
to be regulated by cyclic strain was reflected in this study. Whereby we see
an increase in moesin protein expression with cyclic strain (200%). As well,
the investigation led to conclusive evidence of microRNA impacting moesin’s
actual protein expression (50% decrease in moesin protein compared to static
control). Protein as well as phosphorylated moesin (50% reduction compared
to static) was found unable to reach the four fold increase with cyclic strain
when dicer was knocked out. This is shown in (Figure 4.9).
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Figure 4.9: Moesin protein change with dicer downregulation in HAECs
with cyclic strain
HAECs at 106 cells were electroporated with siRNA against dicer/scrambled.
This was seeded onto three wells of a pronectin coated bioflex plate. Cells
were fed after 24 h, after which a further 12 h was past before starting the
cyclic strain (7.5%). The cells were monitored 24 h post cyclic strain for the
following. A) Phospho moesin change in dicer siRNA treated sample. B) Total
moesin change in dicer siRNA treated sample. C) Phospho Moeisn change in
scrambled siRNA treated sample. D) Total moesin in scrambled treated sample
Histograms represent fold change in band intensity relative to unstrained con-
trols and are averaged from three independent experiments ± SEM; All values
are controlled for equal loading by equalising for GAPDH under same con-
ditions. Prior to this it was also controlled for poncoue staining immediately
after protein transfer. Representative blots are shown.∗P<0.05 Statistically sig-
nificant compared to static
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4.2.9 Moesin protein expression with shear stress is regulated
by microRNA system
Here we investigate whether moesin is regulated by microRNAs (directly or
indirectly) during shear stress. Regulation of moesin with microRNA was
found to be not just regulated by cyclic strain. Mechanotransduction in gen-
eral, profoundly is regulated by microRNAs when it comes to moesin. This
study shows shear stress, similarly having an opposing effect when dicer is
knocked out, with moesin protein expression similar to static. This is shown in
(Figure 4.10).
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Figure 4.10: Moesin protein change with Dicer downregulation with shear
stress in HAECs HAECs at 106 cells were electroporated with siRNA against
dicer/scrambled. This was seeded per three wells of a 6-well plate. After
feeding the cells after 24 h a further 12 h was past before starting the shear
stress regime of 10dynes/cm2. The cells were monitored for the moesin protein
change 24 h post shear stress. A) Dicer downregulation B) Scrambled downreg-
ulation. Histograms represent fold change in band intensity relative to static
controls and are averaged from three independent experiments±SEM; All val-
ues are controlled for equal loading by equalising for GAPDH under same
conditions. Prior to this equal loading was also controlled for poncoue staining
immediately after protein transfer. Representative blots are shown. ∗∗ P<0.07
not statistically significant compared to static, ∗P<0.05 Statistically significant
compared to static
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4.2.10 Phospho Moesin with acute stretch is regulated by Rho
A and microRNA
Here we investigate the phosphorylation status of moesin with acute stretch
(2min-10min). Further to this we also investigatewhether the signalingmolecules
regulating moesin is effected by microRNAs.
Acute stretch induces dephosphorylation of moesin in minutes. Two min-
utes of stretch decreases moesin phosphorylation by 40%. This we find is regu-
lated by Rho A and microRNAs. Dicer knockdown and Rho inhibition both
increase moesin phosphorylation 1.5 fold. The similar effect also calls into
question whether Rho A is regulated by microRNAs. And whether, Rho A
is the reason for moesin not dephosphorylating with stretch when microRNA
machinery is down. This is shown in (Figure 4.11).
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Figure 4.11: Rho and dicer regulation of phospho moesin with acute stretch
in HAECs
A) Confluent HAECs was serum starved for 24 h. These were subjected to
non cyclical static stretch biaxially (20% ). This was applied acutely over 0min,
2min, 5min and 10min. B) Cells treated with highly cell permeable C3 trans-
ferase (Rho A inhibitor) and simlarly stretched for 2 min. C) Cells with siRNA
against Dicer and was similarly stretched for 2 min. D) Cells with siRNA
against Dicer was treated with highly cell permeable C3 transferase (Rho A
inhibitor) and was similarly stretched for 2min. E) Cells with siRNA against
scrambled and similarly stretched for 2 min. The cell lysate was monitored for
phospho moesin and total moesin by immunoblotting. Histograms represent
fold change in band intensity relative to non-stretched cells and are averaged
from three independent experiments±SEM; All values of phosphomoesin was
equalised for total moesin to control for equal loading. Representative blots are
shown. ∗ P<0.05 Statistically significant compared to static
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4.2.11 Endothelial cell alignment is disrupted with flow with-
out microRNA regulation
Here we investigate if the characteristic pattern of endothelial cells under flow
is maintained. The normal physiological alignment seen of endothelial cells
subject to shear stress is lost with Dicer knockdown. This is shown in (Fig-
ure 4.12).
186
Figure 4.12: Endothelial cells don’t align with shear when Dicer is downreg-
ulated
HAECs at 106 cells were electroporated with siRNA against dicer, while scram-
bled siRNA was used as a control. Cells were recovered by feeding them 12 h
post electroporation. A further 12 h was past before starting the shear stress
regime of 10dynes/cm2. The cells were monitored for endothelial cell align-
ment 48 h after shear stress. A) Scrambled siRNA treated cells. B)Dicer siRNA
treated cells.
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4.2.12 MicroRNA system regulates uncontrolled microparticle
release during flow and most agonists
We found earlier that microRNAs are needed for a physiologically functioning
endothelium. Here we investigate whether microRNAs are essential to func-
tions regulated by endothelium, such as the microparticle release.
Shear stress induced microparticle release (23,000 MPs in dicer knocked
down cells, compared to 15,000 MPs in scrambled control) accumulated over
48h. This show microRNAs regulating microparticle release with flow. Sim-
ilarly ionophore induction has the same effect (30,000 MPs in dicer knocked
down cells, compared to 20,000 MPs in scrambled control). This is shown in
(Figure 4.13).
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Figure 4.13: Endothelial microparticle increase with Dicer downregulation
with shear and ionophore
HAECs at 106 cells were electroporated with siRNA against dicer, while scram-
bled siRNA was used as a control. Cells were recovered by feeding them 12
h post electroporation. A) A further 12 h was past before starting the shear
stress regime of 10dynes/cm2. The microparicles were allowed to accumulate
from the onset of acute shear over 48 h. B) 24 h post electroporation cells were
induced for microparticles with 10µM ionophore in full media and without.
Prior to agonist induction cells were stained by Calcein AM. The MPs stained
for calcein AM was collected from the supernatant and monitored by FACS.
Histograms represent fold change, absolute numbers and are averaged from at
least three independent experiments ±SEM.
∗∗P<0.05 Statistically significant compared to control for the same treatment.
∗P<0.05 Statistically significant across all samples.
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4.2.13 Proliferation of endothelial cells with cyclic strain is un-
der microRNA regulation
Previous findings show that microRNAs are essential for physiological func-
tioning of the endothelium. The study here investigates proliferation. mi-
croRNAwe find regulatesmechanotransductionmediated proliferation aswell.
The level of change between static control and cyclic strained cells are de-
creased with dicer knockdown. This is shown in (Figure 4.14).
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Figure 4.14: Endothelial cell proliferation: Disruption with dicer Downreg-
ulation
HAECs at 106 cells were electroporated with siRNA against dicer, while scram-
bled siRNA was used as a control. Cells were recovered by feeding them
12 h post electroporation. After a further 12 h the cells were seeded equally
at 104 /cm2 to pronectin coated bioflex plates. 8 h post seeding, they were
stained with 5 µM CFDA-SE (5 min), prepared in PBS. Cells were fed full me-
dia(recovered for 1h) and strained for 24 h. The cells were then harvested and
monitored for proliferation change using FACS. Representative of three inde-
pendent experiments ±SEM
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4.2.14 Conclusion
In this chapter we find that moesin regulation is impacted by microRNAs. This
is evidenced by our studies with dicer knockdown. Furthermore, this regula-
tion is present with shear stress and cyclic strain. We characterize cell functions
such as cell proliferation, endothelial microparticle release and physiology of
the endothelium with blood flow.
Early in the chapter, we identify plausible moesin targeting microRNAs.
They are analyzed to identify their expression pattern with shear stress and
cyclic strain. Moreover, we identify a series of microRNAs regulated by shear
stress and cyclic strain.
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Chapter 5
Endothelial derived
microparticles: Implicating
moesin
5.1 Introduction
Utilizing blood flow, microparticles relay information throughout the organ-
ism. It They present antigens, provide slice of information of cells afar. It
acts like a "news broadcaster" and with pathogenesis and inflammation they
are considerably increased. We suspected moesin the prominent ERM pro-
tien in endothelial cells to have a role in microparticle formation. It is exten-
sively shown how PIP2 is implicated in microparticle release in the introduc-
tion. Cleavage of proteins by calpain is one of the distal factors associated with
most microparticle formation (Geo, 2008). The process of EMP release and PIP2
implication is extensively covered in the introduction.
PIP2 binds to ERM proteins, also to talin via its FERM domain (Flaumen-
haft, 2006). The significance of PIP2 in microparticle formation in platelets has
already been demonstrated(O’Connell et al., 2005). Moesin is the only ERM
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protein in the platelets. Induction with thrombin has shown dynamic transient
change associated with moesin (Shcherbina et al., 1999b). With its pivotal im-
portance in binding to PIP2, we suspect moesin to have a role in endothelial
microparticle formation. This as discussed in the introduction, is important
with respect to cytoskeleton-membrane adhesion.
We have previously shown howmoesin is regulated extensively both chron-
ically and acutely with cyclic strain. We have demonstrated how it is moesin
and not ezrin that is regulated by shear stress. Meanwhile ezrin is also cleav-
able by calpain. Moesinmeanwhile, is insensitive to calpain cleavage (Shcherbina
et al., 1999a). We hypothesise that the reason moesin is expressed highly in en-
dothelial cells compared to its other ERM counterparts, is because moesin is
suited to this environment. Moesin is highly sensitive to mechanotransduction
and possibly is atheroprotective, bufferring against unnecessary microparticle
induction.
Moreover in the last chapter we find endothelial cells lacking dicer, to be
more sensitive towards agonist induced microparticle formation. Dicer down-
regulation affects a lot of proteins as we were knocking down the microRNA
machinery. Nevertheless, we have demonstrated that moesin is under mi-
croRNA regulation.
5.2 Results
5.2.1 Determination of moesin in EMPs
This study investigates if moesin is present in the endothelial microparticles by
western blotting. The induction of microparticles is conducted by TNF-α. Fur-
ther to this the cell crud is removed, and EMPs are pelleted by ultracentrifuge.
Here we find unequivocal evidence of moesin in EMPs using western blotting.
The induction was by TNF-α. This is shown in Figure 5.1
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Figure 5.1: Moesin is in endothelial derived microparticles
BAECs were grown in five T175 plates to confluency. These were then
stiumulated/non-stimulated with TNF-α overnight. The supernatant was cen-
trifuged at 2000xg for 5 min to clear debri. The supernatant was then collected
undisturbed and ultra-centrifuged at 70,000 g for 1 h. The pellet was then ace-
tone precipated. This was immuonblotted for moesin after seperation of the
proteins by gel electrophoresis.
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5.2.2 Microparticles are increased post exercise and with shear
stress
As we discovered earlier that microparticles are released due to shear stress,
for perspective, in-vivo was conducted. Acute shear clearly accumulates MPs
considerably. In in-vitro studies we find shear stress increasing EMPs to 16000
compared to 5000 in static control. In in-vivo studies we find shear stress in-
creasing EMPs to 10000 compared to 2000 in non-exercised control. Further to
the exercise the MPs clear after two hours decreasing to 5000 MPs.
Ethical approval was granted for the exercise study and was conducted
together with Ronan Murphy. We find post exercise that there is an increase
in MPs.
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Figure 5.2: Microparticles are increased post excersice and with shear stress
A) HAECs were grown to confluence, further to which, they were subjected
to shear stress regime of 10dynes /cm2. The microparicles were allowed to
accumulate from the onset of acute shear over 48 h. Prior to shear induction,
cells were stained by calcein AM. The MPs stained for calcein AM was col-
lected from the supernatant and monitored by FACS. B) Blood was drawn
from participants using a 19C needle into 0.32% final concentration citrate.
Anti-coagulant was utilized, after which samples were centrifuged at 1550g
for 20 min. Plasma was subjected to 18890g centrifugation for 30min at 20o.
225µl from the supernatant was mixed with 225µl 1xPBS/citrate. This was
centrifuged for 30min at 18890g at −20o. 225µl was taken, mixed with 75µl
1XPBS/citrate. After incubation in dark for 15min it was subjected to FACS
Histograms represent fold change of absolute numbers and are averaged from
at least three independent experiments ±SEM.
∗P<0.05 Statistically significant compared to control.
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5.2.3 EMPs: Moesin versus Ezrin and the microRNA regula-
tion
Here we compare EMP formation due to ezrin and moesin overexpression. We
also look into the effect of dicer knock down. Meanwhile all parameters are
investigated for calpain activation by utilizing calpeptin to inhibit calpain. For
induction of microparticles we utilize ionophore.
Induction of microparticles with ionophore we find lead to considerably
higher EMPs when ezrin is overexpressed (3000 EMPs). Moesin overexpres-
sion meanwhile leads to a reduction in EMPs (2000 EMPs). This status quo
is maintained in cells releasing microparticles where they are untreated (1500
with ezrin overexpression and 1000 with moesin overexpression). The reduc-
tion of microparticles with calpeptin is slightly higher when ezrin is over-
expressed compared to moesin overexpression (1800 and 1000 EMPs respec-
tively). 4 h of induction of microparticles we find doesn’t lead to more mi-
croparticles than in control (such as in 12 h induction). The sensitivity to
ionophore induction is viable and so is the sensitivity to calpeptin. Cells with
dicer knocked out is also sensitive to calpain induced EMP release (ionophore
induced EMPs are 5000 compared to 1500 EMPs). It is similarly sensitive to cal-
pain inhibition as seen from calpeptin treated cells that reduce to 2200EMPs.
Thus fold differences with induction is suggestive of its sensitivity. This is
shown in Figure 5.3
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Figure 5.3: Endothelial microparticle regulation by Ezrin, Moesin overex-
pression and dicer downregulation mediated by ionophore
Endothelial cells were either overexpressed with FLAG tag constructs of ezrin
or moesin. Also, dicer was down regulated by means of siRNA. Scrambled
was utilized as control and all constructs were electroporated using micropo-
rator. 12 h post electroporation cells were recovered in full media. 24 h post
electroporation cells induced for microparticles with 10µM ionophore in full
media and without. Prior to this the cells were stained with calcein AM in full
media.The MPs were monitored by FACS for effect of moesin, ezrin overex-
pression and dicer downregulation post 4h. Histograms are averaged as abso-
lute microparticle numbers from at least three different experiments. ∗P<0.05
Statistically significant across all samples for the same treatment. P<0.05 Statis-
tically significant against control for the same treatment. ∗∗P<0.05 Statistically
significant across all samples for the same treatment except the control.
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5.2.4 Thrombin mediated EMPs: Moesin versus Ezrin and the
microRNA regulation
In this studywe utilize the same parameters as the previous study, using throm-
bin to induce EMP formation. Here we compare EMP formation due to ezrin
and moesin overexpression. We also look into the effect of dicer knock down.
Meanwhile all parameters are investigated for calpain activation by utilizing
calpeptin to inhibit calpain.
Induction with thrombin we find cells overexpressed with moesin to be
quite sensitive when fold change (3000 EMPs compared to 1800 EMPs in un-
treated) is taken into account. Meanwhile, interestingly cells overexpressed
with ezrin leads to lack of sensitivity to thrombin in terms of microparticle re-
lease. There is also an apparent lack of sensitivity to microparticle release with
thrombin compared to ionophore induction. Dicer knockout renders the cell
sensitive to calpeptin when thrombin is used for induction. Dicer knockout is
also sensitive to EMP release (4800 EMPs compared to untreated having 2800
EMPs) This is shown in Figure 5.4
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Figure 5.4: Endothelial microparticle regulation by Ezrin, Moesin overex-
pression and dicer downregulation mediated by Thrombin
Endothelial cells were either overexpressed with FLAG tag constructs of ezrin
or moesin. Also, dicer was down regulated by means of siRNA. Scrambled
was utilized as control and all constructs were electroporated using micropo-
rator. 12 h post electroporation cells were recovered in full media. 24 h post
electroporation cells were subjected to serum starvation for 12 h. The cells
were then induced for microparticles with thrombin (1 IU/ml) and without.
Prior to this the cells were stained with calcein AM in serum free media.The
MPs were monitored by FACS for the effect of moesin, ezrin overexpression
and dicer downregulation. Histograms are averaged as absolute microparticle
numbers from at least three different experiments. ∗P<0.05 Statistically signif-
icant across all samples for the same treatment. P<0.05 Statistically significant
against control for the same treatment. P<0.05 Statistically significant across
all samples except against moesin for the same treatment.
201
5.2.5 Moesin and Ezrin GFP expression pattern
Overexpression of moesin and ezrin leads to its localization in certain areas
of a cell. We investigate in this study this aspect utilizing microscopy. The
images show the different expression pattern of moesin and ezrin when they
are overexpressed. This is shown in Figure 5.5
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Figure 5.5: Differential expression of ezrin and moesin in HAECs
Moesin GFP and ezrin GFP constructs was overexpressed by electroporation
into HAECs. The cells were then visualised by fluorescence micropscope.
A) Moesin-GFP. B) Ezrin-GFP. C) GFP control. Images are representative of at
least three individual sets of experiments.
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5.2.6 Further confirmation of moesin and ezrin’s differential
expression in HAECs
In this study we investigate how moesin and ezrin is differentially localized
with the unbound PIP2. This study has significance in PIP2 explaining the
membrane-cytoskeletal adhesion. We find moesin, ezrin is differentially local-
izedwhen overexpressedwith phospholipase C (which is amarker of unbound
PIP2). This is shown in Figure 5.6.
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Figure 5.6: Differential expression of ezrin and moesin in HAECs
Moesin and ezrin GFP constructs was overexpressed by transfection into
HAECs in combination with plc−δ−RFP. The cells were then visualised by
fluorescence microscope. A) Moesin-GFP. B) Ezrin-GFP; note differential ex-
pression of ezrin compared to moesin. Images are representative of at least
three individual sets of experiments.
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5.2.7 Visualisation of EMPs
As previous studies showed that moesin and ezrin have differential roles in
EMP induction, we investigate utilizing microscopy to observe EMP forma-
tion.
Visualisation of EMPs reflect the sensitivity to the respectively overexpressed
cytoskeletal proteins (moesin and ezrin) found in the previous study. We thus
find increased EMP formation with ezrin overexpression compared. This is
shown in Figure 5.7.
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Figure 5.7: Visualisation of microparticles
The cells were calcein AM stained after which MPs were induced by
ionophore(10µM in full media). The cells were then visualised with a fluores-
cent microscope after 4h. Notice the granulated MPS on the right pane magni-
fied from the left pane. White arrows in the right pane point to an example of
microparticle. A)Moesin-Flag. B)Ezrin-Flag. C) Mock.
Images are representative of at least three individual sets of experiments.
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5.2.8 Lack of moesin is pathogenic with respect to an increase
in EMPs
Further to our understanding of EMP release by overexpression studies, we
investigate here using moesin knock down.
The knock out study of moesin, shows a huge surge in microparticle release
with moesin knockdown in ionophore treated cells (2.5 fold increase). There is
also an increase in microparticles in untreated cells (1.5 fold increase). This is
shown in Figure 5.8.
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Figure 5.8: Endothelial microprticles: Effect of moesin downregulation
Endothelial cells had moesin down regulated by electroporation utilizing
moesin siRNA. For control, both mock transfection and a scrambled siRNA
was employed. Following calcein AM staining the cells were left either un-
treated or subjected to ionophore treatment. Ionophore was made up in full
media at a conc of 10µM. Following 4h the MPs stained for calcein AM were
monitored by FACS. A) Untreated. B) Ionophore induction. Histograms are
averaged absolute microparticle numbers from at least three different experi-
ments. P<0.05 Statistically significant compared to mock and scrambled con-
trols
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5.2.9 Conclusion
In the earlier chapter we found moesin expression is impacted by microR-
NAs. Moreover we found microRNAs regulation various cell functions with
mechanotransduction including microparticle release. Thus in this chapter we
look into whether moesin regulates microparticle release, owing to its signifi-
cance in the cell cortex.
We find moesin and ezrin having differential roles in microparticle release
owing to non-similar calpain sensitivity. Furthermore, we identify differential
EMP release owing to thrombin and ionophore induction. The results are dis-
cussed in the final chapter. We also discover that shear stress induced acutely
during exercise increase microparticle formation, which is cleared later. The
importance of this is due to the correlation of our earlier finding of moesin’s
presence in EMPs.
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Chapter 6
The urokinase moesin
interaction
6.1 Introduction
Our lab has characterized uPA’s critical role in migration and tube formation
post cyclic strain, in endotheilial cells (Von Offenberg Sweeney et al., 2005).
Moreover Sweeney et al found uPA involved only in strain-induced tube for-
mation. Previous chapters have shown that moesin is highly mechanosensitive
under both shear stress and cyclic strain. We also found moesin increased with
cyclic strain in the first results chapter (chapter 3).
As discussed in the introduction, uPA and uPAR interaction needs other
transducers to interact inwards to the cell and its cellular architecture. These
like integrins (Figure 1.28), recruit cytoskeletal adapter proteins that push, pull
and rearrange the cellular architecture to meet the new needs. These might
require transient phosphorylation or transient dephosphorylation of different
linker proteins. This is found to be the biochemical change required for the
reshuffle. There could be as well, inside out signaling whereby these transient
changes work outwards to the same receptors.
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We wanted to see whether moesin, the actin binding cytoskeletal protein,
is involved in migration and tube formation. We also wanted to see if these
functions recruit uPA/uPAR. In the results elucidate the biochemical needs and
implications of these interactions using different constructs.
6.2 Results
6.2.1 uPA and SRSRY dephosphorylates moesin acutely
We investigate whether moesin phosphorylation is effected by uPA. Biochem-
ically, moesin is dephosphorylated in concert with the effect of uPA. This can
be seen 2 min after uPA induction (60% decrease in phosphorylation). Moesin
is similarly dephosphorylated when SRSRY peptide is used (60% decrease in
phosphorylation after 2 min). The study is shown in Figure 6.1.
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Figure 6.1: uPA and SRSRY dephosphorylates moesin acutely
HAECs were exposed to A) (10nM) uPA B) (1pM) SRSRY acutely for the times
stated above. This was then monitored for phospho moesin protein expres-
sion by western blotting. Histograms represent fold change in band intensity
relative to untreated control and are averaged from three independent exper-
iments ± SEM; All values are controlled for equal loading by equalising for
total moesin under same conditions. Representative blots are shown. ∗P<0.05
Statistically significant compared to untreated.
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6.2.2 Constructs used
Constructs used
1. Parental EC: (HAECs) Endothelial cells at passage 7
2. Mock: Mock electroporated.
All constructs below have GFP at their C terminus, unless specified.
3. N1-GFP: Control GFP vector.
4. Moesin wt GFP/Moesin GFP: Full length Moesin.
5. Inactive Moesin: Full length Moesin with GFP at N terminus (FERM do-
main) due to which it is unable to bind to membrane, and thus to PIP2.
6. T558A: Moesin that cannot be phosphorylated.
7. T558D: Phosphomimetic Moesin.
6.2.3 uPAR peptides and their effect
To explain how peptides used in subsequent study act, the following figure
(Figure 6.2 is used for illustration. The peptides have been extensively utilized
and their efficacy published (Degryse et al., 2001; Degryse, 2008; Degryse et al.,
2005; Dass et al., 2008). Detailed explanation of the various receptors, how they
act following uPA induction is given in the introduction (Blasi and Carmeliet,
2002)
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Figure 6.2: Different uPA peptides used in the studies and their downstream
effectors
uPAR receptor do not have a cytoplasmic domain, thus any effect it has on
cytoskeletal proteins require molecules that span both extracellularly and in-
tracellularly (eg:-FPRL1, αvβ3 / α5β1 integrins). With uPA addition, SRSRY
amino acid sequence is exposed which binds to FPRL1. This peptide is used to
decipher, if FRPL1 is recruited towardsmoesin dephosphorylation. Meanwhile
αvβ3 and α5β1 integrins interact with uPAR post uPA addition. They also in-
teract with uPAR in concert with vitronectin addition. Their binding to uPAR
either way utilize the GEEG (D2A) sequence on the D2 domain of uPAR. This
peptide has been shown to be highly chemotactic. The mutated form GAAG
(D2A-ala) meanwhile inhibits such binding and is found to reduce chemotaxis
substantially (Degryse et al., 2001; Degryse, 2008; Degryse et al., 2005).
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6.2.4 Determination of how moesin interacts with uPA in mi-
grating cells
With addition of uPA, moesin overexpression (Moesin wt GFP) does not seem
to overly increase migration of HAECs. Phosphomimetic construct (T558D) or
dominant negative for phosphorylation (T558A) meanwhile, decrease migra-
tion substantially (50% decrease compared to control treated with uPA). Sim-
ilarly substantial reduction in migration can be seen when FERM domain (1-
382) or when inactive moesin (GFP cloned into the FERM domain, rendering it
unable to phosphorylate due to its inability to bind to PIP2) is overexpressed.
Without uPA, the inactive moesin or T558D when overexpressed reduce
endothelial cell migration (50% decrease compared to control untreated with
uPA). The study is shown in Figure 6.3.
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Figure 6.3: Determination of how moesin interacts with uPA in migrating
cells
Respectively transfected and untransfected HAECs were monitored for migra-
tion to (10nM) uPA containing wells. This was conducted using boyden cham-
ber overnight. Histograms represent fold change in mean migration measured
by counting number of migrated endothelial cells. Cells were visualized by
crystal violet staining. This is averaged from at least three independent ex-
periments ± SEM. P<0.05 All histograms statistically significant to respective
parental EC control.
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6.2.5 Moesin downregulation stops uPA mediated migration
To investigate if there is a critical need for moesin in uPA mediated migration,
down regulation of moesin is necessary. Moesin is highly expressed in mi-
grating cells, hence overexpression of moesin will provide very little evidence
regarding its migratory potential. The study (Figure 6.4), clearly finds moesin
is required to induce migration downstream of uPA. uPA induced migration is
abolished with moesin knocked out.
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Figure 6.4: Moesin downregulation stops uPA mediated migration
Respectively transfected and untransfected HAECs were monitored for migra-
tion to (10nM) uPA containing wells. This was conducted using boyden cham-
ber overnight. Histograms represent fold change in mean migration measured
by counting number of migrated endothelial cells. Cells were visualized by
crystal violet staining. This is averaged from at least three independent ex-
periments ± SEM. P<0.05 All histograms statistically significant to respective
parental EC control.
219
6.2.6 Determining whether SRSRY is the modus operandi of
uPA-Moesin migration
Previous biochemical study showed both SRSRY and uPA inducing dephos-
phorylation of moesin. Hence, in this study (Figure 6.5) migration is investi-
gated downstream of SRSRY.
The study shows predisposition of moesin constructs with impaired phos-
phorylation in reducing migration downstream (50% decrease compared to
moesin wild type control). The constructs T558D, T558A, inactive moesin and
FERM domain (1-382, lacks the segment that could phosphorylate). The results
reflect similar earlier study with uPA.
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Figure 6.5: Determining whether SRSRY is the modus operandi of uPA-
Moesin migration
Respectively transfected and untransfected HAECs were monitored for mi-
gration to (1pM) SRSRY containing wells. This was conducted using boyden
chamber overnight. Histograms represent fold change in meanmigration mea-
sured by counting number of endothelial cells that hasmigrated. The cells were
stained with crystal violet for visualisation. This is averaged from at least three
independent experiments ± SEM. P<0.05 All histograms statistically signifi-
cant to parental EC control.
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6.2.7 How does D2A peptide affect migration with respect to
moesin
This study (Figure 6.6, was devised to investigate how integrins, downstream
of uPA-uPAR interaction results in migration mediated by moesin. The study
reflected previously shown studies here, regarding requirement for intact phos-
phorylation site (3 fold decrease compared to moesin wild type control). Inter-
estingly, integrin mediated migration was substantially enhanced (1 fold in-
crease compared to GFP control) when moesin (Moesin wt GFP) was overex-
pressed.
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Figure 6.6: How does D2A peptide affect migration with respect to moesin
Respectively transfected and untransfected HAECs were monitored for migra-
tion to (1pM) D2A containing wells. This was conducted using boyden cham-
ber overnight. Histograms represent fold change in mean migration measured
by counting number of endothelial cells that has migrated. The cells were
stained with crystal violet for visualisation. This is averaged from at least three
independent experiments ± SEM. P<0.05 All histograms statistically signifi-
cant to respective parental EC control.
223
6.2.8 D2A-ala inhibits migration with respect to moesin
Peptide studies with D2A showed interesting migration pattern when moesin
was overexpressed downstream of integrins.
To further check this, D2A-ala peptide was utilized. This peptide should,
inhibit integrin binding to uPAR at the D2 region, thus stopping the migra-
tion with respect to integrins. The study clearly shows moesin overexpression
(moesin wt GFP) to be further detrimental for migration whilst integrins are
inhibited.
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Figure 6.7: D2A-ala inhibits migration with respect to moesin
Respectively transfected and untransfected HAECs were monitored for migra-
tion to (100pM) D2A-Ala containing wells. This was conducted using boyden
chamber overnight. Histograms represent fold change in meanmigration mea-
sured by counting number of migrated endothelial cells. Cells were visualized
by crystal violet staining. This is averaged from at least three independent ex-
periments± SEM. P<0.05 All histograms statistically significant to parental EC
control. P>0.05 Statistically not significant to parental EC control.
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6.2.9 Vitronecin mediated migration needs moesin’s phospho-
rylation machinery intact
Vitronectin (VN) as discussed in the introduction, can bind both integrins and
uPAR. The study (Figure 6.8), shows that extracellular matrix (VN in this case)
mediated migration requires moesin’s transient phosphorylation apparatus in-
tact (50% decrease in migration compared to moesin wild type control). VN
recruits both integrins and uPAR towards migration.
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Figure 6.8: Vitronecin mediated migration needs moesin’s phosphorylation
apparatus intact
Respectively transfected and untransfected HAECs were monitored for mi-
gration to (1µg/ml) VN containing wells. This was conducted using boyden
chamber overnight. Histograms represent fold change in meanmigration mea-
sured by counting number of migrated endothelial cells. Cells were visualized
by crystal violet staining. This is averaged from at least three independent
experiments ± SEM. P<0.05 All histograms statistically significant to parental
control.
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6.2.10 Moesin increase angiogenic tube length
Studies with collagen gel, showmoesin overexpression stimulating angiogenic
growth compared to control. The phopho-mimetic construct (T558D), increase
tube length the most (1 fold increase compared to GFP control). Moesin over-
expression also increase tube length (0.5 fold increase compared to GFP con-
trol).The experimental setup provides one dimensional approach towards de-
ciphering the angiogenic potential. This is because collagen gel, has no other
components that might interfere with the study.
228
Figure 6.9: Moesin increase angiogenic tube length
HAECs were transfected with the plasmids listed on the graph and seeded
equally on collagen gel. The cells were allowed to invade the matrix overnight
and images takenwith amicroscope. The tube lengthwas thenmeasured using
CellF® software. Histograms represent fold change in mean tube length com-
pared to GFP control and are averaged from five independent experiments ±
SEM. ∗P<0.05 Statistically significant to each other.
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6.2.11 Transient de-phosphorylaton of moesin is required for
uPA mediated angiogenesis
As moesin and uPA interact, the next study was developed to elucidate if the
synergy exists in a multifunctional process such as angiogenesis. Angiogenesis
require digestion of ECM, migration and proliferation to generate new capil-
lary sprouts (Rao et al., 2005). There exists a prerequisite for uPAR receptors
even with the classical VEGFmediated angiogenesis mechanisms (Prager et al.,
2004).
Moesin we find from studies in this chapter is critical in downstream cy-
toskeletal rearrangements leading tomigration. The angiogenesis studies show
uPA increasing angiogenesis (B compared to A). uPA and moesin (overexpres-
sion) interact to further the angiogenesis (D compared to C). Moesin overex-
pression alone increase angiogenesis (A compared to C). We also see the re-
quirement of an intact dephosphorylatory mechanism (F compared to D).
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Figure 6.10: Transient de-phosphorylaton of moesin is required for uPA me-
diated angiogenesis
HAECs were transfected with the plasmids listed below and seeded equally
on matrigel. The cells were allowed to invade the matrix overnight after which
images were taken with microscope. The matrix contained 10nM uPA/ no
uPA. The media added to the matrix contained 0.5% serum. A) GFP control
(no uPA). B) GFP control (uPA). C) Msn GFP (no uPA). D) Msn GFP (uPA). E)
T558DGFP (no uPA). F) T558DGFP (uPA). Images are representative of at least
six independent experiments.
231
6.2.12 Moesin and uPA can modulate endothelial barrier
Further to our understanding of moesin-uPA interaction in migration and an-
giogenesis, we decided to investigate cell permeability. This experiment also
provides us insight into the cytoskeletal modulation with acute induction of
urokinase.
Moesin and uPA independently, tighten endothelial barrier acutely (Fig-
ure 6.11A). The effect starts immediately with moesin overexpression, whilst
uPA starts affecting the barrier post 30 min (Figure 6.11B). Moesin overex-
pression leads to reduced permeability. uPA progressively tightens the barrier
acutely, showing a marked shift compared to moesin overexpression.
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Figure 6.11: Effect of moesin and uPA on endothelial cell barrier
HAECs were transfected with the plasmids for moesin GFP and GFP control.
Following trypsinization was re-plated into Transwell® -Clear plates andmon-
itored for permeability to 40 kDa FITC-dextran. Data points are shown as total
subluminal fluorescence at a given time point (from 0-180 min) expressed as
a percentage of total abluminal fluorescence at t=0 min (i.e. %TEE of FD40 or
% Trans Endothelial Exchange, at t=0 uPA was added/not added). A)Effect
of moesin. B) Effect of uPA. The results are averaged from three independent
experiments ± SEM.
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6.2.13 Moesin and upA interact while modulating endothelial
barrier
Earlier study, showed that moesin and uPA individually reduces cell perme-
ability acutely. Previous findings had shown the synergetic interaction ofmoesin
and uPA. Thus here, we investigate moesin-uPA interaction effecting endothe-
lial cell permeability. This study moreover, provide us the significance of the
acute moesin-uPA interaction on the cell cortex.
When moesin is overexpressed, acute uPA induction results in loss of bar-
rier integrity and an increase in cell permeability (Figure 6.12A). This reduction
in barrier is seen instantaneously, on induction with uPA with a marked shift
at 30 min.
When compared to moesin overexpression alone, the barrier loss is higher
with uPA addition (Figure 6.12B). The effect though, is transient lasting only
to 1 h significantly. This provide insight into moesin-uPA interaction, and the
time scale of its effect on the cell cortex.
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Figure 6.12: Moesin-uPA interaction and endothelial cell barrier
HAECs were transfected with the plasmids for moesin GFP and GFP control.
Following trypsinization was re-plated into Transwell® -Clear plates andmon-
itored for permeability to 40 kDa FITC-dextran. Data points are shown as total
subluminal fluorescence at a given time point (from 0-180 min) expressed as
a percentage of total abluminal fluorescence at t=0 min (i.e. %TEE of FD40 or
% Trans Endothelial Exchange, t=0 uPA was added/not added). A) Effect of
moesin and uPA interaction.B) Effect of uPA on moesin. The results are aver-
aged from three independent experiments ± SEM.
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6.2.14 Visualization of the effect of uPA on moesin
Biochemically, we know that acute induction of uPA results in moesin dephos-
phorylation. Towards understanding this better, we have visualized overex-
pressed moesin (GFP).
plc−δ−RFP was also overexpressed, to understand membrane unbound
PIP2 localization under uPA induction. Moesin can be seen co-localising with
plc−δ−RFP on uPA induction. This suggests uPA effects loss of membrane
bound moesin acutely.
Moreover, the effect is profound, and explains the barrier loss evidenced in
earlier studies. There is considerable shrinkage of the cells and modulation of
the associated cytoskeletal system.
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Figure 6.13: Visualisation of barrier loss with acute induction by uPA
Moesin-GFP construct was overexpressed by transfection into HAECs in com-
bination with plc−δ−RFP. The same cell was visualized by fluorescence micro-
scope following addition of uPA. Right pane has magnified area of interest in
the cell. A) Same cell 0 min. B) 2min after addition; note the cells contracting
(bottom arrow) andMoesin GFP losingmembrane adhesion (with plc−δ−RFP;
upper arrow) Images are representative of at least three individual sets of ex-
periments.
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6.2.15 Conclusion
This chapter details evidence regarding moesin-uPA interaction. Furthermore,
utilizing various constructs, peptides, we delineate the framework of this in-
teraction. During the course of the study we investigate cell function including
angiogenesis, migration and cell permeability. The results and its implication
is discussed in the next chapter.
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Chapter 7
Discussion
7.1 Haemodynamic regulation in the vasculature; the
need for moesin
7.1.1 Characterization of pronectin and fibronectin as an in-
flammatory matrix
This chapter describes the temporal and spatial regulation of moesin, at both
the molecular and cellular levels, with respect to mechanotransduction. In ad-
dition, we also endeavored to investigate the role ofmoesin in various endothe-
lial cell functions. Among the cell fate decisions studied were proliferation,
migration, angiogenesis, barrier function and endothelial cell microparticle re-
lease.
7.1.1.1 Elucidation of cell growth on pronectin and fibronectin
The standard extracelluarmatrix employed duringmechanotransduction stud-
ies is generally pronectin. This is a synthetic RGD containing peptide, used to
facilitate cell adhesion before cyclic strain is applied. This model has been well
characterised in the literature (Kakisis et al., 2004; Sweeney et al., 2004; Hunter,
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2009; Pyle et al., 2008). Pronectin is widely used, due to its high purity (no
contamination) and uniform deposition on hydrophobic plate membranes. We
undertook basic preliminary studies to investigate subtle differences between
cells mechanotransduced on both pronectin and fibronectin coated plates.
At a technical level we discovered the plate membrane to be highly hy-
drophobic, an unfavorable platform for cell adhesion and growth. Moreover,
this renders it difficult to coat with experimental extracellular matrix. The Flex-
cell International Corp, meanwhile utilize a proprietary method for coating the
membranes. They provide, as standard, pronectin coated plates as an alterna-
tive to fibronectin. We overcame the technical difficulties with respect to this
hydrophobicity, by exploiting pronectin coated plates for fibronectin deposi-
tion.
Experimentally, we devised studies on both matrices in order to charac-
terize the specific cellular response elicited. As pronectin is mainly an RGD
containing peptide, its principle binding sites are on specific integrins (see Fig-
ure 7.1 (Takagi et al., 2003). Integrin mediated adhesion involves, mainly the
RGD binding domain of these heterodimeric receptors. As seen (Figure 3.7),
we characterized the cell cycle profile of cells grown on both matrices.
The results obtained indicate no major differences in the cell cycle profile
between pronectin and fibronectin. Previous studies have shown that inte-
grins provide support for cells undergoing mechanotransduction (Hirayama
and Sumpio, 2007; Lehoux and Tedgui, 1998; Wernig et al., 2003; Sweeney et al.,
2004). This is true for both VSMCs and endothelial cells. As oultined in the
introduction, different integrins are engaged with specific matrices, irrespec-
tive of the agonist. Resulting cell fate decisions are also mediated by specific
integrin-matrix engagement. Members of the integrin family containing sub-
unit β1, play an important role in cyclic strain mediated mechanotrasduction.
Specifically α5β1 has been found to facilitate endothelial cell polarization on fi-
bronectin via cyclic strain. In addition α2β1 has been shown to synergistically
facilitate endothelial cell realignment on collagen matrix.
The endothelial cell realignment perpendicular to cyclic strain, on both fi-
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bronectin and collagen, does not involve β3 integrin subfamily (Yano et al.,
1997b; Wernig et al., 2003; Hirayama and Sumpio, 2007). Cytoskeletal remod-
eling via β1 integrin mediated signaling utilize a unique subset of cytoskeletal
proteins. Moesin potentially could play a role in differential integrin signaling
depending on the matrix or stimulus employed.
The lack of differences, thus possibly indicate the key importance of RGD
peptide. In this study investigating the cellular growth pattern i.e., focussing
on cell cycle progression to endothelial cells grown on either pronectin or fi-
bronectin, we identified an increased progression to the G2/M phase. Po-
tentially various biochemical factors could be involved, as fibronectin unlike
pronectin is highly complex. Pronectin an RGD containing peptide, engages
the majority of integrins to the exclusion of other receptors. Conversely, fi-
bronectin due to its complex nature engages both directly and laterally a wide
range of receptors.
7.1.1.2 What is pronectin?
“ProNectin® F is a protein polymer, produced from a synthetic gene via bac-
terial fermentation. This presents multiple copies of the RGD cell attachment
sequence from human fibronectin (http://www.sanyo-chemical.co.jp). While fi-
bronectin a glycoprotein is more complex. It has 4-9% carbohydrate moieties
including the integrin engaging RGD amino acid sequence, it also binds to
diverse biological molecules. These include matrices generated in response to
cyclic strain such as collagen (Wang and Thampatty, 2006). It also binds to hep-
arin, fibrin and a whole array of other molecules, engaging various moeities of
its structure (Pankov and Yamada, 2002; Chiang et al., 2009a).
7.1.1.3 Relevance of pronectin and fibronectin as matrices under mechno-
transduction
The pronectin coated plates still provide information, but if the relevant ques-
tion is poised. These studies would include investigating RGD-integrin me-
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diated outside-in signaling (Figure 7.1). Fibronectin deposition, meanwhile is
increased with inflammation, and thus provides a physiologically relevant in-
flammatory matrix (Gayer and Basson, 2009). Pronectin is also often used as an
alternative towards this purpose. Areas in the vasculature with pathogphysio-
logical shear or cyclic strain leads to inflammation (Hahn and Schwartz, 2009).
When stasis of blood flow occurs, such as during heart failure, the patients
are predisposed to accelerated thromboembolic events resulting in stroke (Ka-
pur et al., 2007). In such a context delineation of differential signaling between
pronectin and fibronectin matrix could be bio-mechanically relevant. In the
second part of the study as outlined in (Figure 3.7), we investigate the role of
both pronectin and fibronectin on cyclic strain mediated cell cycle.
These experiments were carried out under acute conditions for 4h (Yano
et al., 1997b). The study show less apoptotic cells with acute strain, when
grown on pronectin relative to fibronectin. Apoptosis rate was upregulated
for fibronectin, while downregulated with pronectin under strain stasis. Cell
cycle profile meanwhile, show statistical significance in S and G2/M phase for
cells on pronectin.
Figure 7.1: Integrins adhesive to RGD
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Biochemically in such amodel there are different extracellular receptors act-
ing on the cell. Not taking into account other cryptic sites and fragments, such
as the fibronectin self-assembly sites whose exposure induce fibronectin fibril-
logenesis. There is also the FnIII1that localize to lipid rafts (Sechler et al., 2001).
This interaction has importance in cell contraction and cell growth, prolifera-
tion (Hocking and Kowalski, 2002). There are sites with enzymatic activity that
include FnCol-ase, which is a metalloprotease (Vogel, 2006).
7.1.1.4 Fibronectin is a complex matrix
Fibronectin also has integrin activating sites other than the RGD segment. These
include the synergy site Pro-His-Ser-Arg-Asn (PHSRN),which is also recog-
nized byα5β1 integrins (Vogel, 2006).There is also the Ile-Asp-Ala-Pro-Ser (IDAPS)
sequence at the Fibronectin Type III domain (FnIII)13−14 junction in the hep-
arin binding site II (HepII) region of fibronectin which supports α4β1. This par-
ticular interaction plays a role in cell adhesion via mechanical stimulus (Pier-
schbacher and Ruoslahti, 1984; Redick et al., 2000; Takagi et al., 2003; Mould
and Humphries, 1991).
Nevertheless, α5β1 and αvβ3 among other integrins, recognize the RGD
motif (Hynes, 2002a). We find RGD-integrin (grown on pronectin) specific in-
teractions i.e., induce apoptosis with inflammatory cyclic strain. Similarly they
increase proliferation and positively support cell survival. In terms of con-
firming which matrix to use, towards understanding inflammation with cyclic
strain, the complexities laid out are vast with fibronectin. Pronectin is not a
holistic matrix that will allow deciphering of signal transduction. As appreci-
ated earlier, matrix has to be chosen to answer the relevant questions.
7.1.2 Cyclic strain can mould the cytoskeleton to generate a
highly tactile cell
In (Figure 3.8), we show how cyclic strain increase migration of endothelial
cells. Cylic strain induced migration has been found to engage not integrins,
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rather the G-coupled proteins (Von Offenberg Sweeney et al., 2005). We were
able to reflect the results obtained by other groups, including the 2005 pub-
lication from our lab by Nicholas Von Offenberg Sweeney et al. Where as
their study found increase in migration with 5%cyclic strain, we also find a
dose dependent increase in migration with increasing cyclic strain (Von Of-
fenberg Sweeney et al., 2005). The increase in migration rate with increase in
cylic strain was not a linear progression, but was quite dramatic. This differ-
ence shows the profound latent tensile strength on the migratory apparatus,
including the underlying cytoskeleton due to cyclic strain.
7.1.2.1 Outline of relevant molecular determinants that regulate cell migra-
tion post cyclic strain
The study by Sweeney et al, had also shown that uPA is upregulated by 6.7−fold.
Furthermore they had shown G-coupled proteins to be critical in cyclic strain
induced migration and angiogenesis. They found uPA and integrins not to
play a role in this migration induced by cyclic strain. All three though had
roles in increased angiogenesis induced by cyclic strain.
This leads to the question, which particular pathways that engage cytoskele-
ton might be regulated by uPA/uPAR? That is, cytoskeletal elements that are
regulated by hemodynamic forces. We were interested in moesin, an ERM pro-
tein discussed in the introduction. Moesin has been found to be dephospho-
rylated with a ligand against FPRL-1 in a proteomics based study (Boldt et al.,
2006b). uPAR is known to interact with FPRL-1. There is however, no known
association of uPA/uPAR with moesin via FPRL-1. FPRL-1 meanwhile, is also
a G-coupled protein. There is also no evidence of moesin’s role in hemody-
namic force in the literature. We thus wanted to investigate whether moesin
was regulated with cyclic strain. Furthermore, we endeavored to decipher any
association between moesin and uPA/uPAR. This would have implications in
angiogenesis, migration (due to moesin’s known association with G-coupled
proteins).
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Angiogenesis is a multifactorial process also involving proliferation. There
is enough evidence in the literature that show the effect of cyclic strain on pro-
liferation. Our previous study also showed different receptors regulating pro-
liferation with cyclic strain (Figure 3.7). We now wanted to see how an acute
cyclic strain, that is the induction of cyclic strain, might change the cell cycle
profile. This early phase of cell cycle was studied using fibronectin coated flex
plates. As appreciated earlier, fibronectin provides a holistic matrix to study
signal transduction with inflammation. Firstly, the results show differences in
cell cycle progression with cyclic strain.
7.1.3 Understanding different cyclic strain regimes
There is as well two different regimes involved (Figure 3.9). The 0-10% cyclic
strain model and the 8-10% cyclic strain model. During 8-10% cyclic strain, the
elastic surface on which human aortic endothelial cells are grown are strained
equibiaxially to 8%. Here the membrane is held at 8% while it strains upto
10%. This model is reflective of a more subtle change in cyclic strain.The 0-10%
cyclic strain meanwhile induce the maximum equibiaxial strain at 1hz with the
machine.
Mechanical stimuli is the fastest agonist to reach the nucleus compared to
diffused chemical messengers (Wang et al., 2009b). This allows the cell to shift
its cell cycle status in real time. From our results we see differing results for dif-
ferent cyclic strain regimes. Low impact cyclic strain of 8-10% does not show
any significant difference when compared to static cells, though both static and
8-10% does progess into cell cycle. High impact cyclic strain meanwhile, holds
the cell from progressing into cell cycle. This being the case with acute induc-
tion of cyclic strain.
7.1.3.1 Relevance to other cyclic strain studies
Meanwhile others have indicated deformation of adherent cells to be a contrib-
utory factor in cell cycle progression (Orr et al., 2006; Huang and Ingber, 1999).
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Studies have demonstrated increase in proliferation with mechanical stretch.
The regimes they have applied was much higher than what we had applied,
40% stretch and 20% cyclic strain (Liu et al., 2007).
Also, none of these studies investigated cell cycle progression acutely (Liu
et al., 2007). The particular study from Christopher Chen’s lab, also reflected
our study at lower cyclic strain regimes (7%), where they noted no significant
difference between the static. Acute sudden onset of hemodynamic force in-
duce an inflammatory response from the cells (Hahn and Schwartz, 2009). This
is illustrated in (Figure 1.2) in the introduction. Thus a transduction of high
acute force, reflective of a pathogenic stimuli, the cells don’t progress fully
into cell cycle. Meanwhile the low impact cyclic strain is more conductive of a
physiological model. And it reflects other studies at lower strain conducted on
fibronectin coated plates (Liu et al., 2007).
Our primary interest in cytoskeletal dynamics involved the FERM domain
containing protein moesin. We concurred with others that this actin binding
protein is able co-localise with actin on the flex membrane (Figure ??).
7.1.4 Moesin is highly sensitive to mechanical stimuli
Further to this, we were interested in investigating if this protein is responsive
to mechanical stimuli. Endothelial cells subjected to cyclic strain was deci-
phered for moesin’s mRNA, protein and phosphorylation status. We clearly
find moesin responsive to cyclic strain (Figure 3.1). The phosphorylation state
had also increased with cyclic strain.
7.1.4.1 Moesin protein expression is post-transcriptionally regulated
Interestingly, mRNA levels with cyclic strain did not correspond to moesin
protein increase. This could be because moesin protein had a longer half life.
This is quite possible, especially with moesin’s F1 lobe containing an ubiquitin
similar domain. Since its discovery in 1987 there has not been significant work
gone into understanding more about this aspect (Vijay-Kumar et al., 1987). It
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could be that moesin is targeted less to the 26S proteosome with cyclic strain
or otherwise for degradation. This ubiquitin like domain refered to as UBX, is
implicated in protein targeting (Buchberger et al., 2001). Recently discovered
role of moesin in endocytosis reaffirms the need to fill these gaps in knowledge
(Barroso-Gonzalez et al., 2009).
Techniques reviewed in Science (2008) provide powerful high-throughput
method exploiting FACS, to elucidate the time delay of multiple proteins being
targeted to the proteosome (Grabbe and Dikic, 2008). We also speculated that
there could be a role for microRNA machinery, discovered only recently.
7.1.4.2 Relevance of moesin phosphorylation status with cyclic strain
The increase in phosphorylation state suggests an unmasked active moesin,
bound to the actin. This is demonstrated in 24 hours, where moesin is bound
to actin. As well, there is an increase in moesin after 24 hours, thus it definitely
plays a huge role in mechanotransduction. An unmasked moesin thus tugs at
F-actin with its C-terminus while bound to PIP2 at the membrane. This model
seems to be the case over 24 h, what about on the induction of cyclic strain?
7.1.4.3 Moesin can also mediate mechanical stimuli in smooth muscle cells
What about in smooth muscle cells over 24 hours (Figure 3.3)? Moesin seems
to be a key player in VSMCs as well. The change though is quite the oppo-
site to endothelial cells. Opposing roles of same protein in endothelial cells
compared to smooth muscle cells is well characterized. The differential role
of moesin in smooth muscle cells would be interesting to decipher and under-
stand. Pivotally, here there was no change between mRNA and protein levels.
This was indeed intriguing, is there contrasting protein degradation pathways
of moesin associated with smooth muscle to endothelial cells? Smooth mus-
cle cells need paracrine signaling with endothelial cells? And does this lead to
probable microRNA regulation or vice versa?
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7.1.5 Shear stress also regulate moesin expression
Shear stress is the other hemodynamic force resulting from friction of blood
flowing on the endothelium. We find that moesin is regulated by shear stress
as well as cyclic strain. 24 hours of shear stress induced a reduction in moesin
protein expression (Figure 3.4).
Meanwhile, the shear applied was physiological. It will be interesting to
see how shear stress affects a denuded endothelium such as after balloon an-
gioplasty. In such a situation, we would also see smooth muscle cells ex-
posed. Replication of a denuded shear model would also require non con-
fluent HAECs exposed to shear. A clear gap in the study is our knowledge
of moesin’s phosphorylation status. This is something to be investigated in
future, together with their status under cyclic strain in smooth muscle cells.
What about on induction of shear stress, the acute phase rather than the
24 hour chronic phase? Shear stress, we find induced moesin change and has
quite a different response to cyclic strain. We find moesin also peripherally
translocating, aligning itself in in the direction of flow. It is well known that
actin aligns itself in such a manner (Hahn and Schwartz, 2009). Moesin in an
F-actin binding protein, takes on a brushed alignment in response to shear.
Meanwhile static cells are punctuated by moesin (Figure 3.5).
Wewanted to visualize this shift, i.e, frommoesin peripherally realigning in
response to flow (please refer the video www.example.com, (Figure 3.6)). This
response was found to start immediately on induction of flow. Moesin can
been seen realigning, especially in the vicinity of cortical actin and membrane.
This plausibly in conjunction with actin, stablilises the cell adapting it to shear.
7.1.5.1 Moesin is the major ERM protein in endothelial cells capable of me-
diating mechanical stimuli
Radixin and ezrin are not found to the same levels as moesin in cells of ham-
atopoetic lineage and endothelial cells (Berryman et al., 1993; Pataky et al., 2004;
Ivetic and Ridley, 2004). On checking the response to shear stress, ERMmRNA
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levels generated two interesting results (Figure 3.4).
1. Moesin mRNA levels were quite high compared to down regulation of
moesin protein levels in (Figure 3.4).
2. Interestingly this study shows ezrin mRNA not significantly changing
with shear stress.
7.1.5.2 Appropriate mechanical response off ERM proteins, is suited to re-
spective molecular niche
Radixin mRNA changes substantially. Radixin though, is not highly expressed
in endothelial cells. Moesin’s expression dwarfs radixin and ezrin in endothe-
lial cells (Schwartz-Albiez et al., 1995). As well, there might be specialised roles
for these proteins in transducing different mechanical stimuli. Touch, hearing,
flow of urine and flow of blood require sensitive receptors to trasduce mechan-
ical force. The receptors and their associated molecules are specialized to the
organ (Orr et al., 2006). Arterial shear stress generates 1-3 N/m2 (Davies, 1995).
Meanwhile outer ear cell stereocilia needs to be sensitive to 0.001 N/m during
compression stiffness and generates 0.1-20 pN/mV as force/∆ membrane po-
tential. Radixin in contrast to moesin and ezrin, is a component of sterocilia
(Pataky et al., 2004).
Thus in areas of very low shear and low oscillatory shear, radixin might
have a certain "molecular environmental niche" role to play. Cells might be
able to differentiate a pathogenic low flow, due to plausible insensitivity of
moesin versus the high sensitivity of radixin, though radixin is expressed at
low levels. Radixin might be able to take up the function of moesin during
a potential X chromosome linked disorder, albeit with certain functional loss.
This is because moesin in contrast to radixin has the locus on X chromosome
(Wilgenbus et al., 1994). Radixin is found at comparatively higher levels in sin-
uosoidal endothelial cells, though all studies show that moesin is the dominant
ERM protein in endothelium (Doi et al., 1999). Studies into hearing disorders,
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might also provide insightful signaling information associated with such high
sensitivity of radixin.
Nevertheless, radixin due to its hypersensitivity is possibly not suited to en-
gage in endothelial cells. This hypersensitivity might not be suited to normal
physiological flow. This could thus be the reason for radixin’s scant expres-
sion in endothelial cells. If radixin was heavily expressed instead of moesin,
this could result in unalleviated downstream signaling, leading to chronic in-
flammation. Moesin as we discover later is atheroprotective and necessarily
sensitive (chapter relating to microparticle release and thrombin induction).
Expression of radixin is justified in specific organs such as the ear canaliculi
for sound transduction, not for the cardiovascular system regularly exposed to
blood flow (and the various molecules associated).
7.1.6 Moesin in nucleus
7.1.6.1 Moesin is translocated to the nucleus with cyclic strain
Moesin is the major ERM protein in endothelium. It is also regulated by hemo-
dynamic forces in endothelial cells and smooth muscle cells. Earlier we noted
cell cycle regulation by cyclic strain. We now find that moesin is as well,
translocated to the nucleus with cyclic strain (Figure 3.2). We have demon-
strated this using two different biochemical seperation methods.
7.1.6.2 Moesin in sub-confluent cells and its relevance
Moesin has been found to translocate to the nucleus in subconfluent cells.
In this stage, the cells are highly proliferative and migratory, two functions
proven to increase with cyclic strain. Moesin meanwhile is not present in the
nucleus of static confluent cells (Batchelor et al., 2004). This group has shown
undetectable level of moesin in the nucleus when cells are confluent.
Meanwhile, in an injured endothelium such aswith balloon angioplasty, en-
dothelial cells are scraped. This results in sub-confluent monolayer of endothe-
lium which is subject to migration and proliferation. Moesin thus in an injured
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endothelium, i.e., subject to cyclic strain but with a subconfluent phenotype
would be an interesting model. Smooth muscle cells also need to be elucidated
in this context. This is because VSMCs are also exposed under such conditions.
Blindt et al has already shown moesin overexpressed post restenosis in migrat-
ing smooth mucle cells in-vivo. This group has thus also clearly demonstrated
moesin overexpression to increase migration substantially (Blindt et al., 2002).
Thus moesin’s role in an injured endothelium, especially with regard to its
requirement towards the migratory apparatus is intriguing. Our lab has previ-
ously shown uPA involved in migration and post cyclic strain in angiogenesis
(Von Offenberg Sweeney et al., 2005). As we discussed earlier in section i of
this chapter, is moesin an adapter protein regulated by upA/uPAR complex in
migration and angiogenesis?
The persistent increase of moesin with cyclic strain in sub−confluent cells
denote the significance of integrins inmediatingmechanical stimuli viamoesin.
The RGD-matrix pronectin, and fibronectin matrix show similar increase in
moesin further strengthening integrins in this particular role.
7.1.6.3 Moesin increases with mechanotransduction in the cytosol
There is an increase of moesin in cytosol with cyclic strain (Figure 3.2). As
stated earlier, cyclic strain neverthless increase moesin. It would be interesting
to elucidate moesin’s expression in the membrane and cytoskeletal fractions.
A role for moesin in cell cycle is an obvious hypothesis due to its presence in
the nucleus.
7.1.6.4 Phosphorylation ofmoesin foundwith translocation to various com-
partments of the cell
We also find moesin phosphorylated in the nucleus with cyclic strain (Fig-
ure 3.2). The moesin in cytosolic fraction with strain we find is also phos-
phorylated. This is intriguing, as it could potentially have roles in transport of
molecules. The ability of moesin to bind filamentous actin, PIP2 (in the nuclear
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membrane) with phosphorylation possibly facilitates this. There could also be
other unidentified cytosolic proteins that moesin is able to link. Identification
of these proteins utilizing pull-down studies might lead to insightful informa-
tion.
In the nucleus, moesin could have a role in tethering F-actin. In such in-
stance what binds to the FERM domain of moesin? PIP2 as mentioned earlier
has been demonstrated to be on the nuclear envelope, as well as inside the
nucleus (Mazzotti et al., 1995). Also, PIP2 is well charachtersised to stabilize
moesin near to the cell membrane, at the FERM domain for phosphorylation
(Niggli and Rossy, 2008). Thus, it is an obvious FERM domain binding partner
for moesin at the nuclear envelope.
Moesin is also phosphorylated in the cytosol. This implies moesin is bound
to actin, and bound to an unknown FERM domain binding partner. It could be
thatmoesin’s N−ERMAD,might be bound to another ERMprotein’s C−ERMAD.
While this particular ERM protein might be bound to PIP2 on the membrane.
There could also be other interactions, with other adapter proteins being part
of a larger complex. Which might then be stabilising actin bound moesin in
the cytosol. The presence of oligomers are known for ERM proteins, but unlike
heterodimers, their functional significance is unknown (Bretscher et al., 2002).
The increase in cytosolic phosphorylated moesin with cyclic strain is thus of
significance.
7.1.7 Is moesin a determinant for cell proliferation in the vas-
culature?
Our studies with respect to moesin’s role in proliferation has been inconclusive
(not shown). As previously explained Blindt et al have proven moesin overex-
pression to increase proliferation of coronoary smooth muscle cells. Though
VSMCs and ECs have contrasting roles with respect to protein expression and
proliferation.
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7.1.7.1 Plausible regulators ofmoesin derived proliferation in vascular cells
Meanwhile, Raj Kishore et al have proven ezrin the ERM protein, regulating
endothelial cell proliferation. They have shown that ezrin translocates to nu-
cleus post phosphorylation, mediated by Rho kinase downstream of TNF-α
(Kishore et al., 2005). Importantly, we find ezrin expression not changing with
mechanotransduction (Figure 3.6). They also note cyclin A directly mediating
ezrin regulation and show implications in angiogenesis.
A recent publication sheds light on the plausible regulatory elements af-
fected bymoesin’s overexpression, pertinent to proliferation. They noted down-
regulation of p16, cyclin D1 and cdk4 with moesin overexpression in human
dermal microvascular endothelial cells (HDMEC) (Lee et al., 2009). Though
they concluded that lentiviral application must have rendered the increase in
proliferation paradoxical.
7.1.7.2 Matrix mediation in proliferative response
Our studies further show moesin downstream of RGD mediated integrins.
In section i we compared proliferation of endothelial cells, with respect to
pronectin and fibronectin. Meanwhile in the study conductedwith cyclic strain
(Figure 3.1), we also discovered that moesin expression with cyclic strain is
regulated mainly by integrins. This is because, we conducted the studies with
both fibronectin and the pronectin (containing only integrin specific RGD). As
shown in the figure, both resulted in similar moesin expression. There was also
no statistical significance attributed to the difference.
Furthermore, translocation of moesin to the nucleus (under cyclic strain)
results from integrins (owing to pronectin), (Figure 3.2). Sub-confluent cells
indicative of an injured endothelium, also show integrin mediating increase
in moesin with cyclic strain (Figure 3.1). Conversely, any role moesin might
have in proliferation with respect to cyclic strain can be attributed to integrin
signaling. Further investigation into this should yield other interesting results.
Moesin expression is also influenced by confluency under mechanotransduc-
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tion.
7.1.8 Conclusion
Thus there are various roles moesin, the major ERM protein might have in
endothelium. These possibly include proliferation, migration and angiogeneis.
Meanwhile we are also interested to see how uPA modulates these cell fate
decisions. Also, moesin expression with mechanotransduction, did not differ
when either fibronectin or pronectin was used (Figure 3.1). This demonstrates
that integrins are major transducers of moesin under cyclic strain.
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Figure 7.2: Moesin and mechanotransduction
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We also have the added knowledge of its pivotal importance with mechan-
otransduction contrasting other ERM proteins (Figure 3.4). In the following
chapters we investigate why mRNA and protein levels of moesin do not corre-
late. We also see if moesin has a role in microparticle release. We also investi-
gate if moesin is an eligible candidate that link uPA/uPAR signaling towards
angiogeneis and migration.
7.2 microRNA regulation of moesin under mechan-
otransduction
7.2.1 microRNAs regulated by shear stress and cyclic strain
7.2.1.1 Identification of microRNAs that could potentially target moesin
We analyzed microRNAs using in-silico bioinformatic studies. This generated
microRNAs that share homology to moesin mRNA (Figure 4.1). When ho-
mology is considered with respect to microRNA, the importance is in the seed
region (Lewis et al., 2005). As illustrated in (Figure 4.1) this was found in hsa-
miR-221, hsa-miR-489, hsa-miR- 215 and hsa-miR- 767-5p .
7.2.1.2 Current knowledge of identified microRNAs in the vasculature
miR-221 has been found to inhibit normal erythropoiesis, while miR-489 is im-
plicated in breast cancer metastasis (Felli et al., 2005; Foekens et al., 2008). They
found miR-489 in estrogen receptors (ER) positive cells, primarily driven by
these receptors. Estrogen receptor α is known to drive actin remodeling and
endothelial cell migration. Furthermore, the mechanism discovered, was via
Rho A-Rho kinase-Moesin pathway (Simoncini et al., 2006; Sanchez et al., 2009).
With regard to erytropoeisis, moesin’s expression decreased as erythroid cells
progressively matured to erythrocyte (Masumoto et al., 1998; Winckler et al.,
1994).
miR-215 has been implicated in cell cycle arrest owing to its upregulation
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via p53(Braun et al., 2008). Thus in addition to complimentary seed region
these microRNAs have complimentary roles to moesin. The study by Harvey
et almeanwhile, implicated moesin and ezrin regulation by microRNA system
(Harvey et al., 2008). Additionally they found moesin and ezrin downregu-
lation with dicer knock out in podocytes. Generation of mice dicer knockout
mice is not feasible, due to fatality in 7.5 embryonic week. There is a lack of
knowledge in endothelial cells, particularly with mechanotransduction. It was
interesting to note that gelsolin (distally involved in microparticle formation)
was also under microRNA regulation. This has implications in endothelial mi-
croparticles (Figure 1.24) (Piccin et al., 2007).
7.2.1.3 microRNAs that potentially targets moesin are sensitive to mechan-
ical stimuli
Further to this, we have shown how mechanotraduction affects the microR-
NAs identified in the earlier study (Figure 4.2) . The microRNA responsible
for sharp shifts in cell proliferation hsa-miR-215, did not change with mechan-
otransduction and neither did hsa-miR-767-5p. Meanwhile we find variations
in hsa-miR-221 and hsa-miR-489.
The full list ofmicroRNAs analyzed and their change is given in (Figure 4.3),
(Figure 4.4), (Figure 4.5), (Figure 4.6), (Figure 4.7). Since presenting this profile
at three international conferences, there are now few reported microRNAs con-
firmed in mechanotrasduction (Kuang et al., 2009).
It is clear from these studies that there exists a large difference between hsa-
miR-489 with shear and cyclic strain. The shift is in opposing directions, when
compared between shear and cyclic strain. This interestingly reflects differing
moesin expression with shear stress and cyclic strain. With shear stress mean-
while, we see a bigger shift in moesin protein expression when compared to
its mRNA. In future, it will be easier to tease out the specific microRNAs in-
volved, with respect to moesin. This is because our studies found only two
microRNAs (that plausibly targets moesin mRNA), hsa-miR-221 and hsa-miR-
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489 under mechano-regulation. Thus overexpression studies will provide in-
formation whether moesin is impacted by these microRNAs. Knocking out
these microRNAs concurrent to induction of mechanical stimuli (shear stress,
cyclic strain) will provide more conclusive evidence. This study will further
confirm if the effects due to dicer knockdown is specifically due to these mi-
croRNAs. Furthermore, reporter based study (commercially available from
Applied Biosystems®) will confirm the specificity of microRNAs to moesin
mRNA.
7.2.1.4 Moesin is regulated by microRNAs
Further to this study we wanted to demonstrate how actual moesin protein ex-
pression, is impacted by microRNA regulation (Figure 4.9). For this we looked
for inspiration to Suarez et al’s study (Suarez et al., 2007). Their studies utilizing
dicer downregulationwere elegant. They showed role of microRNA regulation
in diverse functions, such as angiogenesis, proliferation and in other functional
aspects.
7.2.1.5 Appreciation of Dicer knockdown
In the introduction it is explained howDicer, drosha andAgo proteins generate
microRNA. Dicer down-regulation thus is a better target than drosha or Ago
proteins, for understanding microRNA system. This is because, all microR-
NAs equally pass through dicer processing whilst, there are drosha indepen-
dent mechanisms for microRNA generation. There are some microRNAs also
differentially processed by many Ago proteins (Ghildiyal and Zamore, 2009).
Our experiments involved investigating if moesin was under microRNA reg-
ulation. Thus, Dicer down-regulation would be an ideal solution towards this
purpose.
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7.2.1.6 Molecular elements responsible formoesin phosphorylation are reg-
ulated by microRNA
There was a marked change in moesin protein levels with dicer downregula-
tion (Figure 4.9). This demonstrated that moesin is regulated by the microRNA
machinery, when subjected to cyclic strain. The phosphorylation of moesin had
also decreased considerably. This suggests the regulatory mechanism required
for moesin phosphorylation is also under microRNA regulation.
7.2.2 microRNA can activate as well as repress protein expres-
sion
It is a widely held view that microRNAs repress proteins. Our experiments
meanwhile show that with microRNA expression, moesin protein was in fact
up regulated. It has to be noted that the only other research that studiedmoesin
with respect to microRNAs (on kidney podocytes, mentioned earlier), also
demonstrated that moesin downregulation with dicer knock down. Thus, they
too observe increase in moesin expression with intact microRNA machinery
(Harvey et al., 2008).
The study by Vasudevan et al in Science has confirmed that specific microR-
NAs can in fact activate protein translation (Vasudevan et al., 2007). Initially
they found microRNAmiR369-3 oscillating between its repressive and activat-
ing role. There was a dependence on cell cycle, with repression in proliferating
cells. While in a quiescent state (physiologically, endothelium exists in a qui-
escent state unless injured), the microRNA initiated activation of the mRNA
(Dejana et al., 2009). They found these factors holding true for the well studied
Let-7 and miRcxcr4 microRNAs.
Direct identification of specificmicroRNAs utilizing reporter studies is needed
to fully clarify the issue. There could be other answers such as interaction of
other proteins, that could repress or activate the protein studied.
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7.2.2.1 Agonists can differentially regulate same microRNA
Their studies led to identification of TNF-α RNA activation/repression. TNF-
α incidentally phosphorylates moesin (Koss et al., 2006). Furthermore, we has
discussed previously that moesin expression is regulated by cell-cell contact.
Mechanotransduction with respect to moesin as demonstrated previously,
was increased irrespective of cell-cell contact (Figure 3.1). This suggests inte-
grin to be the primary transducer of mechanical stimuli with respect to moesin.
Plausibly, samemicroRNA could differentially activate or repress proteins down-
stream of RGD specific integrins. We identified cyclic strain mediated increase
in moesin during sub-confluence and confluence. Mechanical stimuli engages
integrins irrespective of cell cell contact. Please refer Figure 1.19 for the various
receptors involved with mechanical stimuli. Thus, integrins could potentially
clarify whether microRNA repress or activate proteins.
Activation of proteins by microRNAs was discovered only recently. This
was discovered as stated earlier by Vasudevan et al. They found miR369-3
recruiting proteins Argonaute (Ago) and fragile X mental retardation–related
protein 1 (FXR1). This activated the translation by binding to the TNF-α RNA
at its AU-rich elements (AREs). This clearly has relevance to moesin phoshory-
lation, as TNF-α can phosphorylate moesin (Koss et al., 2006). Science also
published work by Jopling et al, who discovered activation of the viral RNA
(Hepatitis C) by miR-122(Jopling et al., 2005). Widely held view has been that
microRNAs repress protein expression. Mechanical regulation as we discov-
ered, down regulates majority of microRNAs. What significance this will have
on protein expression, require further study. Our research, thus is one of the
only few studies that actually confirm activation of a protein with an intact
microRNA system.
The agonist dependence on microRNA repression or activation is intrigu-
ing. It would also be of interest, if shear induced a differential response. Mechan-
otransduction, might similar to Vasudevan et al’s discovery be agonist/context
dependent. We confirmed repression of moesin translation by microRNA ma-
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chinery under shear stress. Meanwhile down regulation of dicer under shear
stress, spurred moesin protein expression (Figure 4.10). Here we find different
agonists of hemodynamic forces inducing differential microRNA regulation.
7.2.3 Acute stretch induced dephosphorylation, and are regu-
lated by microRNAs
Change in phosphorylation status of moesin with mechanotransduction, as
discussed previously, suggest regulators of moesin might be under microRNA
regulation. We thus devised acute studies to understand the phosphorylation
change of moesin. Biaxial stretch was gently applied according to the study by
Yi-Jen Chiu et al, whereby shear stress was kept minimal (Chiu et al., 2008).
Furthermore, it was interesting to observe how application of acute stretch
dephosphorylated moesin. This we discovered to be maximal at 10 minutes
(Figure 4.11), while chronic (24 hour) application of cyclic strain produced a
hyperphosphorylated moesin (Figure 4.11).
7.2.4 Rho A mediates stretch induced de-phsophorylation
We have a list of possible suspects that might dephosphorylate moesin. In
the introduction we pointed out the unappreciated role of dephosphorylation,
with regard tomoesin. Wewonder, about the structural change associatedwith
moesin dephosphorylation.
Dynamic dissociation is a charachteristic of actin binding adapter proteins
like moesin. We hypothesised that the disruption of cortical actin and the en-
suing turnover will lead to translocation of proteins. This requires moesin to
lose affinity for actin in one area for another. As well this might be a transient
mechanism, universal for agonists that require the same. The stretch applied
on the cell tugs at the actin, which tries to stabilise itself to this mechanical
stimuli (as visible in (Figure 3.6)). This possibly require cytoskeletal remodel-
ing. Dephosphorylation might be a required conformational change to effect
this process.
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7.2.4.1 Rho A and moesin
Rhomediated pathways in BAECs are deemed critical for stress fibers to orient
perpendicularly to stretch (Chien, 2007; Kaunas et al., 2005). Rho Kinase phos-
phorylates moesin, but without the stabilisation by PIP2, it is unable to achieve
this. Further to this, PIP2 is seen as a critical factor in moesin’s phosphoryla-
tion (Matsui et al., 1999; Niggli and Rossy, 2008). Another study meanwhile
has challenged moesin and Rho GTPases, in its ability to regulate each other
in a directly proportional manner. They discovered moesin phosphorylation
and Rho pathway being antagonistic to each other (Speck et al., 2003). Mean-
while we were using fibronectin coated plates, which stimulate inflammatory
pathways. In this context Rho, not Rac is shown to be activated (Gu et al.,
2001). Our study meanwhile found moesin unable to dephosphorylate with
acute stretch, with Rho abrogation whilst grown on fibronectin matrix (Fig-
ure 4.11). We were thus able to confirm the negative feedback between moesin
and Rho, found initially by speck et al (Speck et al., 2003).
7.2.4.2 Dephosphorylatory mechanisms with respect to moesin
From the literature there is the Calyculin-A (phosphatase inhibitor) insensi-
tive threonine phosphatase type 2 protein phosphatase (PP2C), that can de-
phophorylate moesin. The study though was conducted with highly purified
moesin and PP2C. This study first proposed a phophatase and is nevertheless
important (Hishiya et al., 1999). From our observation and the observation of
others, the calyculin sensitive phophatase seems to rapidly dephosphorylate
moesin. This is also possibly functionally related, such as mechanotransduc-
tion (shear stress, cyclic strain) might involve a different phophatase to some
other agonist.
We do find moesin phosphorylation preserved with Calyculin A as shown
in (Figure 3.2). Functionally we appreciated earlier how, phosphorylation of
moesin is pertinent to its ability to translocate to various cell compartments.
Phosphorylation− dephosphorylationmechanisms could also vary between
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shear stress and cyclic strain. It has been shown chemokine stromal cell-derived
factor 1α (SDF-1α) is able to dephosphorylate via calyculin-A sensitive phos-
phatase, and thus is not dephosphorylated by PP2C (Ivetic and Ridley, 2004).
With respect to SDF-1α, it has been shown that it is Rac1 and not Rac2,
Rho, or Cdc42, that is able to block the functional event of microvillar loss.
They went on to prove that Rac-1 is able to do this via dephosphorylating the
ERM proteins (Nijhara et al., 2004b). Structurally the C terminal, especially the
basic residues held there, is responsible for Rac-1 based dephosphorylation of
moesin.
The dephosphorylation event was found by us and others to be very tran-
sient, as this is required to re-arrange the actin cytoskeleton towards the new
agonist’s signaling route. Also, further in the discussion with respect to the
study in urokinase, we note the dephosphorylation as an absolute requirement
to effect chemotaxis.
This is also the case with Rac-1 activation, where it is transiently activated
by the chemokine SDF-1α. This was one of the reasons why others had pre-
viously not observed Rac-1 activation with respect to this chemokine (Nijhara
et al., 2004a; Shaw et al., 2001).
One deficiency in this study, is the lack of insight into merlin’s where-
abouts when Rac-1 is activated. Merlin is phosphorylated by p21-activated
kinase (Pak) in response to activated Rac (and to lesser extent due to cdc42)
(Daniels and Bokoch, 1999). As explained earlier merlin has more affinity
towards the unbound monomer of ERM proteins than to its own unbound
monomer. Thus, a plausible mechanism is whereby recently unbound mer-
lin(activated/phosphorylated) clutches to the nearby moesin. Moesin is more
expressed than its couterparts in endothelial cells and leukocytes and thus has
higher probability to be targeted (Berryman et al., 1993; Pataky et al., 2004).
Localising the phophatases to its substrate obviously makes it a target. Thus,
there are other possible phophatases thatmight be involved, such as themyosin
phosphatase, whose subunit myosin binding subunit (MBS) interacts withmoesin.
There is also positive loop systemwith respect to ROCK, one of the well known
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phosphorylator of moesin. ROCK also phosphorylates myosin phosphatase,
which inactivates its phosphatase function (Fabian et al., 2007).
Protein tyrosine phosphatase (PTPL1) is a cytoplasmic protein and a tyro-
sine phosphatase, that also contains the FERMdomain. Thismakes it a possible
target for the C-ERMAD of the ERM proteins. There are no known associations
so far with the ERM proteins. Even though this FERM domain exists, PTPL1 is
a tyrosine phophatase and thus not relevant tomoesinwhich is only phophory-
lated at the threonine residue. Ezrin on the other hand is phosphorylated at the
tyrosine residue, and this might be a route of inhibition with active moesin. In-
cidentally, PTPL1 also targets PIP2 (major stabilizer of ERM proteins, for their
phosphorylation) on the plasma membrane (Bompard et al., 2003; Abaan and
Toretsky, 2008). This might cause ezrin to encourage forming heterodimer for-
mation with actin bound active moesin. If heterodimer does form, this will
result in dephosphorylation of moesin. Further, it will lead to a decoupling of
actin from the membrane and PIP2 disassociation from the cytoskeleton. Thus,
all phosphatases that interfere with the ERMprotein self associatedmonomers,
active actin bound monomers, oligomers (with other FERM domain proteins,
such as merlin and probably talin) will have profound effect on the cytoskele-
tal architecture. This could result in sudden loss of membrane adhesiveness
to the cytoskeleton, leading to increased microparticle formation with role in
cell-cell adhesion thus resulting in spurt of permeability loss. This is also true
with respect to cleavage of ezrin with calpain, the only calpain cleavable ERM
protein (Shcherbina et al., 1999a). This might be also a mechanism of transient
change, required for plasticity of the cytoskeleton towards any agonist.
7.2.4.3 Rho A is potentially regulated by microRNAs
We also find moesin dephosphorylation with stretch regulated by microRNAs.
The results (Figure 4.11), have an uncanny reflection of Rho abrogation study.
There was also no statistical significance in any perceived change. We thus
find moesin phosphorylation / dephosphorylation and its expression, is con-
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trolled substantially by the microRNA system. We also provide evidence to the
possibility that activity of Rho is regulated by microRNAs.
Rnd proteins reviewed in the introduction, provide example of GTPases
that are regulated by their expression. These atypical GTPases and moesin,
does seem to be the usual suspects. They are both implicated with respect to
rounding of cells (Chardin, 2006; Rosenblatt, 2008). Phosphorylation of moesin
is critical to rounding of cells. Researchers are finding it hard to pin the entire
phosphorylation event on Rho A, with respect to cell rounding. Our findings
with respect to microRNA regulation with respect to Rho A, moesin and the
speculation regarding Rnd proteins, might be significant here.
Our findings here thus endeavor to answer questions raised earlier in this
section, regarding differences in moesin protein expression to its mRNA. There
are other plausible mechanisms which could equally contribute. There are
many open questions regarding themechanism bywhich Rho controls dephos-
phorylation. Does sudden change in stretch protect myosin phosphatase from
Rho kinase (Kimura et al., 1996)? Speck et al, meanwhile has showed pheno-
typic change associated with overexpression, similar to abrogation of the other.
Though, what are the intricate mechanisms of Rho antagonism with respect to
moesin (Speck et al., 2003)?
7.2.5 microRNA regulation is critical to physiological function-
ing of the endothelium
7.2.6 microRNAs regulate cell alignment with shear stress
Mechanical stimuli on endothelial cells is impacted by a whole array of mi-
croRNA (Figure 4.3),(Figure 4.4), (Figure 4.5), (Figure 4.6), (Figure 4.7). We
were also able to demonstrate that endothelial cells are dysfunctional and don’t
align in the direction of flow when Dicer is downregulated (Figure 4.12). Har-
vey et al has shown how cytoskeletal proteins including moesin is downregu-
lated with dicer knockdown (Harvey et al., 2008). Our own studies have also
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shown moesin’s role in dynamically associating with cortical flow (Figure 3.6).
Here we demonstrate holistic architectural change in HAEC with dicer knock-
down. This demonstrates that microRNAs play a role in maintaining normal
cell alignment with hemodynamic flow. Obviosly, lack of mechano sensitive
proteins such as moesin and others mould the cells in this manner. The impact
on the cells, we show to be profound with dicer down regulation.
7.2.6.1 Endothelial cells are hypersensitive to microparticle release when
lacking microRNA regulation
We find HAECs more prone to endothelial derived microparticles when an
agonist is introduced (ionophore and chronic shear stress) (Figure 4.13). Inter-
estingly microRNA machinery knockdown do not constitutively activate mi-
croparticle formation. This could be due to reduction in gelsolin, which has
been demonstrated (Harvey et al., 2008). Gelsolin, together with calpain are
majorly involved inmost microparticle formation as a distal event (Figure 1.24)
(Piccin et al., 2007).
7.2.6.2 microRNAs regulate endothelial cell proliferation under cyclic strain
We were able to reflect the studies by Suarez et al, where with dicer down reg-
ulation decreased proliferation of endothelial cells occur (Figure 4.14) (Suarez
et al., 2007). As this study was conducted with subconfluent cells, we discover
cell-cell contact does not change the status quo in terms of proliferation (as dis-
covered by Suarez et al).
We also discovered that dicer downregulation affected the shift in prolifer-
ation with mechanotransduction. When microRNA system is intact, the shift
being higher. The results also show cyclic strain to reduce proliferation in en-
dothelial cells. Furthermore, Liu et al has already shown that endothelial cells
proliferate maximally at suconfluence even when stretched. They found re-
quirement for cell-cell contact and identified cadherin’s role (Liu et al., 2007).
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7.2.7 Conclusion
microRNAs that have the seed region complimentary to moesin are implicated
with shear stress and cyclic strain. We have also discovered a list of microR-
NAs, and their associated change.
Figure 7.3: microRNA regulation of mechanotransduction
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We see that moesin protein levels are controlled by shear stress cyclic strain
and regulated bymicroRNAs. Furthermorewe findmoesin de−phosphorylation
with stretch controlled bymicroRNAs. The identification of Rho associated de-
phosphorylation was intriguing, so was its regulation by microRNAs.
Further, we demonstrate the profound implications of these regulatorymech-
anisms in terms of lack of cellular alignment with shear stress (flow). We also
show the significance of microRNA machinery in cytoskeleton−plasma mem-
brane adhesion, in terms of microparticle formation. Here we see, both shear
and ionophore agonist inducing blebs in cells that lack microRNA regulation.
With respect to cell proliferation, lack of microRNAmachinery curtails the pro-
liferative response of the cell. This reflects the study by Suarez et al (Suarez
et al., 2007). Furthermore, we show mechanotransduction induced prolifera-
tive responses are also sabotaged by lack of microRNA machinery.
7.3 Endothelial derived microparticles: Implicating
moesin
7.3.1 Implication of cytoskeletal protein moesin, in micropar-
ticles
TNF-α was able to induce microparticles which contained moesin as demon-
strated by western blotting (Figure 5.1). Moesin as an actin binding protein, is
structurally important. Microparticles meanwhile being an actin derived pro-
cess (Flaumenhaft et al., 2009), could involve moesin structurally. It has been
shown recently, what was speculated over time, that microparticles presents
proteins based on the their mode of induction. The microparticles as appreci-
ated in the introduction, are thus also representative of cells from which they
are derived (Peterson et al., 2008). Thus, TNF-α owing to its phosphorylation
of moesin, plausibly shift moesin to the microparticle (Koss et al., 2006). Inher-
ent structural and cytoskeletal changes with moesin phosphorylation, is also
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obvious (McClatchey and Fehon, 2009).
The mechanisms that underlie moesin’s significance to microparticle re-
lease is unclear. As an actin binding protein with intricate linkage to the mem-
brane, independent of the agonist, moesin plausibly plays key role in the re-
lease of microparticles. Moreover, moesin is highly expressed in endothelial
cells. Also it is mechanically sensitive unlike ezrin. Could there be thus a dif-
ference in terms of microparticle release, between ezrin and moesin?
7.3.2 Microparticles increase with variation in shear stress
Mechanically, we have shown that microRNA regulation protects endothe-
lial cells from undue microparticle release (Figure 4.13). We have also shown
moesin to be under microRNA regulation. Following it up, acutely, shear ac-
cumulated EMPs over 48 h (Figure 5.2). Exercise acutely, also produce EMPs
to similar levels (Figure 5.2). Exercise increases both cyclic strain and shear
stress substantially. Thus, this is an in-vivo confirmation of a phenomenon we
discover in-vitro (Birukov, 2009a; Kojda and Hambrecht, 2005). Chronically the
effect of exercise may also lead to decrease in EMPs. The trend towards this
can be seen 2 h post exercise. Thus studies, conducted possibly a day after
exercise might see a substantial reduction in EMPs. This though, needs exper-
imental verification. Exercise even moderately leads to NO production and is
well characterized to be atheroprotective (Hahn and Schwartz, 2009). There are
gaps in our knowledge about mechanosensitive proteins, that archtietecturally
mould the cells imparting atheroprotectiveness.
7.3.3 Moesin has the ability to buffer microparticle release
7.3.3.1 Moesin and ezrin differs in its ability to regulate microparticle re-
lease
We decided to compare microparticle induction with moesin overexpression.
We utilized the FLAG-tag construct of moesin and ezrin (for comparison) at-
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tached to the C- terminus. This FERM domain is able to bind via its PH domain
to PIP2. Interestingly we found clear evidence of moesin overexpression sub-
stantially decreasing endothelial microparticle formation (Figure 5.3). Ezrin
overexpression rendered endothelial cells sensitive to microparticle produc-
tion. This clearly illustrates that moesin expression is constitutively atheropro-
tective. Moreover, agonist (Ca+) induced EMP production is buffered when
moesin is overexpressed. Calcium ionophore has been shown to induce calpain
signaling downstream with the associated cleavage of proteins (Chua et al.,
2000). Detailed in the introduction calpain induces microparticle formation,
while ionohore is used to study this mechanism.
The study by Falati et al was the basis of our study with respect to stain-
ing the microparticles with calcein AM (Falati et al., 2003). They have recently
published in Blood, actin rather than microtubules to be involved in micropar-
ticle formation (Flaumenhaft et al., 2009). We used calpeptin to block calpain
formation with ionophore induction (O’Connell et al., 2005). With calpeptin,
moesin and ezrin overexpression derived microparticles both were reduced
(Figure 5.3).
Clearly from these studies a few factors are pertinent. Moesin seems to
downregulate microparticle formation in endothelial cells. Overexpression of
a calpain cleavable protein ezrin (due to its redundancy), takes on moesin’s
role, but is unable to stop the blebbing and microparticle formation. Moesin
and ezrin interestingly differ in their sensitivity to calpain (Shcherbina et al.,
1999a).
7.3.3.2 Moesin is sensitive to thrombin, unlike ezrin with regard to mi-
croparticle release
Meanwhile studies with thrombin (Figure 5.4), that directly activate moesin
show how moesin is significant to vasculature (Shcherbina et al., 1999b). Ezrin
like in the previous study constitutively increase EMPs, compared to when
moesin is overexpressed. But, when induced with thrombin, moesin overex-
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pressing cells increase EMPs, while cells overexpressing ezrin remain insensi-
tive. The EMPs are still significantly less compared to ezrin overexpression.
This has implication in thrombosis and haemostasis. This shows that moesin
is able to buffer endothelium against blebbing, loss of plasma membrane− cy-
toskeleton adhesion and thus microparticle formation. Moesin though, still
retains the subtle sensitivity required of the endothelial cells with respect to
thrombin induction.
7.3.3.3 Ezrin overexpression leads to constitutive microparticle release
The images of ionohphore induced microparticle formation in HAECs compli-
ments our biochemical studies (Figure 5.7). Here we can visualize endothe-
lial microparticles. Ezrin and moesin both bind to the PIP2 via their PH do-
main. Meanwhile as discussed in the introduction, we know the significance of
PIP2 towards cytoskeleton−plasma membrane adhesion (Raucher et al., 2000).
We have also appreciated how, phosphatidylserine’s localization is a defin-
ing process of microparticle formation (Yeung et al., 2008, 2009). Plc−δ−rfp
binds to only the free PIP2 and not when PIP2 is bound to a binding part-
ner (Raucher et al., 2000). Thus plc−δ−rfp is an inverse indicator of protein
bound PIP2 , whereby, more red (rfp) expression, less protein bound PIP2 is
available in the cell. Utilization of this technique, shows that moesin and
plc−δ−rfp co-overexpression results in less rfp expression compared to sim-
ilarly co-overexpressed ezrin and plc−δ−rfp (Figure 5.6). More unbound PIP2
meanwhile, is sequestered away over time by plc−δ−rfp, decreasing the cytoskeleton−
plasma membrane adhesion. This experiment visually demonstrates the cleav-
age of ezrin and the insensitivity of moesin to calpain, resulting in microparti-
cle formation (Shcherbina et al., 1999a). Meanwhile, we also show how moesin
and ezrin localize in endothelial cells, with its overexpression (Figure 5.5).
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7.3.3.4 Moesin is critical to membrane-cytoskeletal integrity with regard to
microparticle release
We demonstrate this further with our study utilizing moesin siRNA. The study
show endothelial microparticles production dramatically affected. There is a
massive increase in EMPs with and without ionophore treatment. Moesin loss
has been shown to induce blebbing in cells previously (Rosenblatt, 2008). Our
study shows how lack of moesin generates microparticles with cells unable to
focus the curvature of its membrane. This, as appreciated in the introduction
results from loss of membrane-cytoskeletal adhesion.
Lack of moesin has also been shown to affect the membrane integrity with
respect to HIV infection. This is through its ability to regulate microtubules,
but the role of actin has not been excluded (Naghavi et al., 2007). There are
as well, differences in signal transduction with respect to viral entry between
moesin and ezrin. Such as the CagA-mediated Src inactivation leading to ezrin
dephosphorylation (Selbach et al., 2004). Moesin meanwhile, is immune to this
process, due to the lack of tyrosine phoshorylation residue. Essentially an actin
driven process (Flaumenhaft et al., 2009), microparticle production, we find
require moesin critically towards its regulation.
7.3.3.5 Microparticle release is globally mediated by microRNAmachinery
In the previous chapter we note how microRNAs are also involved in the mi-
croparticle formation. As well, moesin was shown to be under microRNA reg-
ulation. With dicer downregulation, moesin is reduced in static cells (Harvey
et al., 2008). Further wewanted to repeat one of the earlier studies (Figure 4.13),
conducted with ionophore induction (of dicer knockdown HAECs). This was
to see if calpeptin can rein in the micropartilces (Figure 5.3).
In this study, we find lack of microRNA regulation renders the cell sensitive
to calpeptin. In such scenario, calpain thus seems to be the most distal event
in EMP formation. Further evidence, we see with EMPs generated by throm-
bin (Figure 5.4). Thus from our studies in the earlier chapter and here, we find
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microRNA regulation protects endothelium against agonist induced micropar-
ticle formation. It will be interesting to understand using proteomics, the many
different proteins associated with microRNA regulation and microparticle re-
lease (Peterson et al., 2008). Usage of large scale arrays, such as what we used in
the previous section, will elucidate microRNAs associated with microparticle
release.
7.3.4 Conclusion
Thus here, we find moesin as a mechanosensitive cytoskeletal protein able to
buffer microparticle formation (Figure 7.4). Meanwhile moesin is also able to
maintain the necessary sensitivity to signals, associated with thrombosis and
haemostasis. Furthermore, we demonstrate the functional significance of low
levels of ezrin in endothelium compared to moesin. We show ezrin’s inherent
lack of ability to function as a major actin linker protein. In previous chapters
we have also shown ezrin is insensitive to shear stress in contrast tomoesin. We
further demonstrate the global regulation of EMP release, and mechanotrans-
duction by microRNA dynamics.
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Figure 7.4: Moesin and microparticlesMoesin we demonstrate, is a necessity
for buffering endothelial microparticles. Also, we show how ezrin is cleav-
able by calpain thus causing intramembrane blebs. We also find that shear
stress regulates microparticle release. All these process through out our study,
demonstrate to be under microRNA regulation.
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7.4 The urokinase moesin interaction
7.4.1 Mechanical stretch and uPA both induce moesin dephos-
phorylation to effect its downstream partners
Different agonists such as mechanical force (Figure 4.11) or urokinase (Fig-
ure 6.1), both effect same biochemical response in moesin. Moesin is dephos-
phorylated within minutes of introduction of either of them.
We discover from the biochemical study, that moesin is dephosphorylated
acutely. This dephosphorylation event is transient, lasting up to 30 min. Fur-
ther to the studies shown in HAECs, the results have been replicated in BAECs.
BAECs showed similarly de-phsophorylation of moesin one minute post uPA
induction.
As noted earlier, this response is similar with acute induction of stretch.
We have also demonstrated in the previous chapter, how stretch mediated de-
phosphorylation is under Rho A regulation. Furthermore, we also showed this
dephosphorylation event mediated by microRNAs. This is illustrated in the
Figure 7.5.
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Figure 7.5: Stretch and uPA effect moesin de-phsophorylation
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7.4.1.1 FPRL1 mediates uPA induced moesin dephosphorylation
Meanwhile we have also shown moesin dephosphorylation by the SRSRY se-
quence of amino acids (Figure 6.1). Exposed in the c-suPAR when cleaved, this
sequence activates FPRL1. fMLP (formyl−methionyl−leucyl−phenylalanine),
meanwhile is the major activator of FPRL1 (N-formyl-peptide receptor 1). An-
other study byKarsten Boldt et al, discovered FPRL-1 stimulation to de-phosphorylate
moesin (Boldt et al., 2006a). Thus, we find c-suPAR transducing the signals
downstream via FPRL1 towards moesin. An open question is whether Rho
mediates in this dephosphorylation (Alblas et al., 2001). There is evidence to-
wards this as a study has shown fMLP to activate Rho A in a highly transient
manner i.e., in 30 seconds. Also we have shown that Rho A regulates dephos-
phorylation of moesin with stretch (Figure 4.11). Our lab has previously shown
that migration and tube formation is modulated via G-coupled receptors with
cyclic strain (Sweeney et al., 2004; Von Offenberg Sweeney et al., 2005).
7.4.2 Moesin and uPA interaction is chemotactic and is adju-
dicated by its ability to transiently de-phosphorylate
As described in the introduction, c-suPAR signaling via FPRL1 is highly chemo-
tactic (Blasi and Carmeliet, 2002). Similarly Sweeney et al, has shown uPA me-
diated migration with cyclic strain in endothelial cells (Sweeney et al., 2004;
Von Offenberg Sweeney et al., 2005). Meanwhile we find moesin and uPA in-
teraction only provides a slight increase in migration (Figure 6.3). Interestingly
we find full length moesin was a requisite for this chemotaxis. This seems
quite logical as we have shown moesin dephosphorylating immediately on in-
duction with SRSRY and uPA. The non-full length moesin such as the T558D
stifles this migration.
As this study looks into multiple parameters, we also see the FERM (1-
382) domain on its own quite migratory, compared to other mutated moesin
constructs. This is especially true when induced with uPA. FERM domain, be-
cause it lacks the C terminus, is originally unbound to actin, thus immune to
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the acute requirement of dephopshorylation. Without the locked C terminus
such as the T558A / T558D, FERM domain is denied the ability to hinder the
migratory response to a similar fashion. This is as stated earlier is because of
the lack of C-terminus, where phosphorylation / dephosphorylation occurs.
The other constructs meanwhile are all halted by uPA due to their non de-
phosphorylatory segments. The importance of the C terminus of moesin is still
evident in the study, when you compared to the migration rate with moesin
full length protein.
7.4.2.1 Membrane-cytoskeletal adhesion mediated by moesin is required
for chemotaxis
The "inactive-moesin" is a construct which is unable to bind cell membrane due
GFP cloned onto the N-terminus. PIP2 is the main binding partner of moesin
to the membrane. PIP2 interaction also is a requirement for moesin to be acti-
vated, i.e, phosphorylated. Thus purely overexpressing inactive moesin do not
increase chemotaxis with uPA interaction. Thus there seems to be a require-
ment for rather a reversible nature, a possible transient de-phopshorylatory
mechanism involved. This in conclusion reflects our biochemical study. A
locked construct such as the T558D / T558A, might have therapeutic values in
treating metastasis.
7.4.3 Moesin is critically required for uPA induced chemotaxis
to engage
We found in the same study, moesin overexpression do not increase migration
dramatically. Interestingly, thus moesin dephosphorylation is the major critical
requirement for uPA mediated migration. We cannot entirely absolve moesin
and shift all migratory ability of moesin-uPA interaction to moesin’s biochem-
ical status. Though, we find dephosphorylation is important, down regulation
of moesin also had a dramatic decrease in uPAmediatedmigration (Figure 6.4).
Thus we find without moesin uPA mediated migration is stopped.
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We also find the same reversible de-phosphorylatory requirement found
with uPA mediated migration holding true with our studies with SRSRY (Fig-
ure 6.5). Thus though there might be other transducers, FPRL1 is a transducer
of uPA signaling towards moesin, critically requiring the reversible dephos-
phorylation of moesin in effecting the migratory apparatus.
7.4.4 Other inducers
7.4.5 Appreciation of integrin as another transducer ofmoesin-
uPA interaction
7.4.5.1 αvβ3/α5β1 integrins are engaged with moesin-uPA interaction
There are other modes of uPAR mediated migration whereby it can increase
the migratory response due to vitronectin-αvβ3 interaction (Figure 6.2), (Fig-
ure 1.28). uPAR is known to induce migration by laterally interacting with
αvβ3 integrin. D2A is a synthetic peptide from the D2 region of the uPAR re-
ceptor shown to induce migration via specific interaction with αvβ3 and α5β1
integrins. It has been shown that the D2 region of the uPAR is the lateral latch
that increase the VN-αvβ3 migration (Degryse et al., 2001; Degryse, 2008; De-
gryse et al., 2005; Dass et al., 2008).
The D2A peptide has the sequence GEEG. This peptide specfically activate
integrins and are reflective of the uPARmediated cytoskeletal overhaul. Mean-
while the other peptide "D2A-ala" is a mutated version of this peptide and is
GAAG, where the two glutamic acids have been replaced by alanine residues.
This peptide is found to inhibit migratory response through these mechanisms
(Figure 6.2).
7.4.5.2 uPAR-integrin-moesin association mediated migration is uniquely
different to uPA-moesin migratory apparatus
We wanted to see if moesin downstream of uPAR-integrin-VN interaction is
similarly migratory. The experiment utilized D2A peptide for this purpose.
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The results (Figure 6.6) clearly show moesin is very pertinent to these signals
with increase in migration. The increase was considerably higher relative to
moesin-uPA mediated migration (Figure 6.3) (when wt type moesin is over-
expressed). Similarly we see previously unseen migration increase with the
"inactive moesin". This construct has the GFP on the FERM domain disabling
its binding ability to membrane (hence plausibly to PIP2). As previosly stated,
PIP2 stabilizes moesin for phosphorylation. While T558A (constitutively de-
phosphorylated) and T558 D (constitutively phosphorylated) overexpression
didn’t increase migration. This showed that the reversible dephosphorylation
of moesin is still a necessity for migration. Thus there is possibly a mecha-
nism that is able to reversibly phosphorylate moesin without PIP2 attachment,
unique to uPAR-integrin-VN interaction.
7.4.5.3 Other plausible intracellular mechanisms
The intracellular mechanisms involved with migration through this pathway
seems very different from migration induced by uPA alone. Though the re-
versiblity of the phosphorylation is important, we don’t know if dephospho-
rylation is still the initial change induced on moesin. If it is, this could initially
rescue "inactive moesin" from dephosphorylation, but moving it into a niche
enviroment capable of PIP2 independent phosphorylation. This is because it
exits in de-phophorylated state normally, while still retaining all other facul-
ties for re-phosphorylation except for the inability to bind to the PH domain of
PIP2. Moesin overexpression clearly is very chemotactic when integrin is ac-
tivated. It will be interesting if uPA based migration allows moesin to induce
inside out signaling via integrinβ3 orβ1.
7.4.5.4 Moesin mediated migration involves the D2 domain of uPAR bind-
ing to integrin
Our next study (Figure 6.7), with the synthetic peptide "D2A-ala" reduce mi-
gration of moesin overexpressed cells. This proves that moesin is involved in
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signaling mechanisms emanating from the D2 region of the uPAR with respect
to this interaction. As moesin response was quite robust in the earlier study
(Figure 6.6), moesin is involved in integrin mediated migration with respect to
VN.
7.4.6 Vitronectin matrix further confirm moesin requirement
for migrating cells involving integrins
We found this to be true when VN alone (Figure 6.8) was used. Meanwhile we
also find moesin’s reversible dephosphorylation necessarry to this response
from T558A. Interestingly here we don’t see the increase in migration when
inactive moesin is overexpressed. Thus it seems that particular response is
unique to uPA-integrin-VN based chemotaxis. The physiological response is
that alternate mechanisms possibly exists to phosphorylating moesin without
PIP2 stabilisation. There could as well be interplay with merlin and other ERM
proteins in the heterodimer formation. It has to be borne in mind that merlin
has higher affinity to moesin’s monomer than its own. These are open ques-
tions which will provide interesting insight to further workings.
7.4.7 Angiogenesis employs moesin mediated mechanisms
7.4.7.1 Moesin overexperssion increase angiogenic tube length
Functionally, studies into migration has implications in angiogenesis. Angio-
genesis utilises invasive response of the cell, as well digestion of ECM and
proliferation. We found T558D moesin having high angiogenic potential (tube
length) (Figure 6.9), in a one dimensional environment of just collagen. We did
not use Matrigel® in this particular study as it contains many different growth
factors. By using such a one dimensional study we were able to tease out how
moesin overexpression alone affects tube length. Interestingly we found T558D
quite high in its angiogenic potential. This was interesting, as we found re-
versiblity of moesin’s phosphorylation quite important in earlier studies with
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respect to migration. Angiogenesis utilizes multiple functions of a cell to in-
vade, migrate, proliferate and grow. We know from chapter 3 that moesin is
phosphorylated in the nucleus when mechanically stimulated (Figure 3.2). It
might be that phosphorylated moesin is proliferative. There are studies that
corroborate the proliferative response of moesin (Lee et al., 2009). Nevertheless
there needs a better understanding of moesin’s phosphorylation status with
respect to angiogenesis. This is necessary for any targeted therapeutic applica-
tion. The studies have shown moesin overexpression to be angiogenic.
7.4.7.2 Delineation of uPA-moesin interaction with respect to angiogenesis
In the following experiment (Figure 6.10), we investigate what responses from
migration studies hold true. The studies clearly show moesin is highly angio-
genic when interacting with uPA. T558D, when interacting with uPA is unable
to proliferate similar to full length functional moesin when overexpressed. The
change though not as dramatic as we see in migration independently, it is still
significant. It is a substantial decrease compared to the previous study where
there was no uPA (Figure 6.9).
It has to be also noted that matrigel on its own also contain some uPA. As
previously stated, our lab has shown migration and tube formation to be mod-
ulated via G-coupled receptors with cyclic strain. The reasonwe chosematrigel
in this experiment was to decipher the therapeutic potential of moesin-uPA
interaction. Matrigel is derived from tumour, specifically Engelbreth-Holm-
Swarm (EHS) mouse sarcoma. They are rich in extracellular matrix proteins
and the major components are laminin, followed by collagen IV, heparan sul-
fate proteoglycans, entactin/nidogen http://www.bdbiosciences.ca (Adini et al.,
2009; Ribatti, 2009; Teklenburg and Macklon, 2009). Thus, they provide patho-
physiological relevance in understanding metastasis, and angiogenesis in a tu-
mour.
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7.4.8 Barrier integrity with endothelial injury, recruit the uPA-
moesin cytoskeletal remodeling apparatus
Further to this we decided use permeability assay as a means towards under-
standing the time scale of transient change in cytoskeletal architecture associ-
ated with uPA addition. It has been previously shown that with thermal injury
both tPA and uPA levels are increased. Further to this the investigators found
increased permeability in-vivo in the brain of mouse with respect to water re-
tention (Patel et al., 2008).
Figure 7.6: Moesin is a critical requirement for uPA mediated functions
Moesin is critical requirement for uPA mediated functions, such as migration,
angiogenesis, endothelial barrier integrity. The main mode of transduction in-
volve dephosphorylation of moesin. The transducers that co-act with uPAR
are integrins (either αvβ3 or α5β1) and FPRL1. The resulting reshuffle of the
cytoskeleton moulds the cell towards a migratory phenotype.
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Figure 7.7: Answering the moesin-uPA questions
The results show how moesin dephosphorylation is effected, by both acute
stretch and uPA. Strainwe have shown utilize RGD-sensitive integrins to trans-
duce their signals. Meanwhile, uPA we find utilize either α5β1 integrins or
αvβ3 integrins (both of whom are RGD-sensitive). uPA signaling we find is
also transduced via FPRL1. Though the partners responsible for moesin de-
phosphorylation with respect to uPA is still lacking, we have shown Rho A
and microRNA regulation with stretch.
7.4.8.1 Moesin and uPA both independently regulate endothelial cell’s per-
meability
We find that on addition of uPA, the permeability in fact decrease in HAECs
(Figure 6.11A). Interestingly moesin overexpression also tightens the endothe-
lial barrier (Figure 6.11B).
As explained in the introduction, in a quiescent monolayer of endothelium,
there is very little uPA or moesin (Reidy et al., 1996; Batchelor et al., 2004). In an
injured model, concurrent to uPA increase cytoskeletal proteins also increase.
We had previously discussed how moesin (Figure 3.1) and uPA both increase
with onset of cyclic strain (Sweeney et al., 2004; Von Offenberg Sweeney et al.,
2005). Moesin and uPA interaction is critical to migration. Thus in an injured
model, wherein the endothelial cells would be sparse, both uPA and moesin
would be increased. Also this rise in their expression will occur with mechan-
otransduction.
7.4.8.2 In injured endothelium andwith cyclic strain, both uPA andmoesin
interact and regulate endothelial cell junctional integrity
Towards identifying uPA-moesin interaction in a confluent monolayer, moesin
was overexpressed, further to which uPA was added. Here we see the tran-
sient effect of moesin uPA interaction, first identified to be important in mi-
gration. We deemed this transient phosphorylation critical in angiogenesis as
well. The study (Figure 6.12)(Figure 6.13), show that they do interact with re-
spect to permeability. Interestingly, we also have insight into the timescale of
their interaction (change at 1.5h post uPA addition, reversal steadily starting at
2 h.
A study reflecting increase in one protein fail to reflect in-vivo models, as
seen from our study where uPA alone actually tighten the permeability. The
latter study, meanwhile show how in injured endothelium, where both moesin
and uPA increase, transient dephosphorylation of moesin is critical to final loss
of permeability as seen in the in-vivo study.
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Further to this, we were able to use this assay to understand the time scale
of cytoskeletal shuffle associated with uPA increase, in an injured model rela-
tive to a single variable.
7.4.9 Conclusion
Moesin and uPA modulate cell fate decisions, such as migration, angiogene-
sis, barrier integrity. Cytoskeletal remodeling is specifically required to mould
the cells towards this purpose. Moesin we find, is critically involved in these
processes.
There is also requirement for moesin dephosphorylation in effecting these
functions. Furthermore, we have identified uniquemechanisms involving FPRL1
and RGD-specific integrins as transducers. We have also delineated their dif-
ferential requirement off moesin. Additionally we strongly speculate moesin
involvement in integrin inside-out signaling.
7.4.10 Brief summary and future studies
Moesin, we find through investigation into different aspects of a vasculature to
be an absolute necessity in its physiological functioning. Moesin is amechanosen-
sitive element and is regulated by microRNA. It is the atheroprotective ERM
cousin and the major mechanically sensitive ERM protein in endothelial cells.
Unlike ezrin, moesin is also subtlety sensitive to thrombosis and haemostasis
with respect to EMPs. This is because of its sensitivity to thrombin unlike ezrin.
Moesin we find is important to EMP release with respect to microRNA reg-
ulation. The major transducers of stimuli to moesin via uPAR receptor are
FPRL1 and either αvβ3 or α5β1 integrins. Moesin meanwhile is up regulated
with mechanotransduction via integrins. This was proven with RGD contain-
ing pronectin relative to fibronectin matrix. Cell-cell contact is important for
moesin, wherein, in static sub−confluent cells moesin is expressed highly. We
still find moesin responsive in sub−confluent cells, implicating integrins.
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Moesinwe also demonstrate as a necessity in effectingmigration, angiogen-
esis and barrier integrity of endothelial cells. Biochemically, moesin dephos-
phorylation is demonstrated as as a prerequisite to cell mechanics, including
migration and mechanotransduction.
This biochemical response we find is regulated by Rho A antagonism. We
find the dephosphorylationmechanism also regulated bymicroRNAs. Through-
out the research we highlight the importance of microRNA in all facets of vas-
cular functioning. We demonstrate its global regulation of mechanotransduc-
tion, endothelial microparticle generation and endothelial cell proliferation. As
illustrated in the discussion, the research also endeavor throughout to show-
case other lateral aspects of the study.
For translating the research for bench to bedside therapeutics, utilization of
d2a-ala peptide (Degryse et al., 2005) and phopho-mimetic moesin constructs
are obvious candidates. Localized treatments such as utilization in stents to
avoid restenosis are some immediately obvious low risk ventures. Moesin and
uPA as appreciated earlier, is highly expressed in injured vasculature prone
to restenosis (Blindt et al., 2002). Our understanding of the synergistic uPA-
moesin interaction could be thus exploited. Metastasis is also an obvious tar-
get.
Furthermore, we have shown EMP release is also an important tool in di-
agnostics. Characterization of ERM signature, i.e, the ratio of ezrin, radixin,
moesin in EMPs physiologically could yield insightful information. Further-
more, this ERM signature could be translated into identifying eventual progress
into arteriosclerosis.
HIV entry has appreciated earlier, has been shown to involvemoesin. Moesin
overexpressionwas found to downregulate the formation of stablemicrotubules,
whereas knockdown ofmoesin increased stablemicrotubule formation (Naghavi
et al., 2007). Viral entry meanwhile, required the stabilization of the micro-
tubules. Studies have noticed enhanced HIV infection with moesin knock-
down. At the molecular level, we show FPRL1 transducing signals toward
moesin via uPAR (SRSRY)-uPA . FPRL1 has been found to be a highly effi-
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cient coreceptor for human immunodeficiency virus (Nobuaki et al., 2008). As
microtubule stabilization is favoured for HIV entry, understanding uPA medi-
ated effects on microtubules via moesin is significant. This might even lead to
an unprobable but possible drug eg:- either uPA or d2a-ala, depending on the
effects. uPA has to be noted, is already a Food and Drug Administration (FDA)
approved drug (http://www.fda.gov). This additionally mean, clinical studies
and translative research borne from this research could be expedited.
More complex approaches possibly involve biomedical engineering for ar-
tificial grafts to utilize ERMproteins. Further understanding of themicroRNAs
involved could lead to novel therapeutics. Designer EMPs that might enable
delivery, targeted antigen presentation, novel vaccination techniques. These
though require thorough studies for understanding risks involved, and in-vivo
studies will have to be undertaken. This will provide the holistic response to
anymode of treatment. Moesin dynamics, nevertheless holds promise in many
facets of cardiovascular and other pathogenesis. Our understanding of it has
taken it that little forward towards this.
7.4.10.1 Further studies
The immediate step will be to translate our understanding of moesin into an
in-vivo model. Further to which, understanding its clinical implications will
be more obvious. There are as well some gaps in our understanding of the
study. These include, specific knowledge of the integrins involved with our
study. We did show α5β1 integrins and αvβ3 involvement. Studies previously
conducted by Ronan Murphy (personal communication) has ruled out a role
for β3 integrin subunit.
Meanwhile, involvement of α5β1integrin could be verified by means of
specific antibodies. These antibodies would recognize activated α5β1integrins.
Overexpression studies with various constructs of moesin will also lead eluci-
dation of α5β1integrins’s activation (Michael et al., 2009). Similarly, β3 integrin
subunit activation with respect to moesin biochemistry (with its various con-
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structs) could be verified and confirmed by utilizing similar antibodies against
β3 integrin subunit (Byron et al., 2009).
Moesin constructs could be also utilized with respect to understanding G
actin and F actin ratios. microRNA regulationwith respect to their ratios, align-
ment with mechanotransduction will yield insightful data. We have also iden-
tified twomicroRNAs (with respect to moesin verified by in-silico) regulated by
mechanotransduction. These could be verified by knock out-knock in studies
(of the microRNAs).
Specific requirement of moesin in endothelial cell proliferation is lacking in
our study. Similar lack of understanding could be seen in migration studies.
siRNA studies with respect to moesin would yield this information.
We also speculate, moesin involvement in inside out signaling with respect
to uPA-moesin interaction. Previously appreciated studies with respect to in-
tegrin activation, could demonstrate inside out signaling mediated by moesin.
The possibility for furthering these studies is limitless, with many interac-
tions (Figure 1.10) occurring in the minute cell. Expanding this knowledge at
the basic level, would at least appeal to our curiosity.
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The list below, identify studies that would further expand our understanding
of moesin dynamics, in the cardiovascular system with relevance to research
here.
Cell Fractionation: Cytoskeleton, Membrane fraction in addition to cytosol
and nuclear fractions
F actin and G actin ratio
This study gives important insight into the F actin/G actin ratio. Below
is enumerated different parameters which will further compliment the study
conducted so far. Towards this a luciferase reporter based system is currently
being characterized.
1. Comparison with ezrin construct for differentiating microparticle forma-
tion with respect to actin change in contrast to moesin.
2. siRNA against moesin.
3. With moesin constructs.
4. Above studies with thrombin and ionophore.
5. uPA and SRSRY interaction (siRNA moesin).
6. Dicer siRNA.
HUTS4 and WOW1 studies
As discussed in the thesis, specific integrin activation due to moesin is still
largely unknown. We have shown αvβ3 or α5β1 mechanistics involved with
respect to uPA-Moesin interaction. Antibodies that target activated integrins
β1 or β3 utilizing HUTS4 and WOW1 respectively this information. Given be-
low are parameters that will compliment this information further to this thesis.
1. siRNA against moesin
2. With moesin constructs , Static versus Strain with Moesin GFP
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3. uPA and SRSRY interaction (siRNA moesin)
Strain induced migration
As shown in chapter 3, the first results chapter, we find cyclic strain induc-
ing dose dependent cell migration. Though, it compliments our study with
urokinase, it lacks specific information with regard to moesin. Thus repeating
the study utilizing moesin knocked out cells would yield interesting insights.
1. siRNA against moesin, cyclic strain induced migration
Dicer siRNA
We have discovered potential regulation of Rho A with microRNAs. This
though obvious, needs information regarding active Rho A (and Rac1). We are
currently utilizing Elisa based system to yield information to this regard.
1. RhoA and Rac1 Elisa
Human study
From our studies on microparticles from exercise induced subjects, shear
stress show its induction. Further to exercise, we find clearance of microparti-
cles post 2h. Thus understanding the proteins expressed in microparticles will
help us understand the clearance mechanism.
Furthermore, we have already shown moesin in EMPs. Thus study on hu-
man subjects, further to isolation of the microparticles will help us elucidate
this mechanism further. Ultimately, a proteomics based approach will help us
deduct the diagnostic importance of specific proteins in MPs.
1. Endothelial microparticles, moesin western
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Thrombin
From our studies we found moesin sensitive to thrombin, unlike ezrin to-
wards microparticle release. This proposed study will help us understand
the significance of thrombin-moesin interaction in MP release. We had dis-
cussed earlier that moesin has been shown to be acutely sensitive to thrombin
(Shcherbina et al., 1999b). Furthermore thrombin induces a differential signal-
ing route in releasing MP release (Sap, 2006).
1. Moesin siRNA and its effect on endothelial microparticle release with
thrombin
PhosphoERM Imaging
To compliment our studies that showmoesin phosphorylation-dephosphorylation
requirement, imaging utilizing specific antibodies could be conducted.
1. Cyclic strain
2. Microparticles via thrombin, ionophore
3. Effect of uPA, SRSRY
Immunoprecipitation
Towards understanding binding partners of moesin-uPA interaction, im-
munoprecipitation would be an important tool. This would involve pulling
down moesin-GFP post induction of uPA using GFP specific antibody. Further
to this approach mass spectrometry could be utilized towards identifying the
binding partners compared to control.
1. Moesin constructs with uPA bound to dynal beads
Ibidi Y slide: disturbed and normal flow areas
Further to our study with Ibidi in chapter 3, more studies with Ibidi Y slide
will provide a platform to investigate areas of the vasculature with bifurcation.
Below are enumerated the parameters that will compliment the thesis.
1. Global actin change siRNA moesin
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2. Ezrin, Moesin GFP or FLAG tag
3. Dicer siRNA
4. Elucidating signaling requirements using different moesin constructs to-
wards global actin change with flow
Shear and cyclic strain
Our studies have mainly focussed on moesin. A derivative of this study
would be to understand Ezrin andMerlin withmechanotransduction. We have
opened up questions, that are discussed in the earlier chapter with regard to
other FERM domain containing proteins. Importantly, the relevance of differ-
ential ERM regulation with mechanical stimuli would be interesting to know.
A starting point would be to characterize using western blotting. Specifically
to the thesis understanding Ezrin protein expression during mechanical stim-
uli alone would suffice.
1. Protein expression of Ezrin, Merlin
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